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This Second Evaluation Report on the Massachusetts capitated model demonstration 
under the Medicare-Medicaid Financial Alignment Initiative, called One Care, is one of several 
reports that will be prepared over the coming years to evaluate the demonstration. The Centers 
for Medicare & Medicaid Services (CMS) contracted with RTI International to monitor the 
implementation of the demonstrations under the Financial Alignment Initiative, and to evaluate 
their impact on beneficiary experience, quality, utilization, and cost. 
This report uses a variety of data sources to analyze One Care’s impact. It provides 
qualitative updates on the implementation of the demonstration for the second and third 
demonstration years (calendar years [CYs] 2015 and 2016), with relevant updates through early 
2017. The report describes the demonstration’s key features; the policies, administrative 
processes, and strategies the State adopted as it implemented the demonstration; and successes 
achieved and challenges encountered. Specifically, this report addresses the demonstration’s 
approach to integrating the Medicare and Medicaid programs; providing care coordination to 
enrollees; enrolling beneficiaries into the demonstration; and engaging stakeholders in the 
oversight of the demonstration. We also provide impact analyses using enrollment and 
encounter/claims data, analyses of service utilization patterns and quality metrics using both pre-
demonstration and demonstration periods from October 1, 2011 to December 31, 2015. We also 
provide a summary of preliminary findings related to Medicare savings results through the 
second demonstration year, January 1, 2015 through December 31, 2015 (therein, demonstration 
year 2). Demonstration year 3 refers to the January 2016 through December 2016 timeframe.  
Demonstration Overview  
The One Care demonstration is a capitated model of service delivery in which CMS, the 
Commonwealth of Massachusetts (the Commonwealth), and Medicare-Medicaid Plans (MMPs) 
enter into three-way contracts to provide comprehensive, coordinated care for eligible 
beneficiaries. One Care is the only demonstration under the Financial Alignment Initiative that 
limits enrollment to Medicare-Medicaid beneficiaries age 21 to 64 at the time of enrollment. 
Approximately 105,000 Medicare-Medicaid beneficiaries in Massachusetts were eligible for and 
over 14,000 enrolled in the demonstration as of December 2016. The demonstration operates in 
nine of the Commonwealth’s 14 counties.  Initially, the demonstration was served by three 
MMPs, but one withdrew from participation as of September 30, 2015. The demonstration was 
initially authorized through December 31, 2016; CMS, MassHealth, and the remaining two 
MMPs executed a contract amendment on July 5, 2016, that extended the demonstration by 2 
years. On January 19, 2017, CMS sent a letter to MassHealth offering an extension through 
December 31, 2020, and in response, Massachusetts submitted a non-binding letter of interest to 
CMS. Updates on the anticipated extension will be included in the next report.  
1
Since initial implementation, eligibility for and the overall design of One Care has not 
changed significantly. One Care continues its aim to deliver member-centered, coordinated, and 
culturally competent care. Of the changes that were made to One Care since the last evaluation 
                                                 
1 In Plymouth County, One Care is not available in the towns of East Wareham, Lakeville, Marion, Mattapoisett, 
Wareham, and West Wareham.  
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report, most have affected financing and other operational aspects. For example, in the fall of 
2016, CMS and the Commonwealth agreed to allow passive (automatic) enrollment in counties 
where only one MMP operates and in counties only partially served by the demonstration; this 
had not been permitted previously.  
Integration of Medicare and Medicaid  
Joint management. The One Care demonstration integrates Medicare and Medicaid into 
a unified set of benefits. The Contract Management Team (CMT) is the primary vehicle for joint 
management by CMS and MassHealth and includes staff from both organizations. Operational 
CMT staff are involved in day-to-day oversight, and policy CMT staff focus on the policy issues 
impacting the demonstration. Officials from both CMS and MassHealth reported close 
collaboration at all levels of the CMT and described it as an effective vehicle for co-
management. 
Integrated delivery systems. The demonstration was initially served by three MMPs. 
One of the three, Fallon Total Care (Fallon), withdrew its participation effective as of September 
30, 2015. The remaining two MMPs, Commonwealth Care Alliance (CCA) and Tufts Health 
Unify (Tufts), have signed a contract amendment extending the demonstration through 
December 31, 2018. Starting on February 1, 2017, Tufts expanded its coverage area to include 
portions of Middlesex County.  
MassHealth and other stakeholders report that the One Care model provided the 
opportunity and incentive for One Care plans to institute new or expanded services. Additionally, 
MassHealth has continued to invest in the development of webinars, educational sessions, and 
other trainings to support MMPs and other providers, in recognition that the underlying 
principles of One Care are consistent with larger reforms to enhance integrated and person-
centered care.  
The integration of Commonwealth-level Medicaid policies, procedures, and systems with 
Federal-level Medicare policies, procedures, and systems introduced a significant amount of 
complexity and effort into operational implementation and service delivery at both the 
Commonwealth and MMP level. Some stakeholders and MMP representatives noted that certain 
aspects of the demonstration were not fully integrated as designed. Regardless of its complexity, 
CMS, MassHealth, MMPs, and other stakeholders continue to show strong support for the 
demonstration and its key goal of integration. MassHealth officials emphasized that despite the 
challenges, Massachusetts did not regret its decision to go forward with the One Care 
demonstration. One MassHealth official noted that integrating Medicare with Medicaid was 
“critical” to the success of the care model for One Care, which primarily serves Medicare-
Medicaid beneficiaries under the age of 65.  
Eligibility and Enrollment 
Generally, beneficiaries can opt into the demonstration or be passively (automatically) 
enrolled. However, enrollment limits were in place for part of the period covered in this report. 
Although passive enrollment had been anticipated for the second half of demonstration year 2 
(CY 2015), the process was delayed after Fallon reported that it would be withdrawing from One 
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Care effective September 30, 2015. Although officials from Fallon expressed support for the 
demonstration’s integrated care model, they also reported on-going financial concerns that led to 
a decision to withdraw from the demonstration. The next phase of passive enrollment into One 
Care did not occur until demonstration year 3 (CY 2016). Beneficiaries could continue to opt 
into the demonstration during CY 2015, but the opt-in process was severely restricted by 
enrollment caps during the second half of that year. All enrollment caps were lifted in CY 2016. 
Following Fallon’s announcement in June 2015, MassHealth, CMS, and Fallon 
developed a plan to transition Fallon enrollees to other Medicaid and Medicare service options. 
Although some beneficiaries transitioned to another One Care MMP, most returned to the FFS 
system, thereby decreasing overall enrollment in the demonstration. MassHealth, CMS, and 
stakeholders described the transition process as highly collaborative, with all parties trying to 
ensure adequate communication and minimum disruption to enrollees. 
A total of three passive enrollment phases occurred in 2016. MassHealth and CMS 
initiated quarterly passive enrollment phases beginning in January 2017. These quarterly phases 
target newly eligible Medicare-Medicaid beneficiaries as well as other eligible beneficiaries. 
Additionally, CMS and MassHealth amended enrollment guidance in late 2016 to allow for 
passive enrollment in counties where only one MMP participates and in counties only partially 
covered by the demonstration. As of December 1, 2016, enrollment in the demonstration totaled 
approximately 14,300 beneficiaries. Total enrollment in One Care increased to slightly over 
16,000 beneficiaries as of January 1, 2017 due to additional passive enrollment.  
Care Coordination  
Care coordination is a hallmark of the One Care delivery model and is integral to helping 
beneficiaries access the full spectrum of needed services and to improving quality and ultimately, 
reducing costs. Both MMPs reported improved assessment processes due to lessons learned from 
early implementation experiences and, in part, due to lack of passive enrollment in 2015. Both 
MMPs reported better results reaching and engaging new enrollees by using staff to research the 
whereabouts of new enrollees or community outreach workers to reach and engage them. 
MassHealth officials, many stakeholders, and MMP representatives reported that as the 
demonstration matured, the focus on care coordination and care planning increased. MassHealth, 
MMPs, and other stakeholders cited examples in which the assessment and integrated care 
planning between behavioral health and medical care had improved beneficiaries’ health.  
Stakeholder Engagement  
Stakeholder engagement has been a critical component of the One Care demonstration 
from its inception, and a robust level of engagement has continued from earlier years. Since One 
Care’s inception, MassHealth has held meetings open to the public to present and discuss issues 
relevant to the demonstration. MMPs are required to establish Member Advisory Boards 
(MABs) at the plan level. The MMPs have reported that the feedback and input they receive 
from enrollees participating on their MABs has been valuable not only in identifying issues and 
concerns but also in helping to improve services and their delivery.  
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The design of One Care includes an Implementation Council that consists of up to 21 
members.  Implementation Council members highlighted two key successes in demonstration 
year 2: (1) the level of collaboration with MassHealth and others to achieve a smooth transition 
for members affected by the withdrawal of Fallon from the demonstration, and (2) effective 
advocacy that achieved greater financial stabilization for the MMPs remaining in the 
demonstration.  
2
Financing and Payment 
All covered Medicare and Medicaid services are paid on a capitated basis. In addition to 
the capitation rates, the demonstration incorporates other reimbursement methodologies, 
including savings percentages and risk corridors. From the outset, MassHealth officials, MMPs, 
and stakeholders reported concerns about the adequacy of the demonstration’s financing. In the 
first 18 months of operation, all three MMPs reported losses. This loss was a key factor in 
Fallon’s decision to withdraw from the demonstration as of September 30, 2015.  
The financial status of the remaining MMPs improved after changes for rate years 2015 
(retrospectively) and 2016 were made following a contract amendment executed in December 
2015. Changes included updating the Medicare Parts A & B and MassHealth components of the 
rate, eliminating savings percentages, and reducing the quality withhold percentages. Another 
contract addendum, executed July 5, 2016, extended the demonstration through December 31, 
2018, and specified quality withhold amounts, savings percentages and risk corridors for the 
additional 2-year period. Stakeholders and officials from MassHealth and CMS reported that 
these changes helped improve One Care’s financial stability.  
Based on financial data provided by the MMPs to MassHealth, the average per member 
per month (PMPM) spend for demonstration year 2 was $2,560 for CCA and $1,952 for Tufts, 
increases from demonstration year 1 of 16 and 30 percent, respectively. In part, MassHealth and 
officials from the MMPs attributed this change to increased complexity of beneficiaries enrolled 
in the demonstration. MassHealth officials and others reported preliminary indications of some 
returns on the early investments in the care model. In demonstration year 3, the PMPM service 
spend was $2,783 for CCA and $2,468 for Tufts, representing increases of approximately 9 
percent and 26 percent from demonstration year 2, respectively. 
The results of preliminary Medicare cost savings analyses using a difference-in-
differences regression approach do not indicate savings or losses due to the Massachusetts 
demonstration. Neither savings nor losses were identified in either demonstration year 1 or 
demonstration year 2. The costs savings analyses do not include Medicaid data due to current 
data availability, but these data will be incorporated into future calculations as they become 
available.  
Quality of Care 
MMPs are required to report on several quality measures; some are core to all 
demonstrations under the Financial Alignment Initiative, and others are specific to One Care. In 
the first year of the demonstration, MassHealth reported that a key quality oversight challenge 
                                                 
2 Please see the first Annual Report for additional information on the Implementation Council.  
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was a lack of sufficient data; the demonstration had not yet matured to the point where data were 
available. As the demonstration matured, the challenge shifted from data collection to achieving 
meaningful data measurement. Although MassHealth and MMP officials are now able to report 
data on these measures, they noted that it was still too early to draw any conclusions or identify 
trends from the data, especially given the small sample of beneficiaries reported for some 
measures.  
An additional quality measurement challenge arose due to One Care’s eligibility being 
limited to Medicare-Medicaid beneficiaries under the age of 65 at the time of enrollment. 
Because all other demonstrations under the Financial Alignment Initiative also include 
beneficiaries age 65 and older, MassHealth and MMPs have had difficulty finding adequate 
benchmarks for the unique population served by One Care.  
The Implementation Council has continued to play a key role in monitoring access to 
health care and compliance with the Americans with Disabilities Act (ADA), tracking quality of 
services, and promoting accountability and transparency. The One Care Ombudsman (OCO) 
program is responsible for providing independent advocacy on behalf of beneficiaries and for 
identifying broader systematic issues impacting quality of care. The MMP MABs also provide 
feedback on demonstration management issues and quality of enrollee care. 
Beneficiary Experience 
One of the main goals of the demonstration is to improve the experience of beneficiaries 
who access Medicare and Medicaid services. Data sources on beneficiary experience include 
Consumer Assessment of Healthcare Providers & Systems (CAHPS) and other surveys (such as 
a Quality of Life survey); reporting on grievances and appeals; and RTI evaluation team 
interviews. Additionally, RTI conducted three focus groups in February 2016.  
Generally, MassHealth and MMP officials, as well as other stakeholders, reported 
anecdotes of positive beneficiary experiences under One Care. Many focus group participants 
reported satisfaction with One Care. Factors contributing to satisfaction included the availability 
of new benefits and assistance provided through care coordination. Focus group participants 
provided several examples of new services they are taking advantage of, including dental, 
optical, smoking cessation classes, nutrition classes, weight loss coaching, and in-home 
behavioral health services. Participants reported the elimination of pharmacy co-pays as an 
important advantage of participating in the demonstration. Additionally, most 2015 and 2016 
CAHPS survey respondents indicated that they had a favorable view of their health plan. Most 
focus group participants expressed satisfaction with their primary care providers. This is 
generally consistent with the findings of the Quality of Life survey administered to One Care 
enrollees in 2016 by MassHealth, in collaboration with the Implementation Council and the 
University of Massachusetts Medical School; over three-quarters (77 percent) of respondents 
indicated that they had good relationships with their health care and other providers (Henry et al., 
2015, 2016). Focus group feedback from One Care enrollees was mixed on whether and to what 
degree providers shared information and worked as a team.  
Focus group participants provided mixed feedback regarding the degree of provider 
choice and the ease of access to services. Several focus group participants reported quality issues 
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with non-emergency transportation that impacted access to appointments and other needed 
services. This feedback was consistent with grievance data compiled and reported by 
MassHealth which showed that from April 2015 through December 2015, at least half of all 
grievances for two MMPs pertained to transportation. Data on grievances and appeals are 
collected by the MMPs, MassHealth, CMS, and the One Care Ombudsman Program. Most 
grievances and appeals are filed directly with the MMP: from CY 2015 to CY 2016, the highest 
rate of grievances for One Care combined across MMPs was 77.4 per 1,000 enrollees, during 
quarter 4 of 2015, the quarter following Fallon’s departure from One Care. The highest rate of 
appeals was 9.6 per 1,000 enrollees during quarter 2 of 2016, two quarters following Fallon’s 
departure from One Care.  
Service Utilization Analyses  
We find evidence that the Massachusetts demonstration resulted in significant changes in 
utilization patterns, including changes in quality of care and care coordination. These include 
higher monthly inpatient admissions (including inpatient admissions for ambulatory care 
sensitive conditions [ACSC]), physician evaluation and management (E&M) visits, skilled 
nursing facility (SNF) admissions, and all-cause 30-day readmission, along with a lower 
probability of any long-stay nursing facility (NF) use and lower quarterly follow-up after mental 
health inpatient discharges. Follow-up after mental health inpatient discharges may be partially 
lower because any follow-up by a care coordinator would not be included. The demonstration 
had no impact on monthly emergency room (ER) visits overall or on preventable ER visits.  
An overview of the results from impact analyses using only Medicare and Minimum Data 
Set data is provided in Table ES-1. The direction of all statistically significant results at the 
p < 0.1 significance level (derived from 90 percent confidence intervals) is shown. Monthly 
inpatient admissions, physician E&M visits, SNF admissions, ACSC admissions (overall and 
chronic), and all-cause 30-day readmission were higher for the Massachusetts demonstration 
group than the comparison group. At the same time, the probability of any long-stay NF use and 
quarterly follow-up after mental health inpatient discharges was lower, although any follow-up 
by a care coordinator would not be included. The demonstration did not have a statistically 
significant impact on overall or preventable ER visits. The impacts of the demonstration on 
beneficiaries who used long-term services and supports (LTSS) and beneficiaries with severe and 
persistent mental illness (SPMI) followed the same pattern as the impacts for the overall 
demonstration eligible population. 
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Table ES-1 
Summary of Massachusetts demonstration impact estimates for demonstration period 
(October 1, 2013, to December 31, 2015) 










Inpatient admissions Increased Increased Increased 
Ambulatory care sensitive condition 
(ACSC) admissions, overall  
Increased Increased Increased 
ACSC admissions, chronic  Increased Increased Increased 
All-cause 30-day readmission  Increased Increased Increased 
Emergency room (ER) visits NS NS NS 
Preventable ER visits NS NS NS 
Quarterly follow-up after mental health 
discharges 
Decreased Decreased Decreased 
Skilled nursing facility (SNF) admissions Increased Increased Increased 
Probability of any long-stay nursing 
facility (NF) use 
Lower N/A N/A 
Physician evaluation and management 
(E&M) visits 
Increased Increased Increased 
LTSS = long-term services and supports; N/A = not applicable; NS = not statistically significant; SPMI = severe and 
persistent mental illness. 
SOURCE: RTI analysis of Medicare and Minimum Data Set data. 
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1. Evaluation Overview 
1.1 Purpose 
The Medicare-Medicaid Coordination Office (MMCO) and the Innovation Center at the 
Centers for Medicare & Medicaid Services (CMS) have created the Financial Alignment 
Initiative to test, in partnerships with States, integrated care models for Medicare-Medicaid 
beneficiaries. CMS contracted with RTI International to monitor the implementation of the 
demonstrations under the Financial Alignment Initiative and to evaluate their impact on 
beneficiary experience, quality, utilization, and cost. This report includes qualitative evaluation 
information for the second and third demonstration years (calendar years [CYs] 2015 and 2016, 
respectively), with relevant updates from early 2017. This report provides updates to the first 
Annual Report in key areas, including enrollment, care coordination, beneficiary experience, and 
stakeholder engagement activities, and discusses the challenges, successes, and emerging issues 
identified during the reporting period. Results on quality of care, service utilization, and costs for 
the entire predemonstration and demonstration periods spanning October 1, 2011 to 
December 31, 2015 are also presented. 
The first Annual Report, which includes extensive background information about the 
demonstration, can be found here: https://www.cms.gov/Medicare-Medicaid-
Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/Downloads/MASSFirstAnnualEvalReport.pdf. 
1.2 Data Sources 
Data sources used to prepare this report include the following. 
Key informant interviews. The evaluation team conducted site visits in the 
Commonwealth of Massachusetts (the Commonwealth) in June 2016. The team interviewed the 
following individuals either during the site visits or during follow-up phone calls: 
Commonwealth officials, including MassHealth (Massachusetts’ Medicaid program) policy 
leaders, operations and contract staff, quality management staff, data staff, and representatives 
from other Commonwealth agencies; officials from CMS’ regional and central offices; 
representatives from One Care Medicare-Medicaid plans (MMPs); representatives from 
community-based organizations (CBOs), including the Independent Living Centers (ILCs), 
Recovery Learning Communities (RLCs), and Aging Services Access Points (ASAPs); 
representatives from provider organizations; stakeholders from the Implementation Council; and 
representatives from the One Care Ombudsman program and from Disability Advocates 
Advancing our Healthcare Rights (DAAHR). To monitor demonstration progress, the RTI 
evaluation team also engages in additional periodic phone conversations with officials from 
MassHealth and CMS.  
Focus groups. The RTI evaluation team conducted three focus groups in Massachusetts 
specific to racial or ethnic minorities. One focus group for Hispanic participants was held in 
Holyoke on February 3, 2016. Two other focus groups were held in Springfield on February 4, 
2016, one group for Hispanic participants and another for Black participants. A total of 12 One 
Care enrollees participated in the focus groups.  
2 
Surveys. Medicare requires all Medicare Advantage plans, including One Care plans, to 
conduct an annual assessment of beneficiary experiences using the Medicare Advantage 
Prescription Drug Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey 
instrument. In addition, the RTI evaluation team added 10 supplemental questions to the CAHPS 
survey and MassHealth added nine questions. This report includes survey results for a subset of 
the 2015 and 2016 survey questions. Findings are available at the MMP level. The frequency 
count for some survey questions may be suppressed because too few enrollees responded to the 
question. Comparisons with findings from all Medicare Advantage plans are available for core 
CAHPS survey questions but not for the RTI supplemental questions. Survey response rates 
varied by plan as follows: Commonwealth Care Alliance, 2015—28 percent, 2016—29 percent; 
Fallon Total Care, 2015—22 percent, 2016—not applicable; Tufts Health Unify, 2015—27 
percent, 2016—21 percent. 
This report also includes data from the 2015 and 2016 Quality of Life surveys conducted 
by MassHealth in collaboration with the Implementation Council and the University of 
Massachusetts Medical School. The 2015 survey was administered by mail and phone to a 
random sample of 600 One Care enrollees and had a response rate of 29.3 percent. The 2016 
survey was administered by mail with telephone follow-up for non-responders to a random 
sample of 800 One Care enrollees and had a response rate of 35.2 percent.  
Demonstration data. The RTI evaluation team reviewed data provided quarterly by 
Massachusetts through the State Data Reporting System (SDRS). These reports include 
eligibility, enrollment, opt-out, and disenrollment data, and information reported by 
Massachusetts on its integrated delivery system, care coordination, benefits and services, quality 
management, stakeholder engagement, financing and payment, and a summary of successes and 
challenges.  
Demonstration policies, contracts, and other materials. The RTI evaluation team 
reviewed a wide range of demonstration documents, including demonstration and state-specific 
information on the CMS website;3 and other publicly available materials on the Massachusetts 
One Care website and the Massachusetts Executive Office of Health and Human Services 
(EOHHS) website.  The RTI evaluation team reviewed available minutes and presentations from 
MassHealth Open Meeting  and Implementation Council meetings.   65
4
Complaints and appeals data. Complaint (also referred to as grievance) data are from 
three separate sources: (1) complaints from beneficiaries reported by One Care plans to 








  3 
Chicago (hereafter referred to as NORC);  (2) complaints received by MassHealth or 1-800-
Medicare and entered into the CMS electronic Complaint Tracking Module (CTM); and 
(3) complaints received by the One Care Ombudsman (OCO) program and reported to 
MassHealth and the Administration for Community Living (ACL), the federal agency that 
provides technical assistance to Financial Alignment Initiative ombudsman programs. Appeals 
data are generated by MMPs and reported to MassHealth and NORC. This report also includes 
critical incidents and abuse data reported by One Care MMPs to MassHealth and NORC. This 
report also includes data compiled and received by the Medicare Independent Review Entity 
(IRE), Maximus, for January 2014–December 2015. 
7
Service utilization data. Evaluation Report analyses used data from many sources. First, 
the Commonwealth provided quarterly finder files containing identifying information on all 
demonstration eligible beneficiaries in the demonstration period. Second, RTI obtained 
administrative data on beneficiary demographic, enrollment, and service use characteristics from 
CMS data systems for both demonstration and comparison group members. Third, these 
administrative data were merged with Medicare claims and encounter data, as well as the 
Minimum Data Set. 
Although Medicaid service data on use of LTSS, behavioral health, and other Medicaid-
reimbursed services were either not available or not useable in current form for the 
demonstration period and therefore are not included in this report, CMS administrative data 
identifying eligible beneficiaries who used Medicaid-reimbursed LTSS were available, so that 
their Medicare service use could be presented in this report. Future reports will include findings 
on Medicaid service use once data are available. 
Cost savings data. Two primary data sources were used to support the savings analyses, 
capitation payments, and Medicare claims. Capitation payments paid to One Care plans during 
the demonstration period were obtained for all demonstration enrollees from CMS Medicare 
Advantage and Part D Inquiry System (MARX) data. The capitation payments were the final 
reconciled payments paid by the Medicare program after taking into account risk score 
reconciliation and any associated retroactive adjustments in the system at the time of the data 
pull (March 2017). Fee-for-service (FFS) Medicare claims were used to calculate expenditures 
for all comparison group beneficiaries, demonstration beneficiaries in the baseline period, and 
demonstration eligible beneficiaries who were not enrolled during the demonstration period. FFS 
claims included all Medicare Parts A and B services. 
                                                 
7 The technical specifications for reporting requirements are in the Medicare-Medicaid Capitated Financial 
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2. Demonstration Overview 
2.1 Demonstration Description and Goals 
The goals of One Care are to alleviate fragmentation of care, improve coordination of 
services, enhance quality of care, and reduce costs. Key objectives include improving the 
beneficiary experience in accessing care, delivering person-centered care, promoting 
independence in the community, improving quality, and eliminating cost shifting between 
Medicare and Medicaid (MOU, 2012, pp. 2–3). As more fully described in the first Annual 
Report, the One Care demonstration integrates the full array of functions performed by Medicare 
and Medicaid. Targeted case management services and rehabilitation option services are not 
included as part of the integrated One Care benefit; they continue to be provided as part of the 
Medicaid fee-for-service (FFS) system. As in Medicare Advantage, Medicare hospice services 
continue to be provided as part of the Medicare FFS system. Of note, One Care is the only 
demonstration under the Financial Alignment Initiative that limits enrollment to Medicare-
Medicaid beneficiaries age 21 to 64 at the time of enrollment.  Initially, beneficiaries who turned 
65 while enrolled in the demonstration could remain enrolled in One Care as long as they met 
eligibility for MassHealth Standard and continued to meet other demonstration criteria. In late 
2016, eligibility criteria for remaining in the demonstration was expanded to include enrollees 
who met criteria for MassHealth CommonHealth. Implementation of this change continued into 
2017. 
8
Approximately 105,000 Medicare-Medicaid beneficiaries in Massachusetts were eligible 
for and over 14,300 enrolled in the demonstration as of December 1, 2016. One Care operates in 
nine of the Commonwealth’s 14 counties.  Initially, the demonstration was served by three 
Medicare-Medicaid plans (MMPs), but one withdrew from participation as of September 30, 
2015. MassHealth intends to reprocure MMPs for One Care effective January 1, 2020. ,  In 
past interviews, MassHealth officials reported that they would like to see the demonstration 
formalized into a regular program beyond the demonstration phase. 
1110
9
2.2 Changes in Demonstration Design 
The One Care demonstration is a capitated model of service delivery in which CMS, the 
Commonwealth of Massachusetts, and One Care MMPs enter into a three-way contract to 
                                                 
8 Beneficiaries enrolled in any of the following programs are eligible for the demonstration only if they disenroll 
from the program and meet the other eligibility criteria: a Medicare Advantage plan; Program of All-Inclusive 
Care for the Elderly (PACE); Employer Group Waiver Plans (EGWPs), other employer-sponsored plans, or 
plans receiving a Retiree Drug Subsidy (RDS); or the CMS Independence at Home (IAH) demonstration. 
Enrollees using home and community-based services (HCBS) waiver services or residing in an intermediate care 
facility for individuals with intellectual disabilities (ICF/IDD) are not eligible to enroll (MOU, 2012, pp. 8–9). 
9 In Plymouth County, One Care is not available in the towns of East Wareham, Lakeville, Marion, Mattapoisett, 
Wareham, and West Wareham.  
10 CMS reported that its role in the reprocurement process would be limited to review and approval of any new 
plans responding to the One Care procurement; requiring reprocurement of existing MMPs is a state-level 
decision. 
11 https://www.commbuys.com/bso/external/bidDetail.sdo?docId=BD-18-1039-EHS01-EHS02-
20518&external=true&parentUrl=bid . Bid # BD-18-1039-EHS01-EHS02-20518. 
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provide comprehensive, coordinated care for eligible beneficiaries. The demonstration was 
initially authorized through December 31, 2016. CMS, MassHealth and the remaining two 
MMPs executed a contract amendment July 5, 2016 extending the demonstration by 2 years.  
Since initial implementation, eligibility and the overall design of the care model within the One 
Care demonstration have not changed significantly. One Care design components are described 
in detail in the first Annual Report. MassHealth officials reported that they are “still very 
confident” in One Care’s design features, although minor adjustments have been made from time 
to time. Some benefit changes have occurred, recent examples being the addition of gender 
dysphoria coverage and expanded coverage of certain medication assisted treatment in 
methadone clinics. Generally, the benefit changes are not limited to One Care, but impact other 
MassHealth beneficiaries as well. 
12
Most of the changes in One Care design that occurred since the last evaluation report 
affected financing and other operational aspects. Several changes were made to the financial 
structure of the demonstration as part of a contract amendment executed in December 2015. 
These changes will be discussed in greater detail in Section 3.5, Financing and Payment. Other 
operational changes included the extension of the demonstration through December 31, 2018. 
More recently, CMS and the Commonwealth agreed to allow passive (automatic) enrollment in 
counties where only one MMP operates and in counties only partially served by the 
demonstration.  
2.3 Overview of State Context 
Before the One Care demonstration, Medicare-Medicaid beneficiaries younger than age 
65 were not eligible to enroll in Medicaid managed care in Massachusetts.  
Massachusetts lacked a mechanism to provide comprehensive care coordination and care 
management services to Medicare-Medicaid enrollees under the age of 65 and a way to integrate 
Medicare and Medicaid payments and services. As a result, Medicare-Medicaid beneficiaries 
received long-term services and support (LTSS) services through the existing FFS system under 
the Medicaid State Plan. Services for Medicare-Medicaid beneficiaries included a personal care 
services benefit delivered through a participant-directed delivery model only. Some beneficiaries 
may have received services in a Program of All-Inclusive Care for the Elderly (PACE), which 
serves people age 55 or older. Many One Care beneficiaries were also not eligible for existing 
1915(c) home and community-based services (HCBS) waivers. 
MassHealth officials reported that One Care represented a learning experience in 
effectively serving individuals with complex needs. As one official reported: 
From the very beginning, or before the beginning really, we knew that it was 
going to be unique to any experience we had ever had before, and it was…. It’s 
been a very, very challenging program, challenging in good ways and bad ways 
for us. In a good way it’s really kind of pushed us in our delivery system concept. 
                                                 
12 By letter dated January 19, 2017, CMS offered Massachusetts, along with Washington and Minnesota, the 
opportunity to extend the demonstration for an additional 2 years, through December 31, 2020. Massachusetts 
submitted a non-binding letter of intent to pursue the extension, which will be covered in greater detail in the 
next evaluation report.  
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It was the most advanced delivery system approach that we had really taken in our 
managed care book ever. We were pretty ambitious with that. I think that paid off 
for us. That is the way we wanted this program to be. We wanted it to push and it 
has pushed the system for us. And when we get into that question of ‘how does 
this fit into the bigger picture,’ you'll see that it’s really the model that we’re 
using to move and to how we approach folks with complex needs and integrated 
care, generally speaking.  
MassHealth officials reported leveraging this experience into other, broader MassHealth 
reforms. In June 2016, MassHealth submitted an amendment to its 1115(a) MassHealth 
demonstration waiver to CMS that outlined restructuring of the MassHealth care delivery system 
and creating Medicaid Accountable Care Organizations (ACOs) as a new option alongside its 
current Primary Care Clinician (PCC) Plan and Managed Care Organization (MCO) program for 
the mandatory managed care population. The intent of the new delivery system is to promote 
integrated, coordinated care and to hold providers accountable for quality and total cost of care, 
with an explicit focus on establishing a behavioral health system that improves outcomes and 
coordination of care, including for members with serious mental illness and co-morbid 
conditions. Although Medicare-Medicaid beneficiaries are not included in the ACO initiative, 
MassHealth officials reported that experiences with One Care factored into the ACO design. For 
example, ACOs and MCOs share the principles of One Care, to provide member-centered, 
coordinated, and culturally competent care.  As described by one MassHealth official: 13
Our new 1115 [waiver] is predicated on the idea that our managed care programs, 
including One Care and SCO,  are to be expanded…I see us almost having 
doubled down on One Care, on SCO, on PACE, in our managed care book. 
14
In November 2016, CMS approved an amendment to Massachusetts’ current 1115(a) 
demonstration waiver, and a new extension of the demonstration waiver to begin in July 1, 2017. 
Pilot ACOs were launched in December 2016; full implementation of the ACO program was in 
March 2018. MassHealth also reprocured its MCOs for March 2018 and plans to bring LTSS 
into the scope of covered services for MCOs in the latter part of the 1115(a) extension period.  
                                                 
13 The 1115(a) waiver demonstration includes requests for Delivery System Reform Incentive Payment (DSRIP) 
funding for upfront investments to support delivery system transformation over five years, with explicit funding 
to build community capacity for behavioral health and LTSS providers and health-related social services. 
14 Senior Care Options (SCO) is a Dual Eligible Special Needs Plan (D-SNP) and MassHealth managed care 
program for Medicare-Medicaid beneficiaries age 65 and older at the time of enrollment.  
8 
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3. Update on Demonstration Implementation 
In this section, we provide updates on important aspects of the demonstration that have 
occurred since the first Annual Report. This includes updates on integration efforts, enrollment, 
care coordination activities, stakeholder engagement activities, financing, payment and cost 
savings, and quality management strategies.  
3.1 Integration of Medicare and Medicaid  
 
 
The One Care demonstration integrates Medicare and Medicaid into a unified set of 
benefits. From the beneficiary’s perspective, One Care is designed to integrate access to and 
delivery of services covered under both programs. From the perspectives of MassHealth, CMS, 
and MMPs, the integration of these programs depends on the alignment of policies, procedures, 
and systems at many levels. This section provides updates on joint management functions and 
integrated delivery systems.  
3.1.1 Joint Management of the Demonstration 
As described in the first Annual Report, the CMT is the primary vehicle for joint 
management of One Care by CMS and MassHealth. The CMT includes representatives from the 
MassHealth Provider and Plan Unit, MassHealth central policy office, CMS regional office 
Medicare and Medicaid staff, and representatives from the Medicare-Medicaid Coordination 
Office (MMCO). The One Care CMT includes both an operational and policy component, with 
the former more involved in the day to day oversight and the latter involved on larger policy 
issues impacting the demonstration. The operational group, known as the CMTO, changed from 
weekly to bi-weekly meetings while the policy CMT has continued to meet weekly. The CMTO 
meets separately with each MMP on a bi-weekly basis. The weekly CMT meeting generally 
includes the CMTO members as well, with many members reporting “true co-management” and 
close collaboration at all levels of the joint management team. The CMT reviews set agenda 
Highlights 
• Joint management of the demonstration has continued through the Contract 
Management Team (CMT); MassHealth and CMS continue to report a high degree of 
collaboration at both the operational and policy levels. 
• Although progress has been made in integrating Commonwealth-level Medicaid 
policies, procedures, and systems with those of Federal-level Medicare, the 
demonstration continues to be challenging to operationalize. 
• One Care fostered a relationship among the MMPs that was mostly collaborative, 
rather than competitive. 
• Strong support for the demonstration and its goals of integration continue; the 
Commonwealth initially extended the demonstration for an additional 2 years, through 
December 31, 2018, with an additional 1-year extension through December 31, 2019. 
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items, such as grievances and appeals and monitoring access to care issues, as well as ad hoc 
issues, including questions or concerns raised in discussions with the MMPs. An all-plan 
meeting is held monthly. Typically, these meetings focus on opportunities for programmatic 
enhancements and sharing of best practices. As one CMS official remarked about the MMPs: 
They have taken a really collaborative approach to sharing what they're doing in 
certain areas and are not at all taking an approach of “this is proprietary 
information and we’re using it to our competitive advantage” or anything like 
that. There has been very much a focus on wanting to ensure the demonstration 
succeeds, wanting to bring the plans up to the highest possible level rather than 
having plans performing at different levels. That’s something we've really 
appreciated. 
3.1.2 One Care Plans 
The first Annual Report describes the MMPs and information relevant to experience and 
enrollment approaches during early implementation. Since then, the most significant change 
occurred in demonstration year 2, with the withdrawal of Fallon Total Care (Fallon), one of the 
three MMPs participating in the demonstration. Fallon’s withdrawal was effective as of 
September 30, 2015 and is described in Section 3.2, Eligibility and Enrollment. Commonwealth 
Care Alliance (CCA) and Tufts Health Unify (Tufts) have signed a contract amendment 
extending the demonstration through December 31, 2018. Additionally, Tufts expanded its 
coverage area to include portions of Middlesex County effective February 1, 2017. 
3.1.3 Provider Arrangements and Services 
Requirements regarding provider networks are described in the first Annual Report. 
MMPs report that they have generally continued to reimburse most providers on an FFS basis 
because of the volatility experienced initially on the financial side of the demonstration. 
Although MMP officials reported some capitation payments and some limited incentive 
arrangements tied to utilization and quality, they noted that overall the data and care model was 
still considered too new to transition to risk-sharing arrangements. As discussed in Section 3.3, 
Care Coordination, one MMP has a long-standing relationship with several primary care and 
behavioral health and human services providers to which it delegates care coordination activities 
for approximately 18 to 20 percent of its enrollees. These providers are reimbursed on a per 
member per month basis and are provided an opportunity to earn an additional incentive based 
on meeting certain process measures, such as blood pressure and diabetes control for its primary 
care practices. 
The One Care model provided the opportunity and incentive for MMPs to develop or 
contract for new service delivery models. As noted in the first Annual Report, one MMP opened 
two new community-based residential programs as an alternative to inpatient psychiatric 
services, providing community support programs and crisis stabilization services to better serve 
individuals in a less restrictive, less costly setting. One site opened in fall 2014 at a hospital that 
had an empty wing. The other site, opened in June 2015, is a 14-bed behavioral health 
stabilization unit that is an unlocked safe place where people can be treated without needing 
hospitalization. According to one of the MMPs: 
  11 
Our inpatient utilization for behavioral health has gone down and they [One Care 
beneficiaries] are using these outside diversionary services, the day programs. 
They’ve done a great job with that so that has been a big win for the program.  
According to MassHealth and the MMP, this was possible because of the flexibility 
provided by capitated Medicare and Medicaid rates in the demonstration. 
3.1.4 Training and Support for Plans and Providers 
MassHealth has continued to invest in the development of webinars, educational sessions, 
and other training to support providers, community-based organizations (CBOs), and MMPs. 
Many of these training modules were designed by MassHealth and the University of 
Massachusetts Medical School in collaboration with providers and beneficiaries, including 
members of the Implementation Council. Topics covered in the webinars and video modules 
include: strategies for enhancing care to individuals who are homeless and to individuals with 
co-occurring mental health and substance use disorders; self-direction and independent living 
principles; promoting behavioral health privacy principles; and approaches to engaging 
beneficiaries in their own care.  MassHealth officials continued to invest resources into these 
provider trainings in recognition that the underlying principles went beyond One Care itself and 
were consistent with larger reforms to enhance integrated and person-centered care. 
15
3.1.5 Major Areas of Integration 
Integrating Commonwealth-level Medicaid policies, procedures, and systems with 
Federal-level Medicare policies, procedures, and systems introduced a significant amount of 
complexity and effort into every level of operational implementation and service delivery. 
Generally, MassHealth officials noted progress in this area but also recognized there had been 
some challenges in aligning Medicare and Medicaid requirements, with one MassHealth official 
noting, “It’s been a tough two and a half years.” As one official from a MMP remarked:  
The program is a high-touch, high-need program from the point of view of a 
Federal demonstration. I’ve been doing this kind of work for several decades and 
have never seen a program as hard to operationalize as this one. 
Others noted that certain aspects of the demonstration—including the appeals and 
grievance processes; the ability to retain separate encounter data reporting for Medicare and 
Medicaid services; and the receipt of three separate capitation rates—were not fully integrated as 
designed. One MMP described the lack of integration in several operational areas as a “failed 
promise” of the demonstration; the lack of a completely combined, integrated program added to 
administrative costs and other operational challenges that interfered in the ability to effectively 
and efficiently scale the program. 
Regardless of its complexity, officials from MassHealth, CMS, and the MMPs, as well as 
its other stakeholders, remain committed to the success of One Care. One MassHealth official 
noted that integrating Medicare with Medicaid was “critical” to the success of the care model for 
                                                 
15 One Care maintains a shared learning website with recorded webinars and related training materials at 
https://onecarelearning.ehs.state.ma.us/  
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this population. That same MassHealth official reinforced that despite the challenges, 
Massachusetts did not regret its decision to go forward with the One Care demonstration. 
MassHealth officials described their experiences with One Care as instrumental in helping to 
define their current culture and direction in health care delivery reform. The MMPs noted that 
CMS and MassHealth had both been very responsive to issues over the course of the 
demonstration, illustrating a strong commitment to the success of One Care. One MMP noted 
that the responsiveness of CMS and MassHealth played a role in its decision to participate in the 
demonstration for an additional 2 years. 
3.2 Eligibility and Enrollment 
 
 
This section provides updates in eligibility and enrollment processes, including 
integration of eligibility systems, enrollment methods, and outreach. This section also outlines 
significant events affecting enrollment patterns during the timeframe of this report, including the 
withdrawal of one of the three MMPs participating in the demonstration and more recent 
enrollment activities. 
3.2.1 Eligibility and Enrollment Process 
Eligibility 
No changes were made to eligibility requirements during the timeframe of this report. Of 
note, One Care is the only demonstration under the Financial Alignment Initiative that limits 
eligibility to Medicare-Medicaid beneficiaries age 21 through 64 at the time of enrollment. 
Massachusetts did not set an enrollment target for the demonstration although enrollment caps 
were established in the second half of demonstration year 2 (CY 2015), as described below in 
Enrollment Experience sub-section. As of December 1, 2016, approximately 105,000 Medicare-
Medicaid beneficiaries were eligible for the demonstration. 
Highlights 
• Enrollment declined during demonstration year 2 (calendar year [CY] 2015) from 
approximately 17,900 to 12,300 enrollees, due, primarily, to the withdrawal of the 
second largest MMP and limited enrollment by remaining MMPs. Enrollment started 
to recover in demonstration year 3 (CY 2016), with total enrollment of 14,300 as of 
December 1, 2016. As of January 1, 2017, enrollment increased to slightly over 
16,000 beneficiaries.  
• CMS and MassHealth amended enrollment guidance in late 2016 to allow for passive 
enrollment in counties where only one MMP participates and in counties only partially 
covered by the demonstration.  
• One of the MMPs that operates in Suffolk and Worcester counties began operations in 
portions of Middlesex County in early 2017; three counties are now served by more 
than one MMP. 
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Enrollment Systems  
As noted in the first Annual Report, the integration of Medicare and Medicaid eligibility 
and enrollment systems resulted in operational challenges for MassHealth, CMS, and the MMPs. 
Although alignment issues in the underlying enrollment systems have not improved significantly 
since implementation, MassHealth officials described a “smoother process” for enrollment 
beginning in demonstration year 2. MassHealth officials attributed the improvements to 
utilization of an on-line processing tool. This on-line processing tool, an innovation the 
Commonwealth reported learning about in conversation with other states in early 2015, allows 
for quicker, more automated remediation of enrollment errors. Additionally, there was no passive 
enrollment into the demonstration during demonstration year 2, and the number of new 
enrollments significantly decreased from the previous year with the departure of one of the three 
MMPs. MassHealth officials reported that system enrollment errors continued to be caused by 
discrepancies in the spelling of, or changes to, beneficiary names, or other incorrect demographic 
information that does not match in the Medicare and Medicaid enrollment systems. MassHealth 
officials noted that the time and effort required to update and correct enrollment information 
presented barriers for beneficiaries; additionally, enrollees did not always complete the necessary 
authorizations allowing for representation by SHINE  counselors who otherwise could assist 
them. Some of these barriers were attributed to the high behavioral health needs of this 
population. 
16
Enrollment Processes  
In demonstration year 1, beneficiaries could opt into the demonstration at any time or be 
passively (automatically) enrolled.  Although additional passive enrollment had been 
anticipated for the second half of demonstration year 2, that process was delayed after one MMP 
(Fallon) reported that it would be withdrawing from the demonstration as of September 30, 2015. 
The next phase of passive enrollment did not occur until demonstration year 3 (CY 2016). 
Although beneficiaries could continue to opt into the demonstration during demonstration year 2, 
that ability was severely restricted during the second half of that year due to enrollments caps, as 
described below. The restrictions were lifted in demonstration year 3. Enrollees may choose to 
opt out of the demonstration at any time (three-way contract, 2015, p. 29). 
17
Enrollment Experience 
Fallon notified MassHealth and CMS in June 2015 of its intent to withdraw from the 
demonstration effective as of September 30, 2015. As the second largest MMP in terms of 
enrollment and counties of operation, Fallon’s withdrawal had significant negative impacts on 
enrollment, not only decreasing overall enrollment in the demonstration but also impacting the 
enrollment activities of the two remaining MMPs. Table 1 shows total enrollment in the 
demonstration for the 3 months immediately prior to and after Fallon’s withdrawal. Table 2 
identifies the counties in which the three plans operated in the first 24 months of operation as 
compared to the counties in which the remaining two plans operated following Fallon’s 
withdrawal.  
                                                 
16 The SHINE Program (Serving the Health Insurance Needs of Everyone) is the name for Massachusetts’ state 
health insurance assistance program funded by the Administration for Community Living. 
17 There were four phases of passive enrollment in demonstration year 1, as described in the first Annual Report. 
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Table 1 
Total enrollment prior to and after Fallon’s withdrawal, by month 
July 1,  
2015 
August 1,  
2015 
September 1,  
2015 
October 1,  
2015 
November 1,  
2015 
December 1,  
2015 
17,671 17,518 17,179 12,657 12,366 12,285 
SOURCE: MassHealth, Enrollment Reports, July 2015; August 2015; September 2015; October 2015; November 
2015; December 2015. 
Table 2 
Counties where One Care MMPs operated 
County 
October 1, 2013 to September 30, 2015 As of October 1, 2015 
Commonwealth 







Essex X     X   
Franklin X     X   
Hampden X X   X   
Hampshire X X   X   
Middlesex X     X   
Norfolk X     X   
Plymouth X (partial)     X (partial)   
Suffolk X   X X X 
Worcester X X X X X 
SOURCE: MassHealth, August 17, 2015. 
Following Fallon’s announcement in June 2015, MassHealth, CMS, and Fallon 
developed a plan for transitioning Fallon enrollees to other options. Fallon sent a letter to its 
enrollees on July 28, 2015, notifying them of its withdrawal from One Care; the letter included 
information about the transition, preliminary coverage options, and how to get help. Fallon also 
hosted two enrollment sessions, and MassHealth created a new page on its One Care website 
with information related to Fallon’s withdrawal. MassHealth began holding monthly Open 
Meetings, including one in Worcester, and invested significant resources to ensure that 
authorizations and transition plans for enrollees were in place. Overall, MassHealth, CMS, and 
stakeholders described the transition process as highly collaborative, with all parties trying to 
ensure adequate communication and minimum disruption to enrollees. Although some 
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beneficiaries transitioned to another One Care MMP, most returned to the FFS system, thereby 
decreasing overall enrollment in the demonstration.   18
Because of Fallon’s decision to withdraw and concerns on the part of the two remaining 
MMPs regarding the financial sustainability of the demonstration, both MMPs limited new 
enrollment shortly after Fallon’s notice of withdrawal; this significantly restricted the ability of 
enrollees served by Fallon to transition to another MMP. As shown in Table 2, Fallon operated 
in three counties: Hampden, Hampshire, and Worcester. As of August 2015, CCA instituted a 
freeze on any new enrollments for individuals not previously enrolled with CCA in all counties 
in which it operated, including all counties in which Fallon operated. Tufts continued to accept 
enrollment in Suffolk county (where Fallon did not operate), but it limited enrollment in 
Worcester county (where Fallon did operate) up to 500 new enrollees. These changes not only 
severely restricted new enrollment into One Care overall but also significantly limited the 
options for enrollees previously served by Fallon to remain in the demonstration. MassHealth 
reported that approximately 610 enrollees in Fallon transitioned to either Tufts or CCA for 
effective enrollment dates between August 1 and November 1, 2015.  Approximately 4,700 
beneficiaries transitioned back to the FFS system (MassHealth presentation to Implementation 
Council, October 16, 2015). 
19
Fallon’s withdrawal also impacted passive enrollment activities since, at that time, 
passive enrollment was only allowed where more than one MMP was in operation. CCA 
modified their enrollment cap to allow for limited enrollment in counties where passive 
enrollment into Tufts was occurring.  Effective June 1, 2016, CMS and MassHealth lifted 
CCA’s enrollment cap, and CCA began again to accept opt-in enrollment across all nine counties 
where the demonstration operated.  
20
Three passive enrollment phases into Tufts MMP occurred in 2016. MassHealth and 
CMS have also initiated quarterly passive enrollment phases, which began January 2017. Passive 
enrollment was planned for both MMPs; these quarterly phases will target newly eligible 
Medicare-Medicaid beneficiaries as well as other eligible beneficiaries. As of December 1, 2016, 
enrollment in the demonstration totaled approximately 14,300 beneficiaries. Total enrollment in 
                                                 
18 Enrollees were provided a number of options that included:  
• MassHealth fee for service with Medicare fee for service and a Medicare Part D plan 
• MassHealth and a Medicare Advantage plan 
• Another One Care MMP, if available 
• Program for All-Inclusive Care for the Elderly (PACE)—for members 55 and older and who had nursing 
facility level of care 
• Senior Care Options—an integrated Dual Eligible Special Needs Plan (D-SNP) program for members 65 
and over 
 Enrollees who did not take any action were automatically enrolled in MassHealth fee for service, Medicare fee 
for service and Humana Insurance Company for Medicare prescription drug coverage, although members were 
able to choose a different Medicare Part D plan (EOHHS, August 17, 2015).  
19 Those enrolling in CCA did so prior to CCA’s enrollment freeze. In addition, CCA continued to accept re-
enrollment of beneficiaries who had previously been enrolled in CCA but had transitioned to another plan or 
disenrolled from One Care. 
20 The first passive phase of enrollment into Tufts occurred in Suffolk County with an effective date of January 1, 
2016. Another round occurred in Suffolk and Worcester counties with an effective date of May 1, 2016.  
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One Care increased to slightly over 16,000 beneficiaries as of January 1, 2017 due to additional 
passive enrollment.  
As initially designed, passive enrollment was not allowed in counties with only one MMP 
or in counties only partially served by the demonstration. CMS and MassHealth agreed to allow 
passive enrollment in both situations, and MassHealth enrollment guidance has been updated to 
reflect these changes. The passive enrollment phase effective January 2017 included 
beneficiaries from across the Commonwealth in accordance with this change. Additionally, one 
of the MMPs, Tufts, expanded its coverage area to include portions of Middlesex County 
effective February 2017. Overall, officials from CMS and MassHealth, and the MMPs and other 
stakeholders, emphasized that enrollment in the demonstration was on a much firmer footing at 
the end of 2016 than it had been a year earlier. At the end of demonstration year 2, One Care was 
still impacted by the withdrawal of its second largest MMP; by the end of demonstration year 3, 
both MMPs were actively seeking to expand enrollment, and one MMP was in the process of 
initiating operations in an additional county.  
Disenrollment experiences of individuals who ended their coverage after it started varied 
between MMPs. One MMP reported that this was an area of concern, especially for those 
beneficiaries who remained in the demonstration for months before choosing to disenroll as 
opposed to opting out of the demonstration before enrollment. The disenrollment rates impacted 
financial performance because, in the words of one MMP official, “getting members enrolled 
and engaged is very, very difficult and we spend an enormous amount of time and energy doing 
it.” For enrollees remaining in the demonstration, these initial costs could potentially be 
recouped over time through comprehensive care management. Although MassHealth, CMS, and 
the MMP reported wanting to improve their understanding of factors influencing disenrollment, 
no beneficiary surveys or other data were available to inform this experience. 
Enrollment Outreach 
In the first half of demonstration year 2, MassHealth continued education and outreach 
activities for beneficiaries not yet enrolled in the demonstration. MassHealth reported that these 
activities included collaborative presentations with the One Care Ombudsman Program and the 
One Care MMPs. MassHealth implemented a beneficiary-focused, paid media campaign in 
Boston, Springfield, and Worcester that included transit advertising, billboards, and media in 
both English and Spanish, and featured One Care enrollees. In the third quarter of demonstration 
year 2, MassHealth shifted its outreach from trying to increase new enrollments to assisting 
enrollees affected by Fallon’s withdrawal from the demonstration, described in greater detail 
below.  
MassHealth initiated targeted outreach activities to support the passive enrollment of 
beneficiaries into Tufts during 2016, with a goal of reducing the percent of beneficiaries who 
opted out. MassHealth adapted its outreach practices based in part on feedback received through 
the work of the Implementation Council, a stakeholder group described in Section 3.4, 
Stakeholder Engagement. Changes included updating enrollment materials and structuring 
community-based outreach events in selected areas where there were high concentrations of 
beneficiaries impacted by passive enrollment. These events offered light refreshments and other 
giveaways such as branded gloves and tote bags for attendees. These events included 
representatives from MassHealth eligibility and enrollment, SHINE, the OCO, as well as 
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enrollees serving on Tufts’ Member Advisory Board (MAB). Members of the Implementation 
Council were also invited to attend, although some Implementation Council members noted that 
the lack of a stipend to cover transportation and other costs was a barrier for members and 
deterred participation. MassHealth moved over time to structuring these outreach events as drop-
in events rather than formal presentations. 
Although neither MassHealth nor Implementation Council members reported that the 
outreach events garnered significant attendance, both felt that the events were valuable as 
learning opportunities and as an opportunity for collaboration. Both noted the importance of 
word of mouth and having enrollees available to talk about their experiences. Some 
Implementation Council members expressed a preference for MassHealth partnering more 
strongly with community-based organizations to lead future outreach efforts, rather than having 
events conducted by MassHealth or MMP representatives. MassHealth reported “moving the dial 
ever so slightly” on lowering the opt-out rate in the first two phases of passive enrollment in 
2016, but officials were not able to attribute the change directly to these new processes.  
As part of the overall growth strategy for One Care, beginning in 2016, MassHealth 
developed strategies to reengage beneficiaries who had previously opted out of One Care. Of 
note, MassHealth conducted targeted outreach to former Fallon enrollees in the fall of 2016, 
letting them know of their ability to enroll in One Care again. Former enrollees residing in 
Hampshire and Hampden counties were also notified if their primary care provider was available 
in the provider network for the MMP serving those counties. These efforts were part of a larger 
initiative to increase opt-in enrollment. 
Contacting and Locating Enrollees 
Once a member is enrolled in a plan, the plan is required to establish contact and conduct 
an initial assessment within 90 days of the enrollment date. As reported in the first Annual 
Report, MMPs had difficulties in locating enrollees—particularly those who had been passively 
enrolled—to conduct the initial assessments. Although the number of new enrollees was 
significantly lower in demonstration year 2, MMPs reported continuing challenges in this area. 
As one MMP noted:  
Again, looking over the arc of the program, the major challenges really haven’t 
changed. Getting members enrolled and engaged is very, very difficult, and we 
spend an enormous amount of time and energy doing it.  
The effort required to reach and engage new enrollees resulted in administrative costs as 
well as other costs related to continuing care without the benefit of a comprehensive assessment 
of needs and coordination of services.  
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Table 3 shows the percentage of members that the plans were unable to reach.  For 
demonstration year 2, the percentage that MMPs were unable to reach within 90 days improved. 
The percentage of enrollees One Care plans were unable to reach declined steadily over time 
from the last quarter of demonstration year 1 (calendar year [CY] 2014) through the second 
quarter of demonstration year 3 (CY 2016). This decline was followed by an uptick in the third 
quarter of demonstration year 3 (CY 2016) when the percentage of enrollees that were 
unreachable increased to slightly under one-third. 
21
Table 3 
Percentage of enrollees that One Care plans were unable to reach following three attempts, 
within 90 days of enrollment  
Quarter CY 2014 CY 2015 CY 2016 
Q1 38.0% 31.0% 19.9% 
Q2 36.6% 26.3% 14.0% 
Q3 39.1% 23.5% 28.0% 
Q4 32.8% 21.9% 19.5% 
NOTES: Data are not available for Quarter 4, 2013. Fallon Total Care withdrew from the demonstration on 
September 30, 2015. Data for Fallon are available through Quarter 3, 2015. Data presented for Quarter 4, 2015 and 
after represent totals for the remaining two plans. 
SOURCE: RTI analysis of MMP reported data for Core Measure 2.1, as of March 2018. The technical specifications 
for this measure are in the Medicare-Medicaid Capitated Financial Alignment Model Core Reporting Requirements 
document, which is available at: https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-
Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/MMPReportingRequirements.html. 
3.2.2 Summary Data 
Enrollment in the demonstration by quarter is shown in Table 4. The distribution of 
enrollees by counties is displayed in Table 5. The counties with the highest penetration of 
enrollment (Hamden, Hampshire, Suffolk, and Worcester) were those in which at least two plans 
were initially operating and where beneficiaries were passively enrolled.  
  
                                                 
21 In order to clarify the reporting requirements, CMS issued guidance in March 2015 that plans should report the 
number of enrollees they were unable to reach after three attempts; and that they should document each attempt 
to reach the member, including the method used. CMS also encouraged the plans to continue beneficiary 
outreach after three unsuccessful attempts and to try to reach members via multiple methods, including phone, 
mail, or email; and to work with community organizations, network providers, and others to determine accurate 
contact information and promote member engagement (CMS, March 6, 2015). 
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Table 4 
Enrollment in One Care plans, by quarter 
  2015 2016 



















10,287 10,430 10,664 10,216 10,022 10,050 10,380 11,771 
Fallon Total Care 5,615 5,474 4,684 — — — — — 
Tufts Health Unify 1,895 1,801 1,831 2,069 2,574 2,988 2,632 2,560 
Total enrollment 17,797 17,705 17,179 12,285 12,596 13,038 13,012 14,331 
Total eligible 97,393 99,136 100,523 100,293 101,835 103,041 103,640 104,415 
— = data are not available because the MMP withdrew from the demonstration. 
NOTES: Enrollment numbers are as of the first day of the last month of each quarter. Quarter 1 2015= January 1, 
2015 to March 31, 2015; Quarter 2 2015 = April 1, 2015 to June 30, 2015; Quarter 3, 2015 = July 1, 2015 to 
September 30, 2015; Quarter 4, 2015 = October 1, 2015 to December 31, 2015. Quarter 1, 2016 = January 1, 2016 to 
March 31, 2016; Quarter 2 2016 = April 1, 2016 to June 30, 2016; Quarter 3, 2016 = July 1, 2016 to September 30, 
2016; Quarter 4, 2016 = October 1, 2016 to December 31, 2016 
SOURCE: MassHealth, Enrollment Reports, March 2015; June 2015; September 2015; December 2015; March 
2016; June 2016; September 2016; December 2016.  
Table 5 








Essex 15,709 1,139 7.3 
Franklin 2,267 93 4.1 
Hampden  1 16,296 3,007 18.5 
Hampshire  1 2,834 226 8.0 
Middlesex 18,852 1,481 7.9 
Norfolk 7,928 628 7.9 
Plymouth 7,617 462 6.1 
Suffolk  1 16,016 4,322 27.0 
Worcester  1 16,896 2,973 17.6 
Total 104,415 14,331 13.7 
1 Counties with two or more plans. 
SOURCE: MassHealth, Enrollment Report, December 2016.  
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3.3 Care Coordination 
 
 
This section provides a summary of the One Care coordination model. It highlights the 
status of and major accomplishments in key care coordination components and processes: 
assessment, care planning, LTSS coordination and the LTS Coordinator role, and information 
exchange. This section also includes selected quotes that reflect key informants’ perspectives on 
care coordination. 
3.3.1 Care Coordination Model 
Care coordination is a hallmark of the One Care delivery model and is integral to helping 
beneficiaries access the full spectrum of needed services and to improving quality and ultimately, 
reducing costs. For medical and behavioral health services, plans must offer care coordination to 
all enrollees through a care coordinator or, for members with complex needs, a clinical case 
manager. With One Care, enrollees may also have an Independent Living and Long-term 
Services and Supports Coordinator (LTS Coordinator) to work with them to incorporate 
community-based services into their care plans, as appropriate. The One Care plans are required 
to contract with community-based organizations (CBOs) for the LTS Coordinator role. (Care 
coordination requirements for MMPs are described fully in the first Annual Report.) 
As noted in the first Annual Report, care coordination was successful in connecting 
beneficiaries to new services, integrating care, and helping beneficiaries access LTSS but had not 
reached its full potential. Challenges to care coordination in demonstration years 2 and 3 were 
similar to those described in the first Annual Report and included a lack of beneficiary trust 
needed to engage in care management and willingness to share information across providers, and 
confusion over different care coordination roles including the LTS Coordinator role. Other 
challenges to care coordination included exchange of information across providers and 
inefficiencies in the collaboration between plans and community-based LTSS providers. Overall, 
Highlights 
• MassHealth officials, stakeholders, and MMPs continue to view care coordination as 
integral to the success of One Care. 
• Both MMPs reported that as the demonstration matured, they focused on improving 
the assessment process and timeliness of assessments; overall trends for One Care 
show that assessment completion rates increased over time, particularly among 
enrollees who were documented as reachable or willing to participate. 
• MassHealth and the MMPs have worked collaboratively with community-based 
organizations and advocates to improve the implementation of the LTS coordinator 
role; it is not yet clear whether those improvements are sufficient to address all 
concerns.  
• Anecdotal stories of successful care coordination highlight the promise of One Care to 
improve care through effective care planning, integrated care teamwork, shared 
enrollee records, and innovative care delivery. 
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however, MassHealth officials and MMP representatives and other stakeholders reported that the 
delivery of care coordination services continued to improve as the demonstration matured.  
3.3.2 Assessment 
One Care plans are responsible for ensuring the completion of an enrollee’s assessment. 
The comprehensive assessment covers immediate and current needs and services, current 
medications, functional status, informal and social supports, and a variety of other areas; it must 
be completed within 90 days of enrollment. The assessment and related processes are described 
in detail in the first Annual Report.  
Both MMPs reported that during demonstration year 2, they focused on improving the 
assessment process and timeliness of assessments. As a result, the MMPs experienced a lower 
volume of newly enrolled beneficiaries in the first 15 months of the demonstration but also 
reported learning from their early experiences. To improve their assessment processes, one MMP 
ceased contracting out assessments to a third-party vendor. Additionally, the MMP began using a 
team approach to more quickly reach recently enrolled beneficiaries and employed community 
health outreach workers to better engage beneficiaries. The other MMP reported that they fine-
tuned the manner in which they contracted out the assessment process to home health agencies 
staffed with personnel experienced with the population served by One Care. This plan reported 
that the assessment completion and timeliness improved as a result. Table 6 shows, among all 
enrollees, overall rates for timely assessment completion ranged from 34 to 58 percent in 2014, 
53 to 70 percent in 2015, and 42 to 69 percent in 2016. Among enrollees who were not 
documented as unreachable or unwilling to participate, rates for timely assessment completion 
ranged from 56 to 93 percent in 2014, 84 to nearly 100 percent in 2015 (during which period no 
passive enrollment occurred), and 58 to 93 percent in 2016.  
Table 6 
Enrollees whose assessment was completed within 90 days of enrollment 
Quarter 
Total number of enrollees 
whose 90th day of 
enrollment occurred within 
the reporting period 
(n) 
Assessment completed within 90 days of enrollment  
(%) 
All enrollees 
All enrollees documented as 
reachable or willing to participate 
2014       
Q1 7,469 34.1 55.8 
Q2 3,973 34.7 56.8 
Q3 6,338 34.9 59.9 
Q4 890 57.8 92.9 
(continued) 
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Table 6 (continued) 
Enrollees whose assessment was completed within 90 days of enrollment 
Quarter 
Total number of enrollees 
whose 90th day of 
enrollment occurred within 
the reporting period 
(n) 
Assessment completed within 90 days of enrollment  
(%) 
All enrollees 
All enrollees documented as 
reachable or willing to participate 
2015       
Q1 1,389 53.4 84.3 
Q2 750 68.1 99.8 
Q3 616 69.6 96.6 
Q4 827 64.2 85.8 
2016       
Q1 815 42.1 57.5 
Q2 201 69.1 83.9 
Q3 1,205 59.6 93.4 
Q4 1,315 59.8 79.6 
NOTES: Data are not available for Quarter 4, 2013. Fallon Total Care withdrew from the demonstration on 
September 30, 2015. Data for Fallon are available through Quarter 3, 2015. Data presented for Quarter 4, 2015, and 
after represent totals for the remaining two plans. 
SOURCE: RTI analysis of MMP reported data for Core Measure 2.1, as of March 2018. The technical specifications 
for this measure are in the Medicare-Medicaid Capitated Financial Alignment Model Core Reporting Requirements 
document, which is available at: https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-
Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/MMPReportingRequirements.html. 
3.3.3 The Care Planning Process 
One Care plans are responsible for developing an individualized care plan (ICP) through 
an interdisciplinary care team (ICT) for each enrollee. The ICP must reflect the enrollee’s 
preferences and needs, and must include a description of how services and care will be integrated 
and coordinated among providers. The care coordinator is expected to ensure that ICT meetings 
and calls are held periodically, monitor the provision and outcomes of services, and ensure that 
mechanisms are in place for enrollees to provide input and feedback. Like findings in the first 
Annual Report, the MMPs have continued to develop their own approaches to organizing and 
staffing care coordination. 
Both MMPs reported contracting out a portion of their care coordination to external 
vendors. One MMP has continued to contract out care coordination activities to primary care and 
behavioral health community providers for about 20 percent of its enrollees, as described in the 
first Annual Report. The MMP reported that this model has remained essentially unchanged 
since the first demonstration year. Among other supports, a nurse practitioner is assigned to these 
practices for case review and additional supports. The other MMP has contracted out some of its 
care coordination functions to the same home health agencies it contracts with for completing 
assessments, a change since the first demonstration year. That MMP emphasized that even 
  23 
though some functions were performed by contracted staff, it provided supportive services 
needed to ensure delivery of comprehensive care coordination to those enrollees.  
MassHealth officials, many stakeholders, and MMP representatives reported that as the 
demonstration has matured, the focus on care coordination and care planning has increased. The 
parties acknowledged a lack of quantitative data on care coordination, but there was broad 
agreement that the implementation of care coordination has improved greatly, though it has not 
yet reached its full potential. Although care coordination activities are occurring, they are not 
adequately reflected in encounter or other data by function (i.e., home visits, telephone 
monitoring, participation on the care team, or overall). Similarly, available data are not sufficient 
for tracking the activities and composition of the integrated care team.  
MMPs are required to report certain staffing data for care coordination, as set forth in 
Table 7. In 2014, the first full year of the demonstration, One Care plans employed a total of 234 
full-time care coordinators. This decreased by nearly one-half in 2015, the year Fallon withdrew 
from the demonstration. MMP-reported data shows a member load of 107.9 in 2014. This 
increased to 122.9 in 2015. Care coordinator turnover rate increased from 11.5 to 16.8 percent 
between 2014 and 2015. 
Table 7 
Care coordination staffing 
Calendar 
year 
Total number of care 
coordinators (FTE) 
(n) 
Percentage of care 
coordinators assigned to 
care management and 
conducting assessments 
(%) 
Member load per care 
coordinator assigned to 






2014 234 70.9 107.9 11.5 
2015 125 80.0 122.9 16.8 
NOTES: Data are not available for 2013, and are not yet available for 2016. Fallon Total Care withdrew from the 
demonstration on September 30, 2015. Data presented for 2015 represent totals for the remaining two plans. 
SOURCE: RTI analysis of MMP reported data for Core Measure 5.1, as of March 2017. The technical specifications 
for this measure are in the Medicare-Medicaid Capitated Financial Alignment Model Core Reporting Requirements 
document, which is available at: https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-
Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/MMPReportingRequirements.html 
During the site visits, plans and stakeholders cited specific instances where the 
assessment and integrated care planning between behavioral health and medical care had vastly 
improved beneficiaries’ health. Others described cases in which care coordination had helped 
beneficiaries gain access to LTSS that ultimately helped them live more independently with 
reported improvements in quality of life. As a representative from one MMP described:  
We really work as a team to understand what the goals of our members are. I 
think that the initial assessment is key for really determining where they stand. 
Our behavioral health integration is critical for the success of these members we 
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work with [to] really understand where they are, what their needs are, meet them 
where they’re at and work with the team to help them achieve their goals. 
Care coordinators reported several anecdotal success stories in which effective care 
coordination had improved access to new or existing services or significantly improved the 
health and quality of life for beneficiaries. Both MMPs reported that they had seen 
improvements in quality of life for enrollees through the integration of care, e.g., through 
interdisciplinary management of behavioral and medical health care. For example, an official at 
one MMP described integrating care for an enrollee who had been receiving care through 
behavioral health providers for a serious mental health condition, but had not been receiving 
treatment for long-term, uncontrolled diabetes: “At the end of the day, it’s really the 
interdisciplinary approach that allows that member to have the best of both [behavioral and 
medical care].”  
Another care coordinator described her experience with a beneficiary who, at the time of 
her first visit, was being treated for a mental health condition, and had a history of trauma, 
physical abuse, and autoimmune disease. After reviewing the beneficiary’s goals, history, and 
medications, the care coordinator arranged for short-term intensive therapy; a health outreach 
worker to help with social coordination including facilitating registration for GED classes; and 
transportation. Over time, the beneficiary was able to decrease her medications to more 
“appropriate dosing,” and her need for skilled nursing services declined from twice daily to none. 
As the care coordinator described:  
Her mental clarity was so much better, and just her overall thought process and 
mental health was [better]. She was a different person about a year after I started 
working with her and got all this going. In the meantime, she had been going 
three times a week to GED classes. So, medications were decreased, nurses were 
gone. She was doing things on her own, visiting her children, working towards 
her GED. She even saved up money to buy herself a laptop to try to further her 
education. 
Both MMPs reported increased use of community outreach workers to help reach 
enrollees or to encourage them to more actively participate in the health care delivery model, e.g. 
through uptake of LTSS. One MMP had bilingual outreach workers or used a telephonic 
translation line to communicate with enrollees. Another plan described using community 
outreach workers to build a relationship that might lead to greater use of care coordination 
among enrollees who did not initially request or want those services. Community health outreach 
workers were already known in the community and therefore were at times viewed as the best 
avenue for gaining the trust of beneficiaries and encouraging engagement with the MMP. 
Stakeholders, MassHealth officials, MMP representatives, and CBO personnel 
acknowledged some confusion around care coordination roles. MMPs have been working to 
improve coordination of care through improvements to the centralized enrollee record, 
improvements to assessment timeliness, and improved relationships and administrative processes 
with LTSS providers. One Care has developed provider and beneficiary guidance aimed at 
improving their understanding of the care team member roles. The Implementation Council 
Behavioral Health Subcommittee has recommended the development of a one-page template for 
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MMP use that would provide enrollees information about the care team membership, contact 
information, ombudsman contact information and the individual’s identified goals every 6 
months to (1) educate enrollees about their care team and care plan and (2) provide a means for 
beneficiaries to engage with their care coordinators around their care plans. The Implementation 
Council reported that it intends to focus on enhancing beneficiaries’ understanding of the care 
planning process and beneficiaries’ role in care planning as part of future activities. 
As part of the demonstration, MassHealth requires plans to track and report data on care 
plan development (see Table 8). The percentage of enrollees with a care plan developed within 
90 days of enrollment has increased nearly every quarter, as has the percent of completed care 
plans within 90 days of enrollment for enrollees willing to participate and who could be reached. 
The percentage of enrollees with a care plan completed within 90 days of enrollment has 
gradually increased over the course of the demonstration. Among all enrollees, the proportion 
with a care plan completed ranged from 23 to 37 percent in 2014, 48 to 68 percent in 2015, and 
51 to 64 percent in 2016. Among enrollees not documented as unreachable or unwilling to 
participate, the percentage of enrollees with a care plan completed ranged from 33 to 59 percent 
in 2014, 65 to 80 percent in 2015, and 64 to 81 percent in 2016. 
Table 8 
Members with care plans within 90 days of enrollment 
Quarter 
Total number of enrollees 
whose 90th day of enrollment 
occurred within the 
reporting period 
(n) 
Care plan completed within 90 days of enrollment  
(%) 
All enrollees 
All enrollees not documented as 
unreachable or unwilling to participate 
2014       
Q1 5,871 22.8 32.8 
Q2 3,977 25.8 41.0 
Q3 6,330 24.8 39.2 
Q4 886 37.0 59.1 
2015       
Q1 1,398 48.1 65.2 
Q2 748 54.3 73.2 
Q3 614 59.3 80.4 
Q4 821 68.3 79.9 
 (continued) 
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Table 8 (continued) 
Members with care plans within 90 days of enrollment 
Quarter 
Total number of enrollees 
whose 90th day of enrollment 
occurred within the 
reporting period 
(n) 
Care plan completed within 90 days of enrollment  
(%) 
All enrollees 
All enrollees not documented as 
unreachable or unwilling to participate 
2016       
Q1 810 50.6 63.5 
Q2 291 61.5 72.8 
Q3 1,208 63.8 81.1 
Q4 1,317 56.4 74.2 
NOTES: Data are not available for Quarter 4, 2013. Fallon Total Care withdrew from the demonstration on 
September 30, 2015. Data for Fallon are available through Quarter 3, 2015. Data presented for Quarter 4, 2015 and 
after represent totals for the remaining two plans. 
SOURCE: RTI analysis of MMP reported data for MA1.1, as of March 2018. The technical specifications for this 
measure are in the Medicare-Medicaid Capitated Financial Alignment Model Massachusetts-Specific Reporting 
Requirements document, which is available at: https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-
and-Medicaid-Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/MMPReportingRequirements.html 
Among enrollees with a care plan, the percentage of members with at least one 
documented discussion of care goals increased from a range of 58 to 64 percent in 2014 to a 
range of 97 to 100 percent in 2015 and 2016 (see Table 9). 
Table 9 
Members with care plans with at least one documented discussion of care goals 
Quarter 
Total number of members with an initial care 
plan developed during the reporting period 
(n) 
Members with at least one documented 
discussion of care goals in the care plan 
(%) 
2014     
Q1 2,218 72.4 
Q2 2,668 57.5 
Q3 3,039 60.1 
Q4 2,892 64.2 
2015     
Q1 1,956 98.4 
Q2 2,038 97.3 
Q3 573 98.8 
Q4 641 99.7 
 (continued) 
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Table 9 (continued) 
Members with care plans with at least one documented discussion of care goals 
Quarter 
Total number of members with an initial care 
plan developed during the reporting period 
(n) 
Members with at least one documented 
discussion of care goals in the care plan 
(%) 
2016     
Q1 501 98.0 
Q2 565 96.6 
Q3 618 99.0 
Q4 970 100.0 
NOTES: Data are not available for Quarter 4, 2013. Fallon Total Care withdrew from the demonstration on 
September 30, 2015. Data for Fallon are available through Quarter 3, 2015. Data presented for Quarter 4, 2015 and 
after represent totals for the remaining two plans. Documented discussion of care goals in revised care plans are 
excluded from these calculations.  
SOURCE: RTI analysis of MMP reported data for MA 1.2, as of March 2017. The technical specifications for this 
measure are in the Medicare-Medicaid Capitated Financial Alignment Model Massachusetts-Specific Reporting 
Requirements document, which is available at: https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-
and-Medicaid-Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/MMPReportingRequirements.html. 
3.3.4 LTS Coordination and LTS Coordinator Role 
To fulfill the LTS Coordinator role, MMPs contract with CBOs, including Aging Service 
Access Points (ASAPs), Independent Living Centers (ILCs), and Recovery Learning 
Communities (RLCs). The RLCs are consumer-driven networks that focus on recovery and 
wellness for individuals with behavioral health needs and were included in the design of One 
Care to tailor the LTS Coordinator role for this population.  
As reported in the first Annual Report, although there was widespread support for the 
role of the LTS Coordinator, implementation of the model proved difficult. For the most part, 
many of these challenges continued into the second and third years of the demonstration. These 
challenges included: lack of LTS Coordinator inclusion as a full member of the ICT; inconsistent 
communication between the MMPs and the LTS Coordinator around service approvals and 
denials; beneficiary knowledge of the LTS Coordinator role on their care team; and contracting 
issues. Relatedly, very few RLCs are contracted to provide LTS coordination; one MMP 
reported during the RTI evaluation interview that it had no contracts with RLCs at that time for 
LTS coordination services. CBOs continue to report differences in implementation of the role 
across MMPs in terms of LTSS assessments, authorizations, and billing practices. 
MassHealth officials reported that they had heard from stakeholders that LTS 
Coordinators do not always have adequate access to the care team, even though the contract 
language specifies that they should be fully included in the team. Several stakeholders and CBO 
representatives expressed interest in modeling the role to be more like that of the Geriatric 
Support Services Coordinator (GSSC) in the Senior Care Options (SCO) integrated Dual Eligible 
Special Needs Plan (D-SNP) program for Medicare-Medicaid beneficiaries ages 65 and older. In 
the SCO program, every enrollee is assigned a GSSC from a CBO, whereas in One Care, 
  28 
enrollees are offered an LTS coordinator but not automatically assigned one. Several distinctions 
exist between the GSSC role and that of the LTS Coordinator, but as one CBO stated: 
We think [coordinators for LTSS are] much more successful in the SCO plan 
where we are much more integral to the model of care and to the care teams; have 
a much greater role around the care plan development. In the One Care program, 
that's not been the case at all. And so, in general, I think that the One Care 
members have not been served well as far as that goes, because on the one hand, 
like I said, they don't really have organizational competence around LTSS, but 
also the LTS Coordinator is not really engaged fully most of the time. 
MassHealth officials noted that the role of the GSSC as designed for the SCO program 
differed from the role of the LTS coordinator and stressed that the design incorporated flexibility 
for the MMPs, CBOs, and beneficiaries: 
Ultimately, we want it to be the member’s choice and we don't want it to be baked 
into the contract that you must have [a certain] number of visits or something like 
that, because it really should be member-specific.  
MassHealth acknowledged that the challenges in balancing a flexible design with 
ensuring consistent and defined roles for the LTS coordinator led to differences of opinion 
among CBOs, advocates, and MMPs as to roles and responsibilities of the LTS coordinator.  
Due to contract issues among several CBOs and one MMP, MassHealth began hosting 
joint meetings between the MMP and CBO providers in September 2015, and MassHealth began 
meeting with CBOs on a regular basis. Key issues were in the areas of payment and billing, 
authorization, and program design. MassHealth developed a work plan for resolving these issues; 
overall, representatives from MassHealth, the MMP, and CBOs noted that these efforts resulted 
in improvements in communication and operations. During RTI evaluation team interviews, a 
number of representatives from CBOs reported they were being granted access to the MMPs’ 
Centralized Enrollee Record (CER), which was a major improvement. CBO staff felt access to 
MMPs’ EHRs promoted communication between LTS Coordinators, MMP care coordinators, 
and the larger care team. 
The Implementation Council LTSS Subcommittee met three times in 2016 to evaluate 
barriers to full integration of the LTS Coordinator into the care team. The subcommittee aimed to 
improve communication between care coordinators, LTS Coordinators, and beneficiaries, and 
recommended amending the three-way contract to clarify the LTS Coordinator role, including 
processes and procedures for working with MMP care coordinators and care teams.  
3.3.5 Information Exchange  
The success of the One Care model of integrated care is dependent on information 
sharing and exchange across interdisciplinary providers. The first Annual Report described two 
challenges to information exchange: behavioral health privacy concerns and inadequate content 
within and sharing of MMPs’ centralized enrollee records.  
  29 
3.3.6 Behavioral Health Privacy  
The first Annual Report outlined tension between One Care’s model for care integrated 
across behavioral and medical health providers and the rights of beneficiaries to maintain privacy 
over their behavioral health records. In demonstration years 2 and 3, the Implementation 
Council, through its Behavioral Health Privacy workgroup, worked on integrating behavioral and 
medical health, including the development of resources for MMPs on guiding principles and best 
practices. In 2016, MassHealth, in collaboration with the University of Massachusetts Medical 
School (UMMS) and the Behavioral Health Privacy workgroup, developed a webinar on 
behavioral health privacy principles and best practices.  
To facilitate care coordination, One Care plans are required to maintain a single, 
centralized, comprehensive record, known as the Centralized Enrollee Record (CER), that 
documents enrollees’ medical, prescription, functional, and social status. Initially, one MMP 
reported some confusion in differentiating between the CER and its other electronic health 
records systems that included an externally-facing member portal. MassHealth clarified that the 
CER parameters were set by contract requirement, and that the CER was primarily a 
management system. MassHealth reported that MMPs’ CER use had grown between 
demonstration years 1 and 2, they perceive the CER as a good tool for understanding what is 
going on with beneficiaries, and plans had worked to improve access among LTS providers. One 
MMP reported that sharing access to the CER with key LTS Coordinators had improved 
communication between the two organizations: 
Previously, it had been sometimes difficult to communicate with them. The 
[LTS Coordinator] would fax assessments and [they] might not get [the 
assessments] quickly. Team communication is much improved.  




• The demonstration continues to embed a robust stakeholder engagement process into 
its structure through such measures as the activities of a consumer-driven 
Implementation Council. 
• Implementation Council members reported key successes in demonstration year 2, 
including collaboration with MassHealth and CMS to assist enrollees affected by the 
withdrawal of one of the MMPs (Fallon) and successful advocacy efforts to increase 
financial support for One Care. 
• One Care requires MMPs to establish member advisory boards; MMPs report relying 
on the input of the enrollees on these boards to identify issues with quality and service 
delivery, provide feedback, and in some cases, assist with outreach to potential 
enrollees.  
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Key informants expressed broad agreement that stakeholder engagement has been a 
critical component of the One Care demonstration from its inception, and that the high level of 
engagement has continued and is a notable success of the demonstration. This section describes 
stakeholder engagement activities during the period of this report and the impact of those efforts 
on the demonstration. 
3.4.1 Commonwealth Open Meetings 
Since One Care’s inception, MassHealth has held public meetings to present and discuss 
issues relevant to the demonstration.  MassHealth held six Open Meetings in demonstration 
year 2 (CY 2015), convening them monthly from June through September to focus on issues 
related to the withdrawal of one of the MMPs (Fallon) from the demonstration. Fallon’s 
withdrawal is discussed in Section 3.2, Eligibility and Enrollment. Only one Open Meeting 
occurred in CY 2016. In part, MassHealth did not conduct as many regular Open Meetings 
because MassHealth staff regularly provided information on One Care as part of monthly 
Implementation Council meetings. As the demonstration has matured and stabilized, MassHealth 
has also shifted some of its resources to other stakeholder processes related to its broader 
Medicaid reforms, described in Section 2, Demonstration Overview. 
22
3.4.2 Implementation Council Meetings 
As described in the first Annual Report, the design of One Care includes an 
Implementation Council that consists of up to 21 members to operate during the length of the 
demonstration. The Implementation Council plays a key role in monitoring access to health care 
and compliance with the Americans with Disabilities Act (ADA), tracking quality of services, 
providing support and input to MassHealth, and promoting accountability and transparency. The 
role of the Implementation Council has remained the same during this entire demonstration. 
Implementation Council members noted that having staff from the University of Massachusetts 
supporting the operations of the council was “critical” to having a robust stakeholder structure: 
I think the model is only as strong as the relationship between representatives 
from the state and the council. So, if those representatives are not supportive of 
the council, supportive of its work, it’s not going to work. There are states where 
they may have a minimalistic approach to the work with the council as opposed to 
[UMass staff], who are fully engaged and support all our activities… the council 
works [as a facilitator] in communicating with the state and the plans. 
Because of resignations and changes in membership, MassHealth published a Notice of 
Opportunity in the summer of 2015 soliciting six new members to serve on the Implementation 
Council through December 2016. One council member noted that the resulting diversity was 
both exciting and challenging; the council member remarked on the council’s pursuit of multiple 
and diverse initiatives while operating within limited resources. Another membership solicitation 
occurred in November 2016 because the terms of all members expired in December 2016. All 
                                                 
22 Agenda and meeting minutes can be viewed at: https://www.mass.gov/service-details/one-care-open-meetings
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members interested in continuing their participation were required to apply; the application 
deadline was extended from December 2016 to January 2017.  23
Generally, the Implementation Council meets monthly; 10 meetings occurred in 2015 and 
11 in 2016. Typical agenda items include presentations by MassHealth and the OCO, with other 
occasional reports from subcommittees and MMPs. In addition to the council meetings, 
subcommittees and workgroups address a range of topics, including behavioral health privacy; 
LTSS; and quality and encounter data. The Implementation Council creates an annual work plan 
and summarizes its work in an annual report. Meeting minutes, presentations, and related items 
are publicly available.  24
Although the Implementation Council provided input and collaboration in a number of 
different areas, council members highlighted two key successes in demonstration year 2: (1) the 
level of collaboration with MassHealth and others to achieve a smooth transition for members 
affected by Fallon’s withdrawal from the demonstration, and (2) effective advocacy that 
achieved greater financial stabilization for the MMPs remaining in the demonstration. With 
respect to Fallon, the Implementation Council worked closely with MassHealth, meeting weekly 
during the summer of 2015 during what one member described as a “tenuous time,” with an 
especially sharp focus on continuity-of-care issues for beneficiaries returning to the fee-for-
service system. Shortly after Fallon announced its intent to withdraw from the demonstration, the 
Acting Director of the CMS Medicare-Medicaid Coordination Office and the Assistant Secretary 
of MassHealth attended an Implementation Council meeting. In early September 2015, two 
council members travelled to Washington, DC, to meet with representatives from MassHealth, 
CMS, and other government agencies to evaluate the financial structure of One Care. As one 
MassHealth official noted, the Implementation Council holds an important role in the 
demonstration:  
If we didn't have tremendous support for the program mainly from the users of the 
program, I don't think we would have got CMS to the table to make the kind of 
changes that we needed to keep the program going. I think if the program had 
been unsupported it would have easily… disappeared in a second.  
The discussions in Washington, DC, resulted in changes to the demonstration’s financial 
structure, as outlined in Section 3.5, Financing and Payment.  
Examples of other ongoing areas of engagement and focus for the Implementation 
Council included: 
• Working to clarify and improve the role of the LTS Coordinator in the delivery of 
LTSS. A subgroup was reconvened in 2016 to address several issues, including 
strengthening communication between MMPs and community-based organizations, 
                                                 
23 Additional information on this process and resulting membership will be provided in the next evaluation report. 
24 Materials from Implementation Council meetings can be viewed at: 
https://www.mass.gov/eohhs/provider/guidelines-resources/services-planning/national-health-care-reform-
plan/federal-health-care-reform-initiatives/integrating-medicare-and-medicaid/implementation-council.html 
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achieving greater integration of the LTS Coordinator into service delivery, and other 
policy and operational issues. 
• Collaboratively working on the topic of behavioral health privacy in an integrated 
care model, including the development of behavioral health privacy principles and the 
sharing of best practices by MMPs.  
• Advocating and enhancing the delivery of culturally-competent services. 
• Developing approaches to enhance enrollment outreach, including making stipends 
available to Council members to attend outreach activities. Outreach activities are 
described in Section 3.2, Eligibility and Enrollment.  
• Advocating for more timely and actionable data to assist the council in better 
monitoring the demonstration. The Implementation Council has been exploring 
potential data dashboards or other publicly accessible information tools for tracking 
and displaying key performance indicators and data points that could be adapted for 
One Care. 
• Improving beneficiary education about the care planning process. 
• Closely collaborating with the One Care Ombudsman (OCO). 
• Some of this work has resulted in suggestions for consideration by MassHealth and 
CMS as potential amendments to the three-way contract. Some stakeholders reported 
a concern that focus would shift from One Care to MassHealth’s broader reforms, in 
part based on the size of the respective initiatives. One goal of the Implementation 
Council was to ensure that this did not happen.  
3.4.3 Member Advisory Boards  
As required as part of the demonstration design, each MMP is required to establish a 
Member Advisory Board (MAB). Both MMPs reported that the feedback and input they receive 
from these boards has been valuable on several levels. As one MMP noted, MABs serve as a 
“great sounding board and a thermometer for how things are going.” MMPs reported using 
feedback from MAB members to improve service design. Enrollees commonly raised issues 
regarding transportation to providers and questions about MMP provider networks. In the case of 
at least one MMP, enrollees provided suggestions for improving the readability of the member 
handbooks and other printed materials provided by the MMPs to enrollees. One MMP also noted 
that the MAB provided a sense of community for the participants where it might not have existed 
before. One MMP used feedback from the MAB to improve service design. The One Care 
Ombudsman program and members of the Implementation Council reported meetings with 
MABs. 
Both MMPs noted that although issues and complaints were raised at these meetings, 
advisory board members also reported positive experiences with the demonstration overall and 
viewed the MAB as an opportunity to provide peer-to-peer outreach to potential new enrollees 
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about actual experiences with the demonstration. One MMP has invited members of the MAB to 
passive enrollment outreach events.  
3.5 Financing and Payment 
 
 
All covered Medicare and Medicaid services are paid on a capitated basis. One Care 
plans receive three monthly capitation payments from CMS and MassHealth. CMS makes a 
monthly payment for Medicare Parts A and B covered services and a separate payment for 
Medicare Part D, prescription drug benefits. MassHealth makes a monthly payment for Medicaid 
covered services—which typically includes non-acute care coverage. In addition to the capitation 
rates, the demonstration incorporates other reimbursement methodologies, including savings 
percentages, high cost risk pools, and risk corridors. This section outlines changes in financing 
and payment since demonstration year 1 and relevant findings relating to these changes. 
3.5.1 Rate Methodology  
As discussed in the first Annual Report, MassHealth officials, MMPs, and stakeholders 
reported concerns about the adequacy of the financing for the demonstration from the outset. In 
the first 18 months of operation, all three plans reported losses. Although a contract addendum 
was executed in September 2014 and another in January 2015,  concerns regarding financial 
sustainability persisted into demonstration year 2. In June 2015, one of the MMPs, Fallon, 
announced its intention of withdrawing from participation in the demonstration as of 
September 30, 2015. Fallon’s withdrawal and the related consequences are discussed in Section 
3.2, Eligibility and Enrollment. 
25
                                                 
25 These contract addenda are discussed in detail in the first Annual Report. 
Highlights 
• All three MMPs reported losses in the first 18 months of operation, leading one MMP 
(Fallon) to withdraw from the demonstration effective September 30, 2015.  
• Several changes to the financial structure of the demonstration were finalized in a 
contract amendment executed in December 2015 that helped to stabilize the 
demonstration.  
• The two remaining MMPs reported improved financial results for CY 2015 and 2016; 
both MMPs reported a goal of increasing enrollment and, in the case of one MMP, 
increasing its geographic coverage area. 
• The percent of enrollees with complex needs has increased over time. While the 
average per member per month (PMPM) spend varied across MMPs and rating 
categories, the average PMPM for demonstration year 2 was $2,560 for one MMP and 
$1,952 for the other, increases from demonstration year 1 of 16 percent and 30 
percent, respectively. 
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On September 2, 2015, representatives from CMS, EOHHS/MassHealth, the Federal 
Office of Management and Budget, the Federal Office of the Actuary, and Implementation 
Council met in Washington, DC, to evaluate the financial structure and payment parameters of 
the demonstration. Several changes were negotiated as part of that meeting which were 
subsequently formalized in a three-way contract amendment executed December 28, 2015 (three-
way contract, 2015). These changes increased capitation rates and revised other financial 
provisions, as described throughout this section. A contract addendum was subsequently 
executed July 5, 2016. This addendum extended the demonstration through December 31, 2018, 
and addressed quality withhold amounts, savings percentages, and risk corridor provisions for 
the 2 additional years of the demonstration. 
3.5.2 Rating Categories and Risk Adjustments 
CMS and MassHealth are each responsible for a portion of the overall capitation rate that 
is paid to MMPs. The Medicaid component is risk-adjusted through the assignment of one of six 
rating categories based on the enrollee’s clinical status and care setting. These rating categories 
are described in detail in the first Annual Report. The Medicare Parts A and B rate component is 
individually risk-adjusted using the prevailing Medicare Advantage CMS-Hierarchical Condition 
Category (HCC) and CMS HCC-End Stage Renal Disease (HCC-ESRD) models. The Medicare 
Part D payment is risk adjusted using the Part D RxHCC model.  
During the time frame of this report, CMS revised the CMS-HCC risk adjustment model 
as it pertains to Medicare-Medicaid beneficiaries for payment of Medicare services.  
Specifically, in November 2015, CMS solicited public comment for a potential revised risk 
adjustment model for Medicare Advantage plans for payment year 2017. In April 2016, CMS 
finalized the revised risk adjustment model for Medicare Advantage for payment year 2017 in 
the CY 2017 Final Rate Notice and Call Letter. The revised model would be implemented in 
both the capitated model demonstrations under the Financial Alignment Initiative and more 
broadly in Medicare Advantage. For payment year 2016, capitated payments to MMPs 
participating in the capitated model demonstrations under the Financial Alignment Initiative 
continued to use the prevailing risk adjustment model. However, CMS adjusted the fee for 
service (FFS) component of the Medicare Parts A and B capitation payments to better align 
payments with FFS costs. 
26
As noted above, the contract amendment executed in December 2015 increased the 
Medicare and Medicaid capitated rates to the plans. The Commonwealth reported that rate 
adjustments over a 2-year period included an increase of $29.8 million in the Medicaid rate and 
an increase of $17.8 million in Medicare. On the Medicaid side, MassHealth increased its base 
rate component to include additional funding for administrative spending, expanded community 
support services, dental services, additional behavioral health services, and complex care 
management.  As MassHealth reported, these changes increased the capitation rates to more 27
                                                 
26 In 2015, CMS evaluated the accuracy of the 2014 CMS-HCC risk adjustment model in predicting costs of 
Medicare-Medicaid enrollees. The evaluation found that the model predicts national costs well for Medicare-
Medicaid enrollees who are long-term residents in facility settings, and under-predicts costs for full-benefit 
enrollees and over-predicts costs for partial-benefit Medicare-Medicaid enrollees residing in the community. 
27 As described in the first Annual Report, not all of these costs had been built into the initial One Care rates. 
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accurately account for spending on administrative and health service components of participating 
MMPs necessitated by the acuity and service need of the population served by One Care. As part 
of the agreements, the remaining two MMPs committed to stay in the demonstration through the 
end of 2016, the anticipated expiration of the demonstration at that time. Specifics of those rates 
can be found in the Final Rate Reports for CY 2016 and CY 2017.  28
CMS, MassHealth, and the MMPs reported that these changes had a significant beneficial 
impact on stabilizing the demonstration. Some members of the Implementation Council 
expressed regret that these changes happened only after Fallon’s withdrawal from the 
demonstration. These members also highlighted the need for transparent public reporting of data 
to allow stakeholders access to timely information on One Care’s performance. Additionally, one 
MMP expressed some concern as to the accuracy of MassHealth’s capitation for certain rating 
categories (specifically the rating category for enrollees with chronic behavioral health diagnoses 
and the most significant service needs, such as co-occurring substance use disorder or serious 
mental illness) compared to MMP cost experience.  
3.5.3 Savings Percentage 
In computing the capitation payment rates, aggregate savings percentages are applied to 
the Medicare Parts A and B component and the Medicaid component of an MMP’s total 
capitation. Savings percentages are not applied to the Part D component. The original savings 
percentages for demonstration years 2 and 3 were reduced as part of the contract amendment 
executed in January 2015 (three-way contract addendum, January 2015, p. 2). Initially set at 1.5 
percent for demonstration year 2 and 4 percent for demonstration year 3, the savings percentages 
were reduced to 0.5 percent and 2 percent, respectively. They were further reduced to zero for 
both demonstration years as part of the contract amendment executed in December 2015.  Per 
the addendum executed in July 2016 that extended the demonstration for an additional 2 years, 
savings percentages were set at 0.25 percent and 0.50 percent for demonstration years 4 and 5, 
respectively.  
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3.5.4 Quality Withholds 
CMS and MassHealth withheld a certain percentage of their respective components of the 
capitation rates (i.e., to the Medicare Parts A and B and Medicaid components; no withhold was 
applied to the Part D component). The withhold amounts repaid to the One Care plans were 
subject to each plan’s performance benchmarked against quality thresholds established for each 
demonstration year. In demonstration year 1, the withhold amount was set at 1 percent, with the 
withhold increasing to 2 percent in demonstration year 2, and 3 percent in demonstration year 3. 
As part of other financial changes made as part of the December 2015 contract amendment, the 
quality withhold percent was reduced to zero for demonstration year 2. Though no financial 
penalties were applied for demonstration year 2, State officials reported that MMPs were still 
                                                 
28 This report can be accessed at: http://www.mass.gov/eohhs/provider/guidelines-resources/services-
planning/national-health-care-reform-plan/federal-health-care-reform-initiatives/integrating-medicare-and-
medicaid/one-care-capitated-rate-reports.html 
29 As reported in the first Annual Report, one criticism by MMPs and stakeholders of the initial rate structure 
design was that the timeframe for expecting savings from the demonstration was too aggressive. Some of the 
factors cited included start-up costs, the need to invest in new models of care, early implementation issues, and 
the need for adequate time to affect outcomes through improved care coordination.  
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expected to report on and meet the required quality measures; the Commonwealth and CMS 
continued to use data collected on these measures for contract management. The quality withhold 
was reduced from 3 to 1 percent for demonstration year 3. 
Because the withhold amounts for CY 2014 were not finalized at the time of the first 
Annual Report, they are included in this report in Table 10 and Table 11. Earned quality 
withhold payments across all three MMPs were approximately $810,000 in Medicaid payments 
(Table 10) and approximately $1,086,000 in Medicare payments (Table 11) in CY 2014. In total, 
Medicaid and Medicare made approximately $1,900,000 in earned withhold payments across all 
three MMPs in CY 2014. Two of the three MMPs (CCA and Tufts) reported quality withholds of 
$0 in 2015 as the quality withhold for these MMPS was set to 0 percent in CY 2015. 
Table 10 
Quality withhold measures: MassHealth payments for calendar year 2014 
One Care plan 
Number of 




Percent of earned 
withhold 
Earned quality payment 
(rounded) 
CCA 3 out of 6 $864,000 50 $432,000 
Fallon 5 out of 6 $318,000 100 $318,000 
Tufts 4 out of 6 $80,000 75 $60,000 
CCA = Commonwealth Care Alliance.  
NOTES: Quality withholds were calculated separately for the first quarter of the demonstration (October 1, 2013–
December 31, 2013). For that quarter, all three MMPs met each of the three required measures. Withhold amounts 
varied from $60,000 to $6,000 and all three MMPs received 100 percent of the earned withhold amounts. 
SOURCE: MassHealth Open Meeting, May 24, 2016. 
Table 11 
Quality withhold measures: CMS Medicare payments for calendar year 2014 









CCA $989, 000 50 $495,000 
Fallon $484,000 100 $484,000 
Tufts $143,000 75 $107,000 
NOTES: Quality withholds were calculated separately for the first quarter of the demonstration (September October 
1, 20131, 2014–December 31, 20143). For that quarter, all three MMPs met each of the required measures. 
Withhold amounts varied from approximately $9,000 to $79,000, and all MMPs received 100 percent of the earned 
withhold amounts. 
SOURCE: CMS, May 2017. 
Quality withholds for calendar year 2014 included three core measures that apply across 
all demonstrations under the Financial Alignment Initiative as well as three State-specific 
measures. The CMS core measures include measures relating to completed assessments; 
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encounter data; and establishment of MMP member advisory boards. The State-specific 
measures include measures related to centralized enrollee record; documented discussion of care 
goals; and access to LTS Coordinators. Quality withhold payments by CMS and MassHealth 
were tied to performance on both the core and State-specific measures. (Three-way contract, 
2015, pp. 206–7). 
3.5.5 High-Cost Risk Pools 
The demonstration design established a high-cost risk pool (HCRP) designed to 
redistribute funding across MMPs in the event of disproportionate enrollment of high-cost 
beneficiaries. The first Annual Report provides detail about how the HCRP operated. The 
January 2015 contract addendum eliminated the HCRPs for demonstration year 1.  It also 
provided flexibility to eliminate HCRPs in future years: subsequently, HCRPs were eliminated 
for demonstration years 2 and 3.  
30
3.5.6 Risk Corridors 
The three-way contract established risk-sharing corridors for demonstration year 1 and 
set forth the method for calculating the percentage of the gain or loss to be shared by the MMP, 
CMS, or MassHealth. The three-way contract was amended in September 2014 and January 
2015 to expand and extend the risk corridors for the demonstration. For MMPs with losses, the 
extension of the risk corridors reduced their share of losses and increased the proportion that 
CMS and MassHealth would have to bear. The July 2016 contract addendum established risk 
corridors for demonstration years 4 and 5, consistent with the methodology for demonstration 
year 3.  
3.5.7 Reported Cost Experience  
Officials from CMS, MassHealth, and the MMPs reported that the financial status of One 
Care improved following the changes made in the December 2015 contract amendment. As one 
MassHealth official noted: 
One Care is in a much more stable place than it was before. It is a stable program. 
It is sustainable. And that was a big focus of when we were going through the 
financial negotiations with CMS. We have to sustain this program, we have to 
stabilize it. We have to get it to a sustainable place. And I think we've very much 
turned the corner on that and done that, and we have positive results to show on 
that so far. 
In addition to the increased Medicare and Medicaid capitation rates, one MMP also 
reported the importance of changing the timing of Part D reconciliation payments. As noted in 
the first Annual Report, MMPs experienced high pharmacy costs, which were attributed in part 
to the Medicare-Medicaid population served by One Care. CMS has increased prospective Part D 
Low Income Cost Sharing Subsidy (LICS) amount and reinsurance payments to more closely 
                                                 
30 The One Care plans expected this change to be budget neutral and health care reimbursement plan withholdings 
were refunded to each plan through May 2015. Beginning in June 2015, the HCRP withholdings were no longer 
withheld as part of the rate payments. . 
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align with the plan’s projected costs, which has reduced the need of the MMP to carry the bulk 
of these pharmacy costs for extended periods of time. MMPs also remarked favorably on other 
adjustments to savings percentages, risk corridors, and other contract changes. Because of these 
combined changes, the MMPs reported improvements in their financial situation in 
demonstration year 2.31 Table 12 presents the One Care plan revenue and spending for 
demonstration years 2 and 3. Both MMPs show increasing revenues and spending in 
demonstration year 3, with one MMP showing increased net gains and the other indicating a new 
loss of almost 12 percent. 
Table 12 
One Care plan revenue and spending for demonstration years 2 and 3 
Revenue and 
spending 
January 1, 2015 to December 31, 2015 January 1, 2016 to December 31, 2016 
CCA Tufts Health Unify CCA Tufts Health Unify 
Total revenue $390,439,960 $53,496,338 $431,736,831 $72,317,561 
Total spending $375,809,100 $51,590,243 $408,492,208 $80,056,801 
Net income $14,813,130 $1,906,095 $23,244,623 ($7,739,240) 
Net gain/loss 3.8%  3.6% 5.4%  (10.7%) 
CCA = Commonwealth Care Alliance.  
NOTES: Financial information from CY 2015 and CY 2016 may not be directly comparable due to the completion 
of financial reconciliation. Total revenue includes Medicaid Premiums; Medicare Parts A & B Premiums; Medicare 
Part D Premiums; Medicare Part D LICS & Reinsurance; Investment Income; Quality Incentive Revenue; Risk 
Corridor Payments; High Risk Cost Pool; Other Revenue—Medicaid; and Other Revenue—Medicare. Total 
spending includes Medical Expenses (Inpatient—Acute, Inpatient—MH/SA, Hospital Outpatient, Outpatient- 
MH/SA, Professional, HCBS/HomeHealth, LTC Facility, Pharmacy Part D, Pharmacy Non Part-D, DME and 
Supplies, Transportation, Incurred but not Reported, and All Other) and Administrative Expenses (HCQU 
Expenditures, Direct Variable Expenses, Direct Fixed Expenses, Indirect Variable Expenses, Indirect Fixed 
Expenses, and Expenses Disallowed by CMS). 
SOURCE: January 1, 2015—December 31, 2015 CCA data are derived from plan reported data to MassHealth as of 
May 1, 2017. January 1, 2016—December 31, 2016 CCA data are derived from plan reported data to MassHealth as 
of July 31, 2017. January 1, 2015—December 31, 2015 Tufts data are derived from plan reported data to 
MassHealth as of April 30, 2017. January 1, 2016—December 31, 2016 Tufts data are derived from plan reported 
data to MassHealth as of July 30, 2017. 
MMPs previously reported the need to make significant up-front investments, which, in 
part, contributed to initial financial losses. One MMP reported seeing some early signs of return 
on some of those initial start-up costs and investments:  
I would echo that it’s early yet and we have some early promising data that 
suggests that over time with people engaged in our model that we’re starting to 
bend the cost curve in certain key areas. One of the key findings is that 
particularly for populations like our One Care population with unmet need, 
marginalization, social/behavioral health complexity, stigma, that engagement 
period takes longer than we would have hoped. But we have lots of certainly very 
                                                 
31 As detailed in the first Annual Report, CCA reported a loss of approximately $18 million for demonstration year 
1 and for Tufts, a loss of approximately $500,000.  
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positive anecdotal evidence like some of the stories told here and many, many, 
many more to show that we can not only engage people, but actually start to 
engage them in meaningful primary preventive care and to defray acute care 
utilization. We have early findings from the first quarter of this year that suggest 
that our medical expenses are making a downward trend, but I think it’s still early.  
MassHealth and the MMPs reported different cost experiences related to disenrollment 
rates. Because of the early cost investments, one MMP was concerned about enrollment retention 
periods, as they were experiencing higher disenrollment rates for certain cohorts: 
One of the challenges for the program is you do all this work, you get people 
enrolled, you spend a lot of money on them. We know that if they stay after nine 
to 12 months, which is longer than the typical managed care population, after that 
period they stabilize and we see some plateauing of their utilization but [right 
now] we don’t keep them. From an underwriting perspective, that’s difficult. 
Although MassHealth, CMS, and the MMP expressed an interest improving their understanding 
of factors influencing disenrollment, no beneficiary surveys or other data were available at the 
time of the RTI site visit to inform this experience. 
Based on financial data provided by the MMPs to MassHealth, the average PMPM spend 
for demonstration year 2 was $2,560 for CCA and $1,952 for Tufts, an increase from 
demonstration year 1 of 16 percent and 30 percent, respectively. MassHealth and officials from 
the MMPs attributed this change, in part, to increased complexity of beneficiaries enrolled in the 
demonstration. For example, both MMPs experienced significant decreases in the proportion of 
enrollees assigned the lowest community rating category (C1)32 in demonstration year 2: CCA 
decreased from 52 to 34 percent, and Tufts decreased from 41 to 30 percent.  
In demonstration year 3, the PMPM medical expense service spend across all rate cells33 
was $2,783 for CCA and $2,468 for Tufts, representing increases of approximately 9 percent and 
26 percent from demonstration year 2, respectively. From demonstration year 2 to demonstration 
year 3, CCA saw an increase in the overall number of member months, with a large decrease in 
the number of member months in the C1 Community: Other rating category (42,425 member 
months to 24,809 member months). All other rating categories had an increase. From 
demonstration year 2 to demonstration year 3, Tufts had an increase in the overall number of 
member months, with an increase in the number of member months in the C1 Community: Other 
and C2A Community: High Behavioral rating categories. 
MassHealth officials reported that average PMPM amounts reflected more significant 
fluctuations when broken down across MMPs and rating categories. Plans reported different 
enrollment patterns, case mix, enrollment numbers, and differences in care approaches, some or 
all of which influence these differences. The MMPs noted that their membership included a 
higher proportion of people with complex behavioral health needs, with a heavy substance use 
disorder overlay.  
                                                 
32 See the first Annual Report for a description of the MassHealth rating categories for One Care. 
33 See Table 13 for the service categories. 
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MMPs also observed that limiting the demonstration to younger Medicare-Medicaid 
beneficiaries presented unique differences from other programs that affected costs. One MMP 
noted: 
We think this demonstration is the right thing to do. It serves a population who 
traditionally have flown under the radar, but we find the under-65 focus in 
Massachusetts to be a blessing and a curse. It’s a blessing because it forces us to 
focus on very hard-to-reach people. It’s a curse because they are really hard to 
serve and we have no offsetting of well elders aging in place with medical frailties 
but with none of the social challenges that the folks [we serve] have.  
Table 13 shows the percentage PMPM service spend in demonstration years 2 and 3 for 
CCA and Tufts. Both MMPs reported similar PMPM spend by service category. 
Table 13 
Percentage PMPM spend by service category: 
Demonstration years 2 and 3 
Service 
January 1, 2015–December 31, 2015 January 1, 2016–December 31, 2016 
CCA: % Tufts: % CCA: % Tufts: % 
Inpatient—Acute 14.8 19.5 13.8 20.6 
Inpatient—Mental health and 
substance abuse 
4.9 6.4 6.1 4.8 
Hospital outpatient 8.3 9.3 8.8 9.2 
Outpatient—Mental health and 
substance abuse 
4.7 5.9 4.5 6.1 
Professional 11.0 7.5 10.8 7.6 
Home and community-based 
services/home health 
15.6 13.8 15.9 13.7 
Long-term care facility 1.4 1.5 1.6 2.0 
Pharmacy Part D 25.7 28.2 22.2 24.6 
Pharmacy non-Part D 0.9 0.5 0.9 0.4 
Durable medical equipment and 
supplies 
3.8 1.2 3.7 2.9 
Transportation 4.3 3.2 4.3 4.0 
Incurred but not reported 0.0 0.1 3.8 1.1 
All other 4.5 3.1 3.6 3.0 
Total medical 100.0 100.0 100.0 100.0 
CCA = Commonwealth Care Alliance.  
NOTE: Incurred but not reported (IBNR) spending is an estimate of costs that have been incurred for services 
provided during the reporting period, but that have not yet been billed or adjudicated. 
SOURCE: One Care Plan Submissions to MassHealth as of August 2017. 
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3.6 Quality of Care 
This section provides information on the quality measures for the demonstration and 
updates on the quality management structure for the demonstration and includes HEDIS results. 
Results of quality measures for the demonstration period are discussed in Section 5, Service 
Utilization.  
3.6.1 One Care Quality Measures 
As described in the first Annual Report, the demonstration requires that MMPs report 
standardized quality measures. These measures include a set of core measures specific to all 
capitated demonstrations under the Financial Alignment Initiative and a set of State-specific 
measures that were selected by One Care staff in consultation with CMS. The demonstration also 
utilizes quality measures required of Medicare Advantage plans, including applicable measures 
from the Part C and Part D Reporting Requirements such as appeals and grievances, pharmacy 
access, payment structures, and medication therapy management. One Care plans submit two 
additional measure sets as part of the Medicare Advantage requirement: selected Medicare 
Healthcare Effectiveness Data and Information Set (HEDIS) measures; and selected Health 
Outcomes Survey (HOS) measures. Several adjustments and changes to reporting requirements 
have been made over the course of the demonstration.  Reporting and performance on some of 
these measures constitute quality withholds, meaning that a percentage amount is withheld from 
capitation rates and returned to the MMPs subject to their performance on certain quality 
metrics. Measures may change for different demonstration years. 
34
While MMP officials reported that the required quality measures were useful overall, 
they observed that some measures appeared to focus more on compliance than quality, and a few 
did not appear particularly useful for the Medicare-Medicaid beneficiaries served by One Care 
As an example, one MMP noted that it reported “infinitesimal numbers” when reporting 
measurements around congestive heart failure and chronic obstructive pulmonary disease. One 





• MassHealth, CMS, the MMPs, and other independent organizations have a role in the
quality oversight of One Care.
• Officials from MassHealth and the MMPs report that while the demonstration is
sufficiently mature to produce data on quality indicators, it is still too early to reach
any meaningful conclusions.
• One Care lacks comparable quality metric benchmarking because it is the only State
with a demonstration under the Financial Alignment Initiative that limits enrollment to
individuals under age of 65 at the time of enrollment.
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MMP noted that the specifications as written did not always translate well into quality 
measurement. 
Both MMPs noted the challenging resource and time requirements needed to report 
measures that relied on extensive provider-level chart review. MassHealth officials recognized 
some issues but noted that overall, the concerns were of the type to be expected for any measures 
set. MMPs also reported a collaborative relationship with MassHealth and CMS around 
interpreting and improving reporting guidelines and procedures. 
In the first demonstration year, MassHealth reported that the demonstration had not yet 
matured to the point where sufficient data were available to inform many of the quality activities 
related to One Care. Moving from demonstration year 2 into demonstration year 3, the challenge 
has shifted from data collection to data measurement. Although data on these measures, 
including HEDIS and CAPHS data, are now being reported, MassHealth and MMP officials 
noted that it was still too early to draw conclusions from the data, and in some cases, too early to 
even identify trends, especially since some reported measures reflected small numbers of 
beneficiaries. Also, MassHealth and MMPs both noted the difficulty of benchmarking quality 
data to other programs in the Commonwealth or to other demonstrations under the Financial 
Alignment Initiative because they were the only demonstration that limited enrollment to 
beneficiaries under the age of 65 at the time of enrollment.  
3.6.2 Quality Management Structures and Activities 
MassHealth, CMS, the MMPs, and other independent organizations have a role in quality 
oversight; the overall quality management structure and activities for One Care are described in 
the first Annual Report. As the demonstration has matured, MassHealth officials reported that 
they have had fewer meetings with the MMPs as a group to review core and state-specific quality 
measures. Meetings were initially held bi-weekly, then monthly, and now meetings are held on a 
quarterly basis. These meetings are also used for best practice development sessions.  
MassHealth conducts on-site clinical reviews on an annual basis (bi-annual in some cases), 
primarily focused on the adequacy of the Centralized Enrollee Record and its required elements.  
35
MassHealth reported a preliminary observation of improvement to the quality of 
beneficiaries’ behavioral health services. This observation was primarily derived through 
anecdotal sources but was consistent with other preliminary One Care data. MassHealth staff 
also reported high satisfaction with the initial CAHPS results.  Both MMPs reported quality 
improvement activities focused on a number of areas including access, utilization, beneficiary 
experience, and beneficiary outcome. Both MMPs have primarily focused on required quality 
activities at this point in the demonstration, including but not limited to HEDIS measures, 
CAHPS surveys, chronic care improvement projects (CCIP), and quality improvement projects 
(QIP). For CY 2015 and 2016, one MMP focused on cardiovascular disease prevention in high-
risk diabetics as its CCIP and on investigating beneficiary experiences with the LTSS 
coordinator role as its QIP (KEPRO [formerly APS Healthcare]: Massachusetts External Quality 
Review Reports for CCA and Tufts: Calendar Year 2015, 2016). The other MMP focused on 
36
                                                 
35 These meetings were initially held bi-weekly, then monthly. 
36 CAHPS results are reported in Section 4, Beneficiary Experience. 
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improving diabetes health outcomes as its CCIP and on emergency department utilization and 
LTSS as its QIP.  
3.6.3 Independent Quality Activities 
The Implementation Council plays key roles in monitoring access to health care and 
compliance with the Americans with Disabilities Act (ADA), tracking quality of services, and 
promoting accountability and transparency. In part, the Implementation Council examined 
quality by reviewing issues raised through the grievances and appeals process and One Care 
Ombudsman reports, soliciting beneficiary feedback, and monitoring access to services. 
Additionally, the Implementation Council and MassHealth established a quality subgroup; 
MassHealth collaborated with this subgroup to design a Quality of Life survey for One Care 
beneficiaries (Henry et al., 2015, 2016). MassHealth expressed a preference for ad hoc meetings 
of the quality subgroup, in part they felt the flow of data reporting did not lend itself to regular 
monthly or quarterly meetings. 
Additionally, the One Care Ombudsman (OCO) program provides independent advocacy 
on behalf of beneficiaries and identifies broader systematic issues impacting quality of care. The 
OCO reports quarterly to MassHealth and regularly attends and presents on quality issues at the 
monthly Implementation Council meetings. Data on complaints and grievances is presented in 
Section 4, Beneficiary Experience. At the end of demonstration year 2, MassHealth was in the 
process of extending the OCO’s contract through May 31, 2017. MassHealth reported its 
intention to submit an application in January 2017 in response to a funding opportunity through 
CMS for on-going support of the OCO. Funding has since been awarded and is expected to begin 
on June 1, 2017. 
An External Quality Review Organization (EQRO) annually validates Medicaid’s 
performance measures and its CCIPs and QIPs. For the purposes of these reports, the 
performance rates of One Care plans are compared to the national Medicaid percentiles. As 
described previously, MMPs are required to have a member advisory board to provide regular 
feedback on issues of demonstration management and enrollee care. The member advisory 
boards are also described in Section 4, Beneficiary Experience. 
3.6.4 Results for Selected Quality Measures 
HEDIS Quality Measures Reported for One Care Plans 
Twelve Medicare HEDIS measures for MMP enrollees are reported in Table 14. RTI 
identified these measures for reporting in this Evaluation Report after reviewing the list of 
measures we previously identified in RTI’s Aggregate Evaluation Plan as well as the available 
HEDIS data on them for completeness, reasonability, and sample size; 2015 calendar year data 
were available for two out of the three One Care plans. Detailed descriptions of the measures can 
be found in the RTI Aggregate Evaluation Plan.37 As noted in Table 14, several of these 
measures also serve as quality withhold measures for One Care. Results were reported for 
measures where sample size was greater than 30 beneficiaries. In addition to the results for each 
                                                 
37 https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-Coordination/Medicare-
Medicaid-Coordination-Office/FinancialAlignmentInitiative/Downloads/EvalPlanFullReport.pdf 
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MMP, the mean value for Medicare Advantage plans in 2015 for each measure is provided for 
comparison.  
Table 14 


















Adult body mass index (BMI) assessment 93.0 — 77.9 — 92.2 
Adults’ access to preventive/ambulatory 
health services† 
94.7 96.9 97.5 96.4 96.0 
Annual monitoring for patients on persistent 
medications 
          
Annual monitoring for members on 
angiotensin converting enzyme (ACE) 
inhibitors or angiotensin receptor blockers 
(ARB) 
92.6 89.6 91.1 82.3 85.2 
Annual monitoring for members on 
digoxin 
57.4 — — — — 
Annual monitoring for members on 
diuretics 
92.9 90.9 90.3 81.7 86.3 
Total rate of members on persistent 
medications receiving annual monitoring 
91.9 89.9 90.6 81.8 85.5 
Antidepressant medication management            
Effective acute phase treatment1 69.6 65.0 56.6 — 83.1 
Effective continuation phase treatment2 55.6 53.7 45.3 — 74.7 
Blood pressure control3†† 67.6 54.7 61.1 63.4 64.1 
Breast cancer screening 72.3 — 83.1 — — 
Colorectal cancer screening 66.7 — 46.2 — 57.5 
Comprehensive diabetes care            
Received Hemoglobin A1c (HbA1c) 
testing 
93.1 95.9 93.2 91.9 88.8 
Poor control of HbA1c level (> 9.0%) 
(higher is worse) 
28.4 55.2 58.2 31.6 29.7 
Good control of HbA1c level (< 8.0%) 61.8 35.8 35.0 56.6 62.0 
Received eye exam (retinal)  68.3 66.9 66.2 72.8 63.1 
Received medical attention for 
nephropathy 
95.5 92.5 93.7 93.4 93.7 
Blood pressure control (< 140/90 mm Hg) 60.9 66.7 60.8 75.0 69.7 
Follow-up after hospitalization for mental 
illness†† 
51.0 55.4 72.1 78.4 76.6 
Initiation and engagement of alcohol and 
other drug (AOD) dependence treatment† 
          
Initiation of AOD treatment4 32.3 43.8 43.3 32.8 40.0 
Engagement of AOD treatment5 3.2 7.1 11.3 9.4 13.2 
(continued) 
  45 
Table 14 (continued) 


















Plan all-cause readmissions (average 
adjusted probability total) (higher is worse; 
these data are not percentages)† † 
17.3 22.5 22.0 18.2 22.2 
Ambulatory care (Per 1,000 members; these 
data are not percentages)  
          
Outpatient visits 9,161.2 10,825.6 12,192.0 8,831.7 9,581.0 
Emergency department visits (higher is 
worse) 
607.8 1,318.6 1,418.6 1,176.0 1,446.3 
CCA = Commonwealth Care Alliance; — = not available.  
1 Represents the percentage of members who remained on an antidepressant medication for at least 84 days 
(12 weeks). 
2 Represents the percentage of members who remained on an antidepressant medication for at least 180 days 
(6 months). 
3 The following criteria were used to determine adequate blood pressure control: less than 140/90 mm Hg for 
members 18–59 years of age; diagnosis of diabetes and < 140/90 mm Hg for members 60–85 years of age; no 
diagnosis of diabetes and < 150/90 mm Hg for members 60–85 years of age. 
4 Represents percentage of members who initiate treatment through an inpatient AOD admission, outpatient visit, 
intensive outpatient encounter or partial hospitalization within 14 days of the diagnosis. 
5 Represents the percentage of members who initiated treatment and who had two or more additional services with a 
diagnosis of AOD within 30 days of the initiation visit. 
† Indicates HEDIS measure that is included as part of state-specific quality withhold measures. The Massachusetts-




†† Indicates HEDIS measure that is included as part of core quality withhold measures for demonstration years 2–3 





NOTES: Data for fall risk management, physical activity in older adults, and management of urinary incontinence in 
older adults do not apply to the under age 65 demonstration population. Data for which the final sample size was 
< 30 were determined too small to present; in cases where final sample size was unavailable, RTI used eligible 
population to make this determination. Detailed descriptions of HEDIS measures presented can be found in the RTI 
Aggregate Evaluation Plan: https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-
Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/Downloads/EvalPlanFullReport.pdf. 
SOURCE: RTI analysis of 2014 and 2015 HEDIS measures.  
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We provide national benchmarks from Medicare Advantage plans, where available, 
understanding that Medicare Advantage enrollees and demonstration enrollees may have 
different health and sociographic characteristics that would affect the results. Previous studies on 
health plan performance reveal poorer quality ratings for plans serving a higher proportion of 
dual eligible beneficiaries and beneficiaries with disabilities. HEDIS measure performance, in 
particular, is slightly worse among plans active in areas with lower income and populations with 
a higher proportion of minorities (Office of the Assistant Secretary for Planning and Evaluation, 
2016). Benchmarks should be considered with those limitations in mind. These findings on One 
Care MMP HEDIS measure performance represent the early experience in the demonstration, 
and are likely to change over time as MMPs gain more experience in working with enrollees. 
Monitoring trends over time in MMP performance may be more important than the comparison 
to the National Medicare Advantage plans, given the population differences. Several years of 
HEDIS results are likely needed to know how well MMPs perform relative to each other and 
whether they perform above or below any potential benchmark. 
For each measure reported for One Care, results across CCA and Tufts vary, and there 
was not a consistent trend across measures for one MMP versus the other. For four measures 
reported (adults’ access to preventive/ambulatory health services, follow-up after hospitalization 
for mental illness, and initiation and engagement of alcohol and other drug dependence 
treatment), both plans performed better than the national Medicare HMO benchmark value in 
2015. For the remaining measures, one or both plans performed below the 2015 benchmark 
value. These measures related to adult BMI assessment, annual monitoring for patients on 
persistent medications, antidepressant medication management, blood pressure control, 
colorectal cancer screening, comprehensive diabetes care, plan all-cause readmissions, and 
ambulatory care.  
Performance on HEDIS measures remained relatively stable between 2014 and 2015. 
However, CCA experienced decreases in the percentage of enrollees with antidepressant 
medication management, blood pressure control for enrollees receiving diabetes care, and 
disease modifying anti-rheumatic drug therapy in rheumatoid arthritis. CCA also saw a nearly 17 
percent increase in the number of enrollees receiving follow-up after hospitalization for mental 
illness. Tufts saw a decrease in eye exams and blood pressure control among those receiving 
diabetes care, and an increase in control of HbA1c level (< 8.0 percent) for those receiving 
diabetes care and initiation of alcohol and other drug dependence treatment. Ambulatory care per 
1,000 members for outpatient visits increased between 2014 and 2015 for both CCA and Tufts, 
which is desirable, but ambulatory care for emergency department visits also increased for both 
CCA and Tufts, which is not desirable. 
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4. Beneficiary Experience 
 
 
One of the main goals of the demonstration under the Financial Alignment Initiative is to 
improve the beneficiary experience accessing Medicare and Medicaid. This section highlights 
beneficiary experience with One Care and provides information on beneficiary protections, data 
related to complaints and appeals, and critical incident and abuse reports. The section also 
includes information on the experience of special populations.  
4.1 Methods and Data Sources 
In line with all Medicare Advantage plans, One Care plans conducted annual assessments 
of beneficiary experiences using a Medicare Advantage Prescription Drug CAHPS survey 
instrument, which included question items added for the Financial Alignment Initiative 
evaluation of capitated model demonstrations. This section presents results from the 2015 and 
2016 CAHPS survey. This section also presents results from the 2015 and 2016 Quality of Life 
survey, key informant interviews with MassHealth officials, One Care representatives, CBO 
staff, and other relevant stakeholders along with input received from the Implementation Council 
and the MMP MAB. Complaint, grievance, and appeals data are also included in this section. 
Sources of these data include CMS’s Complaint Tracking Module, Report covering October 
2014–December 2016; MMP reported data for Core Measure 4.2; IRE data for January 2014–
December 2015; and ACL’s quarterly data report for January 1, 2015–March 31, 2016.  
Highlights 
• Many success stories about One Care have been reported by beneficiaries directly and 
anecdotally from stakeholders. Medicare-Medicaid enrollees report overall 
satisfaction with One Care. This is often attributed to the availability of new and 
expanded services offered by the demonstration as well as care coordination activities.  
• Across multiple data sources—focus group, CAHPS survey, and Quality of Life 
survey—most One Care enrollees expressed satisfaction with their plan, health care 
and services, and their providers.  
• One Care enrollees considered to be special populations shared mixed feedback about 
access to behavioral health services. A few focus group participants reported 
challenges accessing specialists including behavioral health providers, whereas 
CAHPS survey respondents indicated that between 68 to 87 percent of enrollees who 
needed treatment or counseling were always or usually able to receive it.  
• One Care enrollees in need of home care assistance were able to access and avail 
themselves of this care provided through their plan.  
• Based on data provided by MassHealth, the delivery of transportation services 
continues to generate the largest number of grievances. This is consistent with 
findings from other stakeholder reports as well as the focus groups conducted in both 
2015 and 2016. 
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The RTI evaluation team conducted three focus groups with One Care enrollees who 
were receiving LTSS and had self-reported behavioral health needs. Focus groups targeted 
ethnically and racially diverse One Care enrollees, specifically Hispanic and African-American 
One Care enrollees in Massachusetts. A total of 12 One Care enrollees participated in the three 
focus groups in February 2016. Each session was approximately 2 hours long. Two groups were 
conducted in Spanish and one was conducted in English. The focus groups explored One Care 
enrollees’ experiences with care, their interactions with their providers, their experiences with 
One Care beneficiary protections, and the impact of demonstration services on their lives. For 
Spanish-speaking enrollees, the focus groups also aimed to understand their experience with the 
demonstration as a special population, including the availability of Spanish-speaking care 
coordinators, medical staff, or translators, and the level of cultural sensitivity care coordinators 
and other One Care staff exhibited. Focus group participants received gift cards as a token of the 
RTI evaluation team’s appreciation for their input. Findings from a previous round of focus 
groups conducted by RTI in June 2015 were reported in the first Annual Report. See Section 1.1 
for a full description of these data sources.  
4.2 Impact of the Demonstration on Beneficiaries 
4.2.1 Overall Satisfaction with the Demonstration 
Focus groups and CAHPS and Quality of Life survey results provide insight into how 
satisfied beneficiaries are with the demonstration. The Black and Spanish-speaking focus group 
participants reported experiences with One Care like those participating in the non–Spanish-
speaking focus groups conducted in 2015 and discussed in the first Annual Report.  
Many focus group participants also expressed satisfaction with One Care. Although some 
participants noted issues with service delivery, they often characterized the demonstration overall 
as being better than the care they previously received. One participant said that before enrolling 
in the demonstration, “there was no help.” Another participant stated: 
They changed my plan to [One Care] and it is tremendous. People are concerned 
about me. They do whatever they have to do so I feel well.  
Some of the factors contributing to satisfaction included the availability of new benefits 
and assistance provided through care coordination, feedback that was consistent with the 
findings from the focus groups conducted the previous year.  As one participant reported: 
“Before One Care, I had to fight for everything. Now I love it. As I tell you, it’s magic. If I call 
at 9, I know something will be done at 5.” One participant reported seeing an improvement the 
second year: 
38
The first year, they did the full assessment, everybody came. They made their 
salary that day, but they just didn’t do anything for me, [and the services and 
equipment they talked about never happened]. It was so discouraging that I didn’t 
even fill out the survey… They came the second year, and that time everything I 
                                                 
38 The first set of focus groups were held in July 2015 and are described in the first Annual Report. 
  49 
needed was done within the year, and we even have another plan so for this year 
they were very good… They followed through with everything.  
As indicated in Table 15 below, most 2015 and 2016 CAHPS survey respondents 
indicated they had a favorable view of their health plan. Respondents reported a high degree of 
satisfaction with their health plans, personal doctors, specialists, and drug plans. When asked to 
provide an overall rating (on a scale of 0 to 10 with 10 being the best) of their One Care plan, 
most survey respondents ranked it as a 9 or 10. Only one MMP, CCA, had 2016 CAHPS data on 
the percent of respondents reporting they were “usually” or “always” treated with courtesy and 
respect. One Care plan ratings generally met or exceeded the national distribution for all 
Medicare Advantage contracts and all MMP contracts. 
Table 15 
Beneficiary overall satisfaction, 2015 and 2016 


















Percent rating health 
plan 9 or 10 on scale of 



















Percent rating drug plan 
9 or 10 on scale of 0 



















Percent reporting being 
“usually” or “always” 
treated with courtesy 


















— = data are not available because MMP withdrew from the demonstration. 
MassHealth, MMPs, and other stakeholders also provided anecdotal One Care success 
stories. A member of the Implementation Council noted: 
There are a lot of amazing things happening out there. People who have never had 
access to services are finding those services. They're getting coordination. 
They’ve got access to durable medical equipment and access to behavioral health 
services. I attended three of the outreach programs by the state and I was amazed 
by the stories of folks…. Then I visited the advisory council for [an MMP] and 
was so amazed by what people in that room were talking about they received that 
they hadn’t received before. That’s so exciting and they talked about the value of 
this program. 
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4.2.2 New or Expanded Benefits 
A key design feature of One Care is that it offers new and expanded benefits to enrollees. 
These benefits include diversionary health services, expanded Medicaid services, and new 
community LTSS. Many of the focus group participants described receiving new or expanded 
benefits under One Care, including dental services, eyeglasses, smoking cessation classes, 
nutrition classes, weight loss coaching, and in-home behavioral health services. Similar to 
reports in the first Annual Report, Black and Spanish-speaking focus group participants also 
reported the elimination of pharmacy co-pays as an important feature of One Care. As one 
participant described her experience: 
[One Care] helped pay for a lot of things I couldn’t afford…like dentists, the eyes 
and different medications…. Then to see the zero [for the co-pay] on my 
medications is a blessing.  
Another participant provided the following example: 
[One Care] provided me everything for the bathroom, the railings, the shower, the 
chair for bathing…. They [also] sent me home therapy and I can now walk.  
Some participants in the focus groups conducted in 2016 reported confusion around the 
scope of dental services available under the demonstration. MassHealth and MMP officials who 
were interviewed noted the same issue. MassHealth officials reported a growing trend in dental 
appeals that officials attributed, in part, to a lack of clarity and, in part, to previous unmet need. 
One MassHealth official noted:  
A lot of enrollees haven’t had a comprehensive dental package like they have 
under One Care. One Care has given expansive dental compared to what One 
Care members have had access to before. So, we’re finding a lot of people that 
have had a lot of deterioration in their mouths. Now they finally have access to a 
dentist and they are trying to do a lot of different restorative work that requires 
prior authorization. Sometimes the [physical condition] of the mouth cannot 
support it or there are unique requirements to make sure the right documentation 
is in place.  
In both the 2015 and 2016 focus groups, dental care was an important benefit for 
participants, but one that also led to complaints about access and coverage. In response, 
MassHealth and MMPs reported working together on dental provider education; the goals were 
to better define the scope of dental benefits available to enrollees and expedite the authorization 
process. 
4.2.3 Medical and Specialty Services  
A combined set of Medicare and Medicaid benefits is offered as part of a single benefit 
package under the demonstration. Benefits include coordination by the One Care plans of all 
medical services, including primary care, behavioral health, specialty care, and prescription 
medications. Most focus group participants expressed satisfaction with their primary care 
providers. This is consistent with results reported in the first Annual Report as well as with the 
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findings of the Quality of Life survey administered to One Care enrollees in 2016; over three-
quarters (77 percent) of respondents indicated that they had good relationships with their health 
care and other providers. 
Focus group participants who reported satisfaction specified that their provider knew 
them, communicated well, and cared about their health. Several participants had long-standing 
relationships with their primary care provider; several participants reported relationships going 
back more than 10 years. Participants reported that being able to keep their doctor was an 
important consideration when choosing to participate in the demonstration.  
Although most focus group participants reported overall satisfaction with their providers, 
some expressed dissatisfaction with their primary care provider and, in some cases, reported 
quality of care issues and disagreements over treatment decisions. Despite their dissatisfaction, 
these participants expressed reluctance to switch providers, in part out of concerns that things 
could go “from bad to worse,” that they would “feel bad about it,” or that they were “a bit afraid 
to do so.” Combined grievance data compiled by MassHealth for the period April through 
December 2015 indicated that approximately 10 percent of One Care complaints concerned 
quality of care and provider or network issues.  
In terms of provider communications, some focus group participants reported that their 
primary care and specialist providers communicated well with each other, but other participants 
did not feel there was much communication between them or a team approach. One participant 
noted that lack of communication between medical and behavioral health providers was an 
intentional result of participant preference for separation between those two roles. Of note, 
balancing behavioral health privacy within an integrated care model has been a key focus area 
for the Implementation Council, as described in Section 3.4, Stakeholder Engagement. 
According to the 2016 CAHPS survey data presented in Table 16, approximately two-
thirds of beneficiaries surveyed in all One Care MMPs (range of 63–67 percent) reported having 
the same doctor before enrolling in One Care. This is slightly lower than the percentage of 
respondents who answered affirmatively to the question in 2015 (5 percent lower for CCA, 2 
percent lower for Tufts).  
Table 16 
Beneficiary experience with medical services (including specialists), 2015 and 2016 










Percent reporting that they had the same 











— = data are not available because MMP withdrew from the demonstration. 
SOURCE: RTI Supplemental CAHPS data for 2015 and 2016. 
  52 
4.2.4 Care Coordination Services  
Care coordination is a central component of the One Care demonstration intended to 
ensure comprehensive assessment of enrollees’ medical, behavioral health, and LTSS needs, and 
to coordinate services across the various service systems and providers. One Care MMPs are 
expected to coordinate medical services for enrollees with complex conditions or who are cared 
for by multiple providers. Delivery of care coordination under One Care, including delivery 
systems and models, is discussed in Section 3.3, Care Coordination. This section focuses on 
beneficiary experience with care coordination. By design, One Care enrollees may have multiple 
people coordinating their care. As discussed in Section 3.3, Care Coordination, plans have 
implemented different models of delivery for care coordination, including one MMP that 
contracted out this function.  
While most focus group participants identified a person (or persons) responsible for 
coordinating their care, a few participants reported not having a care coordinator or a person 
calling or checking in with them. Some participants were not able to distinguish among the 
different roles of people involved in their care, especially for participants receiving LTSS though 
a home care agency and working through an LTS Coordinator. As one participant commented: 
I sometimes call ‘eenie, meenie, miny, mo’ for someone and they tell me, ‘No, 
that is not me, that is my co-worker, but I will let her know.’  
For the most part, participants expressed satisfaction with their care coordination services 
and reported that care coordination had helped them access new and existing services. Some 
reported assistance with finding specialists and accessing durable medical equipment. Others 
reported that having a care coordinator provided “peace of mind” and a sense of support. As one 
participant explained: 
My doctor would help me too but [the MMP] is more proactive…When I told [my 
care coordinator] about my eyes, she came up with a name just like that…it’s just 
that my care coordinator is more accessible.  
Table 17 presents CAHPS survey results for beneficiaries’ experience with care 
coordination within the One Care MMPs. Based on 2016 CAHPS survey results, overall between 
30 and 40 percent of respondents had someone from their health plan, doctor’s office, or clinic 
help them coordinate their care. This was a decrease for both plans from 2015, when between 37 
and 44 percent of respondents reported getting help coordinating care. Only CCA had data to 
report on respondent satisfaction with care coordination; that data showed a 1 percentage point 
decrease (from 54 percent in 2015 to 53 percent in 2016) of respondents saying they were very 
satisfied with their care coordination. Between 43 and 56 percent of respondents reported always 
receiving the information they need from their health plan in 2016. For both plans, the 
percentage of respondents that reported always receiving the information decreased between 
2016 and 2015, when the range was between 56 and 61 percent for the same plans. By 
comparison, the national distribution of all Medicare Advantage contracts in 2016 for always 
receiving information was 55 percent and for all MMP contracts was 52 percent. 
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Table 17 
Beneficiary experience with care coordination, 2015 and 2016 





Total Care (%) 
Tufts Health 
Unify (%) 
Percent who had anyone from their health plan, 
doctor’s office, or clinic help them coordinate 












Of those who used care coordination, the 
percent who were “very satisfied” with the help 
from the One Care plan or doctor’s office in 










Percent reporting that health plan “always” gave 











— = data are not available because MMP withdrew from the demonstration. # = sample size too small (greater than 
or equal to 10). 
SOURCE: RTI Supplemental CAHPS data for 2015 and 2016 and CAHPS data for 2015 and 2016. 
4.2.5 Quality of and Access to Care  
Focus group participants provided mixed feedback regarding the degree of provider 
choice and the ease of access to services. Some participants reported satisfaction with their 
ability to access medical care since enrolling in the demonstration. One participant reported: 
It is an exceptionally good plan… because with One Care, I have not had any 
problems getting an orthopedist, cardiologist, and therapist… If there is one I 
cannot go to, they will help me find someone else who is more convenient, who is 
closer, so that you don’t go through any difficulties.  
Other participants reported that they felt provider choice was limited under One Care, and 
a few reported experiencing waiting lists for services, especially for specialists. Based on 
grievance data compiled by MassHealth for the period April through December 2015, the 
number of grievances pertaining to provider networks was not significant (less than 1 percent) 
across the demonstration, but for one MMP, those complaints constituted the second highest 
complaint category after transportation (16 percent of all complaints). The MMP reported 
working with those members individually, with the most common complaint being that the 
beneficiary’s primary care physician or specialist was not in the MMP’s network. The MMP 
noted that its provider network met or exceeded proximity access requirements for facilities and 
providers. Almost three-quarters (74 percent) of respondents to the Quality of Life survey 
administered to One Care enrollees in 2016 indicated that they could easily get the medical 
services they needed.  
Many focus group participants reported issues and complaints about non-emergency 
transportation, which was also discussed in the first Annual Report; lack of transportation 
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impeded access to appointments and other needed services. Some participants reported they no 
longer used the transportation services because of quality issues. In the words of one participant: 
They gave me very bad service…I would have to wait, and I would be late for my 
appointments. And since it was with specialists, I could not be late nor could I 
miss the appointment… I stopped using that transportation because the same thing 
always happened to me.  
Grievance data collected from April 2015 through December 2015 was consistent with 
focus group feedback and indicated that at least one-half of all grievances for both MMPs 
pertained to transportation, ranging from 50 percent to 81 percent. Both MMPs reported 
implementing interventions to improve this service while also noting that less than 1 percent of 
all rides result in a grievance. MMPs also relied on feedback from their member advisory boards, 
where transportation issues were also a topic of concern. 
Table 18 presents the 2015 and 2016 CAHPS survey results for beneficiary experience 
with access to services. Surveys showed that between 30 and 35 percent of respondents needed 
treatment or counseling for a personal or family problem in 2016. This represents a decrease 
from 2015 for CCA. Of those who needed treatment or counseling, 68 and 87 percent of 
responding beneficiaries from Tufts and CCA, respectively, said it was usually or always easy to 
get the treatment they needed in 2016. This is a broader range than reported in 2015, when 
between 83 and 86 percent of respondents had the same response. In 2016, 66 percent of 
respondents from both CCA and Tufts reported that they were usually or always examined on the 
examination table when they visited their personal doctor’s office. This was similar to 2015, 
when 65 and 70 percent of respondents reported this. 
Table 18 
Beneficiary experience with access to services, 2015 and 2016 










Percent who needed any treatment or 











Of those who reported needing it, percent who 
report it is “usually” or “always” easy to get 
the treatment or counseling they needed 











Percent who reported they were “usually” or 
“always” examined on the examination table 











— = data are not available because MMP withdrew from the demonstration. 
SOURCE: RTI and Massachusetts Supplemental CAHPS data for 2015 and 2016. 
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4.2.6 Personal Health Outcomes and Quality of Life  
A key goal of One Care is to positively impact health outcomes and quality of life for 
beneficiaries. Generally, focus group participants reported that the demonstration had positively 
impacted their lives; none reported an adverse impact of the demonstration on health, well-being, 
or quality of life. A few beneficiaries reported significant positive impacts, including an 
individual who was able to access a range of services and assistance not previously available:  
I couldn’t move. I couldn’t walk… I felt I wasn’t going to survive if I didn’t get 
help from [One Care]… I really felt my life was not going to go anywhere; I was 
physically very done, and I didn’t think I had a future… I don’t think I would 
have lived too much longer [without the help One Care gave me]… It helped me 
immensely.  
Most CAHPS survey respondents in both MMPs remaining in the demonstration in 2016 
reported that their doctor usually or always understood how their health problems affected their 
day to day life (see Table 19). In 2016, 81 and 92 percent of respondents reported this; in 2015, 
87 and 90 percent of respondents had the same response. 
Table 19 
Beneficiary experience with personal health outcomes, 2015 and 2016 









Percent reporting that their personal doctor 
“usually” or “always” understands how any 












— = data are not available because MMP withdrew from the demonstration. 
SOURCE: RTI Supplemental CAHPS data for 2015 and 2016. 
4.2.7 Experience of Special Populations 
This section summarizes the beneficiary experience for One Care special populations, 
including individuals with LTSS or behavioral health needs, and racial, ethnic, or linguistic 
minorities. As noted in Section 4.1, RTI conducted three focus groups with Hispanic (two of the 
groups) or Black participants (one group). Generally, Spanish-speaking participants reported that 
they were able to communicate adequately with their MMP and their providers. A few 
participants, especially those who spoke only Spanish, reported that language was a very 
important consideration for them. One MMP reported that using interpreters with whom 
beneficiaries are familiar has been well received and may be helpful in contributing to better 
beneficiary engagement in their care.  
The design of One Care requires enrollees to be offered an LTS Coordinator, who is 
independent of the plans, to coordinate their LTSS. The role of the LTS Coordinator is discussed 
above in Section 4, Care Coordination. Just under half of the focus group participants reported a 
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need for help with activities of daily living (ADLs). Participants did not report many issues in the 
delivery of home care assistance; notably, many of the participants receiving personal care 
assistance self-directed their services, employing a friend or family member, rather than 
receiving services through a homecare agency. As one participant noted: “I said I wanted [to 
employ] my daughter because I don’t trust outsiders.”  
Focus group participants provided mixed feedback on their ability to distinguish their 
MMP-level care coordinator from their LTS Coordinator. In some cases, participants were not 
clear how to distinguish between these staff. As one participant explained: 
And let me tell you, I have two [first name], two [first names], and one [first 
name]. Sometimes [when I need help], I call [and have to ask] “Which one are 
you?”  
Over half of the focus group participants reported depression or anxiety; a third reported 
serious mental illness. Feedback on access to behavioral health services was mixed. A few 
participants reported access challenges for specialists, including for behavioral health. For 
example, one participant reported being on a wait list for psychiatry services, while another 
participant reported increased access to in-home behavioral health services. 
Table 20 presents some CAHPS survey results on beneficiary experience from 
respondents characterized as special populations: 
• From 2015 to 2016, both CCA and Tufts had an increase in the percent of 
respondents that said they needed someone to come into their home to give them 
home health care or assistance, with 31 to 32 percent reporting so in 2016. 
• The two plans (CCA and Tufts) diverged in the number of respondents saying that is 
was usually or always easy to get personal care or aide assistance at home through 
their care plan. In 2016, between 67 and 81 respondents reported this, whereas the 
range was between 68 and 73 for the same plans in 2015. The greater difference is 
due to CCA increasing while Tufts decreased the percent of respondents reporting 
this response category. 
• The range in responses also increased for those who had a health problem for which 
they needed special medical equipment. In 2015, the range was 32 to 35 percent of 
respondents needing such equipment, while in 2016, between 22 and 36 percent said 
they did. This represents a 4-percentage point increase for CCA and a 13-percentage 
point decrease for Tufts. 
• In 2016 only CCA had data for whether respondents found it usually or always easy 
to get or replace medical equipment. It had a decrease from 78 to 70 percent of 
respondents who said this from 2015 to 2016. 
• Most respondents were usually or always weighed when they visited their personal 
doctor’s office in both 2015 and 2016, although the range in percent of respondents 
reporting this in 2016 was greater than in 2015. 
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• Only CCA had 2015 and 2016 data on respondents’ need for interpreter services to 
speak with health providers—7 percent of respondents needed these services in both 
years.  
Table 20 
Beneficiary experience among special populations, 2015 and 2016 





Total Care (%) 
Tufts Health 
Unify (%) 
Percent who needed any treatment or 











Of those who reported needing it, percent who 
report it is “usually” or “always” easy to get 
the treatment or counseling they needed 











Percent who needed someone to come into 












Percent who reported it is “usually” or 
“always” easy to get personal care or aide 











Percent who had a health problem for which 
they needed special medical equipment, such 











Of those who report needing it, percent who 
report it is “usually” or “always” easy to get or 
replace the medical equipment they needed 










Percent who reported they were “usually” or 
“always” weighed when they visited their 











Percent who needed an interpreter to help them 










— = data are not available because MMP withdrew from the demonstration; # = sample size too small (≤ 10). 
SOURCE: RTI and Massachusetts Supplemental CAHPS data for 2015 and 2016. 
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4.2.8 Beneficiary Protections  
The One Care demonstration was designed to ensure enrollees have access to high quality 
health and support services (Commonwealth Proposal, February 16, 2012, p. 23). Protections 
include complaint and appeals processes that provide an avenue for beneficiaries to seek redress 
when they have issues or disagree with decisions made by One Care plans or providers, and the 
availability of an ombudsman program to advocate for the beneficiary. The One Care 
Ombudsman Program (OCO) is an independent entity created through Federal funding to ensure 
adequate oversight of these beneficiary protections that began operating in March 2014. This 
section describes the numbers and types of beneficiary complaints and appeals received about 
One Care. Because One Care integrates Medicare and Medicaid services, these data have been 
compiled from several sources, including the OCO, One Care plans, MassHealth, and Medicare. 
Many focus group participants reported that they were aware of their rights to file a complaint or 
appeal about their services.  
Complaints 
Beneficiaries have the option of submitting a complaint (also known as a grievance) to 
their One Care MMP, MassHealth, Medicare, or the OCO. Complaints or grievances are defined 
to include “dissatisfaction with any aspect of the contractor’s or provider’s operations, activities, 
or behavior, regardless of whether remedial action is requested” (three-way contract, 2013, p. 9). 
Most often, beneficiaries submit complaints directly to their One Care plan. Plans are required to 
develop a system to log complaints and to track all actions and final resolution pertaining to each 
complaint. On a monthly basis, plans must report to MassHealth and to NORC, CMS’ 
implementation contractor, on the status of all outstanding complaints. Beneficiaries may also 
file complaints directly with MassHealth or 1-800-Medicare. MassHealth or Medicare 
documents the details of a complaint in the CMS Complaint Tracking Module (CTM), which is 
used to communicate with the One Care plan when resolution requires plan action. In addition, 
beneficiaries may file complaints with the OCO, which is required to maintain a system for 
documenting and tracking complaints.  
The total number of complaints per 1,000 enrollees reported to MMPs, by quarter, is 
shown in Table 21. The highest percent of complaints occurred in the last quarter of 
demonstration year 2. From CY 2015 to CY 2016, the highest rate of grievances—77.4 per 1,000 
enrollees for One Care combined across MMPs—was during quarter 4 of 2015, the quarter 
following Fallon’s departure from One Care, and the highest rate of appeals was 9.6 per 1,000 
enrollees. Also, enrollees filed more than four times as many grievances as they did appeals 
during the fourth quarter of 2016.  
  
  59 
Table 21 
Total number of complaints and appeals across MMPs, by quarter 
Enrollment 
Total grievances per 
1,000 enrollees 
Total appeals per 1,000 
enrollees 
2014       
Q1 9,699 16.703 2.474 
Q2 13,399 29.778 4.254 
Q3 17,729 27.243 5.753 
Q4 17,919 31.140 2.735 
2015       
Q1 17,792 33.273 2.136 
Q2 17,708 36.989 
Quarter 
4.179 
Q3 17,177 45.875 7.801 
Q4 12,287 77.399 4.558 
2016       
Q1 12,609 43.223 5.790 
Q2 13,057 35.613 9.650 
Q3 13,011 35.047 5.380 
Q4 14,335 31.601 7.743 
NOTES: Data are not available for Quarter 4, 2013. Fallon Total Care withdrew from the demonstration on 
September 30, 2015. 
SOURCE: RTI analysis of MMP reported data for Core Measure 4.2, as of March 2017. The technical specifications 
for this measure are in the Medicare-Medicaid Capitated Financial Alignment Model Core Reporting Requirements 
document, which is available at: https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-
Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/InformationandGuidanceforPlans.html. 
As described above, beneficiaries may file complaints directly with MassHealth or 1-800-
Medicare. The most current data available at the time of this report on the number and nature of 
those complaints cover the period October 2013 through June 2016 and are shown in Table 22. 
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Table 22 
Number and category of beneficiary complaints filed with MassHealth and 1-800-Medicare 








Benefits/access 14 23 11 
Confidentiality/privacy 0 2 0 
Contractor/partner performance 1 0 0 
Customer service 9 2 2 
Enrollment/disenrollment 24 2 9 
Exceptions/appeals/grievances 2 4 2 
Marketing 3 0 0 
Payment/claims 2 4 1 
Plan administration 1 3 2 
Pricing/premium/co-Insurance 5 0 0 
Total 61 40 27 
NOTES: This table includes data outside of the time frames generally covered by this report due to limitations in the 
format in which data were available at the time of the report. Demonstration year 1 represents the period from 
October 2013 through December 2014; demonstration year 2 represents the period from January 2015 through 
December 2015; demonstration year 3 represents the period from January 2016 through December 2016. 
Information is current as of February 15, 2017. 
SOURCE: CMS, Complaint Tracking Module. Report covering October 2013–December 2016. Information Current 
as of February 15, 2017. 
Demonstration year 1 represents a period of 15 months; in addition to challenges related 
to demonstration start-up, this longer timeframe may contribute to the higher number of 
complaints reported in demonstration year 1 compared to demonstration year 2. In demonstration 
year 1, the highest number of complaints was reported in the enrollment and disenrollment 
category. In demonstration years 2 and 3, the highest number of complaints was reported in 
benefits/access area. The number of complaints in the area of benefits/access increased from the 
first to the second demonstration year and decreased in the third demonstration year. The data 
indicates decreases in all categories of complaints from the first to the third demonstration years, 
however the number of complaints related to exceptions/appeals increased from the second to 
third demonstration years. Notably, there are complaints for pricing/premium/co-insurance in the 
first demonstration year but not in years 2 or 3.  
Complaints filed directly with the OCO are reported to MassHealth and the 
Administration for Community Living (ACL) as part of the demonstration’s efforts to monitor 
plan complaints.39 Table 23 provides a summary of complaints received by the OCO for 
demonstration year 2 and first quarter of 2016. Access and customer service constituted the two 
highest complaint categories. The OCO reported that assisting beneficiaries who have behavioral 
health needs comprises over 80 percent of its caseload. The OCO also reported that many of the 
complaints appeared to derive from poor communication between the beneficiary and the MMP 
                                                 
39 The OCO began operations in March 2014. 
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or its providers. In some cases, the OCO is able to bridge this divide and either resolve the 
problem or improve the situation for beneficiaries. The OCO noted that some of its staff are One 
Care enrollees; this facilitates more effective communication and interaction with beneficiaries. 
The OCO reported that over 90 percent of the time, beneficiaries who are assisted with 
complaints are pleased or satisfied with the outcome.  
Table 23 











QTR 1 Total 
Medicaid eligibility 4 0 0 9 12 21 
Benefits/access 27 17 25 43 68 180 
Customer service 10 33 12 33 26 114 
Enrollment 2 2 2 4 13 23 
Payment/claims 7 11 4 8 5 35 
Total—number 46 63 43 107 129 388 
SOURCE: Administration for Community Living, Quarterly Data Reported by OCO, Section C – Complaints Issue 
Category/Subcategory for Complaints Received. 
Appeals 
Beneficiaries have a basic right to appeal decisions made by a One Care plan to deny, 
limit, terminate, or suspend a service or procedure (known as an “adverse action”). CMS and 
MassHealth developed a coordinated appeals process that is detailed in the three-way contract 
(three-way contract, 2015, pp. 131–42). The coordinated appeals process is described in detail in 
the first Annual Report.  
The highest rate of appeals occurred in the second quarter of 2016, with 9.65 appeals per 
1,000 enrollees (see Table 24). Information on the first-level appeal by outcome and type is 
shown in Table 24 These represent determinations made at the MMP level.  
Table 24 
Appeals by outcome across plans, by quarter 
Calendar 







2014           
Q1 9,699  24 20.8% 8.3% 70.8% 
Q2 13,399  57 31.6% 3.5% 64.9% 
Q3 17,729  102 50.0% 1.0% 49.0% 
Q4 17,919  49 40.8% 6.1% 53.1% 
(continued) 
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Table 24 (continued) 
Appeals by outcome across plans, by quarter 
Calendar 







2015           
Q1 17,792  38 50.0% 0.0% 50.0% 
Q2 17,708  74 51.4% 5.4% 43.2% 
Q3 17,177  134 37.3% 5.2% 57.5% 
Q4 12,287  56 32.1% 7.1% 60.7% 
2016           
Q1 12,609  73 50.7% 2.7% 46.6% 
Q2 13,057  126 43.7% 8.7% 47.6% 
Q3 13,011  70 48.6% 2.9% 48.6% 
Q4 14,335  111 57.7% 8.1% 34.2% 
NOTES: Data are not available for Quarter 4, 2013. Fallon Total Care withdrew from the demonstration on 
September 30, 2015. Data for Fallon are available through Quarter 3, 2015. Data presented for Quarter 4, 2015 and 
after represent totals for the remaining two plans. 
SOURCE: RTI analysis of MMP reported data for Core Measure 4.2, as of March 2017. The technical specifications 
for this measure are in the Medicare-Medicaid Capitated Financial Alignment Model Core Reporting Requirements 
document, which is available at: https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-
Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/InformationandGuidanceforPlans.html
As described earlier, initial appeals that result in an adverse outcome related to Medicare 
services are automatically referred to the IRE for further review. Table 25 presents data on the 
number of appeals sent to the IRE January 2014 to December 2015. During this time-period, the 
IRE received 80 appeals. Of these appeals, the determination made by the MassHealth plan was 
upheld in 63 cases (78.8 percent); 10 (12.5 percent) were overturned; 3 (3.8 percent) were 
partially overturned; and 4 (5.0 percent) were dismissed. Appeals relating to non-Medicare 
benefits and clinic/lab/x-ray represent the areas where the highest percent of appeals were 
overturned in favor of the beneficiary.  
Table 25 















Practitioner services 8 (10.0) 4 (5) 0 (0) 2 (2.5) 0 (0) 0 (0) 
Emergency room 0 (0) 0 (0) 0 (0) 1 (1.3) 0 (0) 0 (0) 
Acute inpatient hospital 2 (2.5) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Clinic/lab/x-ray 14 (17.5) 0 (0) 1 (1.3) 0 (0) 0 (0) 0 (0) 
Nursing home 2 (2.5) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
(continued) 
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Table 25 















Outpatient therapies/CORF 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Ground transportation 0 (0) 1 (1.3) 0 (0) 0 (0) 0 (0) 0 (0) 
Home health 1 (1.3) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Durable medical equipment 13 (16.3) 1 (1.3) 0 (0) 1 (1.3) 0 (0) 0 (0) 
Outpatient mental health 0 (0) 1 (1.3) 0 (0) 0 (0) 0 (0) 0 (0) 
Hospice 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Non-Medicare benefit 23 (28.8) 3 (3.8) 2 (2.5) 0 (0) 0 (0) 0 (0) 
Summary 63 (78.8) 10 (12.5) 3 (3.8) 4 (5.0) 0 (0) 0 (0) 
CORF = comprehensive outpatient rehabilitation facilities. 
NOTE: Data represented are for calendar year 2014 and 2015. 
SOURCE: RTI calculations from data provided by MAXIMUS Federal Services, Medicare-Medicaid Plan 
Reconsideration Data. 
For appeals relating to Medicaid services, the beneficiary must request an appeal with the 
MassHealth Board of Hearings following an adverse outcome at the first level of review. 
Information provided by MassHealth for appeals filed with the Board of Hearings indicates just 
over 20 beneficiaries filed appeals related to One Care from January 1, 2015 through June 10, 
2016.  More than half of the appeals filed with MassHealth were withdrawn or dismissed at or 
before the hearing; of those that resulted in a hearing decision, approximately half were in favor 
of the beneficiary. Dental benefits constituted the highest number of filed appeals (six), although 
almost all were withdrawn at or before the hearing.  Officials from MassHealth reported they 
often attended these hearings in person or by phone as part of monitoring the demonstration. 
41
40
Critical Incidents and Abuse Reporting 
MMPs are also required to report to MassHealth and CMS’ implementation contractor on 
the number of critical incidents and abuse reports among members receiving LTSS; Table 26 
presents these data for demonstration years 1 through 3.  For all quarters reported, the number 42
                                                 
40 MassHealth officials noted that this information was the best available data available from the Board of Hearings 
specific to One Care, and reported that complete accuracy in the number count could not be confirmed. 
41 MassHealth officials indicated that this generally meant that an adjustment to a full approval or acceptable 
alternative occurred. 
42 Reporting requirements define “critical incident” as “any actual or alleged event or situation that creates a 
significant risk of substantial or serious harm to the physical or mental health, safety, or well-being of a 
member.” Abuse refers to (1) willful use of offensive, abusive, or demeaning language by a caretaker that causes 
mental anguish; (2) knowing, reckless, or intentional acts or failures to act which cause injury or death to an 
individual or which places that individual at risk of injury or death; (3) rape or sexual assault; (4) corporal 
punishment or striking of an individual; (5) unauthorized use or the use of excessive force in the placement of 
bodily restraints on an individual; and (6) use of bodily or chemical restraints on an individual which is not in 
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of critical incident and abuse reports was fewer than 10 per 1,000 members receiving LTSS, 
without an apparent trend throughout this period. The highest number reported was 2.95 reports 
per 1,000 members receiving LTSS in Quarter 2 2014 and lowest in Quarter 3 2015, with 0 
reports. In 2016, the number of reports increased to 1.86 reports per 1,000 members by the last 
quarter.  
Table 26 
Critical incidents and abuse reports by calendar quarter among members receiving LTSS 
Calendar 
quarter 
Total number of members 
receiving LTSS 
Total number of critical 
incident and abuse reports 
during the reporting period 
Number of critical incident 
and abuse reports per 1,000 
members receiving LTSS 
during the reporting period 
2014       
Q1 1,909 1 0.524 
Q2 2,032 6 2.953 
Q3 1,969 1 0.508 
Q4 4,739 4 0.844 
2015       
Q1 5,355 5 0.934 
Q2 4,196 9 2.145 
Q3 4,539 0 0.0000 
Q4 3,926 1 0.255 
2016       
Q1 3,954 7 1.770 
Q2 3,954 7 1.770 
Q3 4,074 6 1.473 
Q4 4,297 8 1.862 
LTSS = long-term services and supports. 
NOTES: Data are not available for Quarter 4, 2013. Fallon Total Care withdrew from the demonstration on 
September 30, 2015. Data for Fallon are available through Quarter 3, 2015. Data presented for Quarter 4, 2015 and 
after represent totals for the remaining two plans. 
SOURCE: RTI analysis of MMP reported data for Core Measure 4.2, as of March 2017. The technical specifications 
for this measure are in the Medicare-Medicaid Capitated Financial Alignment Model Core Reporting Requirements 
document, which is available at: https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-
Coordination/Medicare-Medicaid-Coordination-
Office/FinancialAlignmentInitiative/MMPInformationandGuidance/InformationandGuidanceforPlans.html
                                                 
compliance with Federal or State laws and administrative regulations (CMS, November 12, 2014). In the third 
quarter of 2016, CMS clarified that critical incidents did not need to be limited to those providers defined as 
LTSS providers. 
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5. Service Utilization  
The purpose of the analyses in this section is to understand the effects of the 
Massachusetts One Care demonstration through demonstration year 2 (calendar year [CY] 2015) 
using difference-in-differences regression analyses. In addition, descriptive statistics on service 
utilization are provided for selected Medicare services. Utilization data were analyzed for only 
two of the three MMPs in One Care; Fallon Total Care encounters were not included or analyzed 
because Fallon exited the demonstration before the end of 2015, and therefore, it was difficult to 
assess encounter completeness.  
We find evidence that the demonstration resulted in significant changes in utilization 
patterns, including changes in quality of care and care coordination. These include higher 
monthly inpatient admissions (including inpatient admissions for ambulatory care sensitive 
conditions (ACSC), physician evaluation and management (E&M) visits, skilled nursing facility 
(SNF) admissions, and all-cause 30-day readmission, along with a lower probability of any long-
stay nursing facility (NF) use and lower quarterly follow-up after mental health discharges, 
although any follow-up by a care coordinator would not be included. The demonstration had no 
impact on emergency room (ER) visits overall or on preventable ER visits.  
Table 27 presents an overview of the results from impact analyses using Medicare and 
MDS data through demonstration year 2 (calendar year [CY] 2015). The relative direction of all 
statistically significant results at the p < 0.10 significance level (derived from 90 percent 
confidence intervals) is shown. Monthly inpatient admissions, physician E&M visits, and SNF 
admissions were higher, although the probability of any long-stay NF use was lower for the 
Massachusetts demonstration group than for the comparison group. There was no statistically 
significant difference in monthly ER visits between the demonstration and comparison groups. 
For the RTI quality of care and care coordination measures, overall and chronic ACSC 
admissions and all-cause 30-day readmission were higher for the demonstration group than the 
comparison group, whereas the quarterly follow-up after mental health discharges was lower. As 
with ER visits overall, the demonstration had no impact on preventable ER visits.  
The relative directions of the impact estimates for demonstration eligible beneficiaries 
who used long-term services and supports (LTSS) and those with severe and persistent mental 
illness (SPMI) were similar to the findings for the overall demonstration eligible population.  
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Table 27 
Summary of Massachusetts demonstration impact estimates for demonstration period 
(October 1, 2013, to December 31, 2015) 











Inpatient admissions Higher Higher Higher 
Ambulatory care sensitive condition 
(ACSC) admissions, overall  
Higher Higher Higher 
ACSC admissions, chronic  Higher Higher Higher 
All-cause 30-day readmission  Higher Higher Higher 
Emergency room (ER) visits NS NS NS 
Preventable ER visits NS NS NS 
Quarterly follow-up after mental 
health discharges 
Lower Lower Lower 
Skilled nursing facility (SNF) 
admissions 
Higher Higher Higher 
Probability of any long-stay nursing 
facility (NF) use 
Lower N/A N/A 
Physician evaluation and 
management (E&M) visits 
Higher Higher Higher 
LTSS = long-term services and supports; N/A = not applicable; NS = not statistically significant; SPMI = severe and 
persistent mental illness. 
SOURCE: RTI analysis of Medicare and Minimum Data Set data. 
5.1 Overview of Benefits and Services  
Under One Care, eligible beneficiaries enroll in a One Care plan that covers Medicare 
and Medicaid services, as well as new or expanded services available under the demonstration. 
Generally, these new services include a set of diversionary behavioral health services that have 
been available to Medicaid-only beneficiaries enrolled in managed care, but that have not 
otherwise been a covered service for Medicare-Medicaid beneficiaries in Massachusetts; services 
expanded in amount, duration, or scope over Medicaid State Plan services; and new community-
based services. Targeted case management services and rehabilitation option services are not 
included as part of the integrated One Care benefit, but they continue to be provided as part of 
the Medicaid FFS system. As in Medicare Advantage, Medicare hospice services continue to be 
provided as part of the Medicare FFS system.  
5.2 Impact Analyses on the Demonstration Eligible Population  
The population analyzed in this section includes all beneficiaries who met demonstration 
eligibility criteria in Massachusetts or in the comparison areas for Massachusetts. For context, in 
Massachusetts, only approximately 12 percent of eligible beneficiaries in demonstration year 2 
whose utilization was analyzed were enrolled in One Care. Appendix A provides a description of 
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the comparison group for Massachusetts. Please see Section 3.2 for details on demonstration 
eligibility. Subsections following this section present the results for demonstration eligible 
beneficiaries with any use of LTSS (defined as receipt of any institutional long-stay nursing 
facility services because Medicaid encounters for HCBS were not yet available for use), and for 
demonstration eligible beneficiaries with SPMI.  
Appendix B contains a description of the evaluation design, the comparison group 
identification methodology, data used, measure definitions, and regression methodology used in 
estimating demonstration impacts using a difference-in-differences approach. The regression 
methodology accounts for differences between the demonstration and comparison groups over 
the predemonstration period (October 1, 2011 to September 30, 2013) and the first 2 
demonstration years (October 1, 2013–December 31, 2014 and January 1, 2015–December 31, 
2015) to provide estimates of demonstration impact. 
Regression results for all demonstration eligible beneficiaries over the entire 
demonstration period show at the 90 percent confidence interval (CI) that the Massachusetts 
demonstration reduced the probability of any long-stay NF use and increased chronic and overall 
ACSC admissions and all-cause 30-day readmission. These findings were statistically significant 
in both demonstration years. In addition, the demonstration resulted in higher monthly inpatient 
admissions, physician E&M visits, and SNF admissions over the entire demonstration period, 
and a decrease in quarterly follow-up after mental health discharges. The statistical significance 
of these changes varied by demonstration year.  
Figures 1 and 2 display the Massachusetts demonstration’s effect on key service 
utilization measures for the demonstration group relative to the comparison group through 
demonstration year 2. The demonstration increased monthly inpatient admissions by 0.0015 
admissions per month (90 percent CI: 0.0007, 0.0023), which corresponds to 0.0177 more 
inpatient admissions per eligible beneficiary per year. The demonstration also increased 
physician E&M visits by 0.0482 visits per month (90 percent CI: 0.0157, 0.0806) and SNF 
admissions by 0.0002 visits per month (90 percent CI: 0.00004, 0.0004). The demonstration also 
resulted in a 0.40 percentage-point decrease (90 percent CI: –0.53, –0.28) in the probability of 
any long-stay NF use over the demonstration years. There was no statistically significant 
demonstration effect on ER visits.  
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Figure 1 
Demonstration effects on service utilization for eligible beneficiaries in Massachusetts—
Difference-in-differences regression results for the demonstration period, 
October 1, 2013–December 31, 2015 
(90 and 80 percent confidence intervals)  
 
E&M = evaluation and management; ER = emergency room; SNF = skilled nursing facility.  
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent interval is represented by the top bar 
(black), and the 80 percent interval is represented by the bottom bar (green). 
SOURCE: RTI International analysis of Medicare data. 
Figure 2 
Demonstration effects on long-stay nursing facility use for eligible beneficiaries in 
Massachusetts—Difference-in-differences regression results for the demonstration period, 
October 1, 2013–December 31, 2015 
(90 and 80 percent confidence intervals) 
 
NF = nursing facility.  
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent interval is represented by the top bar 
(black), and the 80 percent interval is represented by the bottom bar (green). 
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Tables 28 and 29 present the demonstration’s effects on service utilization for each of the 
demonstration years. Although the direction of the impacts on service utilization are consistent 
across the two demonstration years, only the reduction in the probability of any long-stay NF use 
is statistically significant in both years, with a 0.26 percentage-point decrease (90 percent CI: 
−0.39, −0.13) and 0.54 percentage-point decrease (90 percent CI: −0.70, −0.37) over the first and 
second demonstration years, respectively. This measure is defined as the number of individuals 
who stayed in a NF for 101 days or more, who were long-stay after the first month of 
demonstration eligibility, and includes both new admissions from the community and those with 
a continuation of a stay in a NF. For the other service measures, only the increase in monthly 
physician E&M visits (up by .0733 visits per month; 90 percent CI: 0.0436, 0.1029) was 
statistically significant in demonstration year 1, while inpatient admissions and SNF admissions 
were the only other statistically significant changes in demonstration year 2. In year 2, monthly 
inpatient admissions increased by 0.0027 (90 percent CI: 0.0016, 0.0039) admissions per month 
and SNF admissions increased by 0.0004 (90 percent CI: 0.0001, 0.007) admissions per month. 
There were no statistically significant effects of the demonstration on ER visits in either of the 
demonstration years. 
Table 28 
Annual demonstration effects on service utilization for eligible beneficiaries in 
Massachusetts 
(* indicates significant at p < 0.20, ** indicates significant at p < 0.10) 
Utilization measure (per month) 
Demonstration year 1  
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Inpatient admissions 0.0004 0.0027** 
ER visits  −0.0015 −0.0003 
Physician E&M visits 0.0733** 0.0194 
SNF admissions 0.0001 0.0004** 
E&M = evaluation and management; ER = emergency room; SNF = skilled nursing facility. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based on 80 
percent confidence intervals are provided here for comparison purposes only. 
SOURCE: RTI International analysis of Medicare data. 
Table 29 
Annual demonstration effects on probability of long-stay nursing facility use for eligible 
beneficiaries in Massachusetts 
Utilization measure (per demonstration year) 
Demonstration year 1  
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Probability of any long-stay NF use  −0.0026** −0.0054** 
NF = nursing facility. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based
(* indicates significant at p < 0.20, ** indicates significant at p < 0.10) 
 on 80 
percent confidence intervals are provided here for comparison purposes only. 
SOURCE: RTI International analysis of Minimum Data Set data. 
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Table 30 provides estimates of the regression-adjusted mean values of the utilization 
measures for the demonstration and comparison groups for the predemonstration and 
demonstration periods for each service. The purpose of this table is to understand the magnitude 
of the difference-in-differences estimate relative to the adjusted mean outcome value in each 
period. The values in the third and fourth columns represent the post-regression, mean predicted 
value of the outcomes for each group in each period, based on the composition of a reference 
population (the comparison group in the demonstration period). These values show how different 
the two groups were in each period, and the relative direction of any potential effect in each 
group over time. In addition to the graphic representation above, the difference-in-differences 
estimate is also provided for reference, along with the p-value and the relative percent change of 
the difference-in-differences estimate compared to an average mean use rate for the comparison 
group over the entire demonstration period.  
As shown in the table, the adjusted mean for monthly inpatient admissions was lower in 
the demonstration group than in the comparison group in the predemonstration period and higher 
in the demonstration period. The difference-in-differences estimate, which was positive (0.0015) 
and statistically significant (p = 0.0019), implies a higher annual relative percentage difference 
of 3.9 percent between the demonstration and comparison groups. The adjusted mean for 
physician E&M visits displayed a similar pattern, with lower mean visits for the demonstration 
group in the predemonstration period and higher mean visits in the demonstration period, with a 
positive (0.0482) and statistically significant (p = 0.0145) difference-in-difference estimate 
reflecting a relative percentage difference of 5.3 percent between the demonstration and 
comparison groups. In contrast, the adjusted mean for monthly SNF admissions in the 
demonstration group was lower than for the comparison group in both the predemonstration and 
demonstration periods, yielding a positive (0.0002) and statistically significant (p = 0.0436) 
difference-in-differences estimate that implies a relative percentage difference of 4.9 percent 
between the demonstration and comparison groups. The largest relative percentage difference 
between the demonstration and comparison group is found for the probability of any long-stay 
NF use per demonstration year over the demonstration period, which has a relative percentage 





Adjusted means and impact estimate for eligible beneficiaries in the demonstration and comparison groups in Massachusetts 
through December 31, 2015 
Measure Group 
Adjusted mean for 
predemonstration 
period 








confidence interval) p-value 
Inpatient admissions Demonstration group 0.0449 0.0389 3.9 0.0015 
(0.007, 0.0023) 
0.0019 
Comparison group 0.0458 0.0382       
ER visits  Demonstration group 0.1046 0.0999 NS −0.0009  
(−0.0038, 0.0019) 
0.5910 
Comparison group 0.0989 0.0954       
Physician E&M visits Demonstration group 0.8573 0.9586 5.3 0.0482  
(0.0157, 0.0806) 
0.0145 
Comparison group 0.8789 0.9336       
SNF admissions Demonstration group 0.0045 0.0036 4.9 0.0002  
(0.0000, 0.0004) 
0.0436 
Comparison group 0.0057 0.0042       
Probability of any long-stay 
NF use 
Demonstration group 0.0208 0.0111 −10.6 −0.0040 
(−0.0053, −0.0028) 
< 0.001 
Comparison group 0.0441 0.0335       
E&M = evaluation and management; ER = emergency room; NF = nursing facility; NS = not statistically significant; SNF = skilled nursing facility. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. The difference-in-differences result obtained from the regression may 
differ from a similar calculation using the results in the adjusted mean columns, due to methodological differences. 
SOURCE: RTI International analysis of Medicare and Minimum Data Set data. 
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Figure 3 displays the Massachusetts demonstration’s effects on RTI quality of care and 
care coordination measures for the demonstration group relative to the comparison group through 
demonstration year 2. The Massachusetts demonstration increased monthly inpatient ACSC 
admissions for overall (higher by 0.0006 admissions per month; 90 percent CI: 0.0004, 0.0008) 
and chronic conditions (higher by 0.0007 admissions per month; 90 percent CI: 0.0005, 0.0009), 
and for all-cause 30-day readmission (higher by 0.02338 admissions for each demonstration year 
over the demonstration period; 90 percent CI: 0.0071, 0.0404). There was also a decrease in 
quarterly follow-up after mental health discharge (lower by 0.0274 follow-up visits; 90 percent 
CI: −0.0532, −0.0017) over the demonstration period. There was no statistically significant 
demonstration effect on preventable ER visits.  
Figure 3 
Demonstration effects on RTI quality of care measures for eligible beneficiaries in 
Massachusetts—Difference-in-differences regression results for the demonstration period, 
October 1, 2013–December 31, 2015 
(90 and 80 percent confidence intervals)  
 
 
ACSC = ambulatory care sensitive condition; ER = emergency room. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent intervals are represented by the top bar 
(black), and the 80 percent intervals are represented by the bottom bar (green). 
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Table 31 presents the demonstration’s effects on the RTI quality of care and care 
coordination measures for each demonstration year. Compared to the service utilization 
outcomes reported in Tables 28 and 29, the findings for the quality of care and care coordination 
outcomes are more consistent across the demonstration years. For example, the monthly ACSC 
admissions (both overall and chronic) are significantly higher in both periods (with effects 
ranging from 0.0008–0.0009 visits in demonstration year 1 and 0.0004 admissions in 
demonstration year 2), as is the change in all-cause 30-day readmissions (increase of 0.0304 and 
0.0484 admissions in each demonstration year). Quarterly follow-up for mental health discharges 
decreased only in demonstration year 2 (down by 0.0406 follow-ups), with a similar trend for 
monthly preventable ER visits, which is lower only in demonstration year 1 by 0.0017 visits. 
Although quarterly follow-up for mental health discharges had a statistically significant effect 
over the demonstration period, preventable ER visits did not.  
Table 31 
Annual demonstration effects on quality of care and care coordination for eligible 
beneficiaries in Massachusetts 
(* indicates significant at p < 0.20, ** indicates significant at p < 0.10) 
Quality of care and  
care coordination measures 
Demonstration year 1  
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Preventable ER visits −0.0017** −0.0013 
ACSC admissions, overall  0.0008** 0.0004** 
ACSC admissions, chronic 0.0009** 0.0004** 
Quarterly follow-up after mental health discharges −0.0163 −0.0406** 
All-cause 30-day readmission 0.0304** 0.0484** 
ACSC = ambulatory care sensitive conditions; ER = emergency room. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based on 80 
percent confidence intervals are provided here for comparison purposes only. 
SOURCE: RTI International analysis of Medicare data. 
Table 32 provides estimates for the regression-adjusted mean value for each of the 
demonstration and comparison groups for the predemonstration and demonstration periods for 
the RTI quality of care and care coordination measures. The purpose of this table is to 
understand the magnitude of the difference-in-differences estimates for quality of care outcomes 
relative to the adjusted mean values in each period. The values in the third and fourth columns 
represent the post-regression, mean predicted value of the outcomes for each group in each 
period, based on the composition of a reference population (the comparison group in the 
demonstration period). These values show how different the two groups were in each period, and 
the relative direction of any potential effect in each group over time. In addition to the graphic 
representation above, the difference-in-differences estimate is also provided for reference, along 
with the p-value and the relative percent change of the difference-in-differences estimate 





Adjusted means and impact estimate for eligible beneficiaries in the demonstration and comparison groups for Massachusetts 
through demonstration year 2 
Measure Group 
Adjusted mean for 
predemonstration 
period 








confidence interval) p-value 
Preventable ER visits  Demonstration group 0.0497 0.0466 −3.3 −0.0015 
(−0.0032, 0.0002) 
0.144 
Comparison group 0.0478 0.0462       
ACSC admission, overall  Demonstration group 0.0042 0.0042 15.8 0.0006  
(0.0004, 0.0008) 
< 0.0001 
Comparison group 0.0048 0.0040       
ACSC admission, chronic Demonstration group 0.0027 0.0033 26.59 0.0007  
(0.0005, 0.0009) 
<0.0001 
Comparison group 0.0028 0.0026       
Quarterly follow-up after 
mental health discharges 
Demonstration group 0.6910 0.6637 −5.3 −0.0274 
(−0.0532, −0.0017) 
0.080 
Comparison group 0.5673 0.5639       
All-cause 30-day readmission  Demonstration group 0.4458 0.4749 12.7 0.0238 
(0.0071, 0.0404) 
0.019 
Comparison group 0.4405 0.4346       
ACSC = ambulatory care sensitive conditions; ER = emergency room. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. The difference-in-differences result obtained from the regression may 
differ from a similar calculation using the results in the adjusted mean columns, due to methodological differences.  
SOURCE: RTI International analysis of Medicare data. 
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The relative percentage differences between the demonstration and comparison groups 
based on the difference-in-differences estimates are generally small for the quality of care and 
care coordination measures. The adjusted mean for overall ACSC admissions was lower for the 
demonstration group than for the comparison group in the predemonstration period but higher in 
the demonstration period. The difference-in-differences estimate, which was positive (0.0006) 
and statistically significant (p < 0.0001), implies an annual relative percentage difference of only 
0.16 percent between the demonstration and comparison groups, with a similar pattern for the 
chronic ACSC admissions (relative difference of 0.26 percent). In contrast, the adjusted means 
for quarterly follow-up after mental health discharge and all-cause 30-day readmission were 
higher for the demonstration group than the comparison group during both periods, reflecting a 
positive and statistically significant relative difference of −0.05 percent and 0.13 percent, 
respectively.  
5.2.1 Descriptive Statistics on the Demonstration Eligible Population 
In addition to the impact results presented for the demonstration eligible population in 
this section, Appendix C, Tables C-1 through C-3 present descriptive statistics for the 
demonstration eligible population for each service for the predemonstration and demonstration 
years to help understand the utilization experience over time. We examine 14 Medicare service 
utilization measures, six RTI quality of care measures, and five nursing facility-related measures 
derived from the Minimum Data Set (MDS). No testing was performed between groups or years. 
The results reflect the underlying experience of the two groups, and not the difference-in-
differences estimates presented earlier. 
The demonstration and comparison groups were similar across many of the service 
utilization measures in each of the predemonstration (baseline) years and the demonstration years 
(Table C-1). However, there were a few outcomes where some differences were apparent. For 
example, ER use tended to be higher for the demonstration group than the comparison group, 
whereas SNF use tended to be lower. As with the service utilization measures, the Massachusetts 
demonstration eligible beneficiaries were similar to the comparison group on many, but not all, 
of the RTI quality of care and care coordination measures (Table C-2). Key differences included 
higher rates of 30-day follow-up after hospitalization for mental illness, higher rates of all-cause 
30-day readmission, and for the demonstration years, more screenings for clinical depression. 
Finally, there are more differences between the demonstration group and comparison group in 
long-stay nursing facility utilization (Table C-3), including fewer new long-stay NF admissions 
and fewer long-stay NF users in the demonstration group. There were also differences in some 
characteristics of long-stay NF residents: demonstration eligible beneficiaries had a lower 
percentage with severe cognitive impairment, better functional status, and relative to the 
comparison group, fewer beneficiaries with a low level of care need during the demonstration 
period. 
5.2.2 Impact Analysis on Demonstration Eligible Beneficiaries with LTSS Use 
Demonstration eligible beneficiaries were defined as using LTSS in a demonstration year 
if they received any institutional services. Approximately 1.5 percent of all eligible beneficiaries 
in demonstration year 2 were LTSS users. As was true for the overall demonstration eligible 
population, demonstration eligible beneficiaries with LTSS use had increased monthly inpatient 
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admissions, SNF admissions, physician E&M visits, ACSC admissions, and all-cause 30-day 
readmission, but lower quarterly follow-up for mental health discharges and a lower probability 
of any long-stay NF use. As for all demonstration-eligible beneficiaries, the demonstration had 
no impact on ER use or preventable ER use for beneficiaries with LTSS use. 
Figure 4 displays the demonstration’s effects on key service utilization measures among 
demonstration eligible beneficiaries who were LTSS users in the demonstration group relative to 
the comparison group through demonstration year 2. The demonstration led to small changes in 
monthly inpatient admissions and SNF admissions and large changes in physician E&M visits. 
Inpatient admissions among those with LTSS use increased by 0.0040 admissions per month (90 
percent CI: 0.0019, 0.0062), which corresponds to 0.0483 more inpatient admissions per year on 
average for eligible beneficiaries with LTSS use; SNF admissions increased by 0.0010 
admissions per month (90 percent CI: 0.0002, 0.0017), which corresponds to 0.0114 more 
admissions per year on average for eligible beneficiaries with LTSS use. By contrast, physician 
E&M visits increased by 0.0832 visits per month (90 percent CI: 0.0293, 0.1370), which 
corresponds to 0.9982 visits per year on average for eligible beneficiaries with LTSS use. There 
was no significant effect of the demonstration on ER visits. 
Figure 4 
Demonstration effects on service utilization for eligible beneficiaries with LTSS use in 
Massachusetts—Difference-in-differences regression results for the demonstration period, 
October 1, 2013–December 31, 2015 
(90 and 80 percent confidence internals)  
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NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent interval is represented by the top bar 
(black), and the 80 percent interval is represented by the bottom bar (green). 
SOURCE: RTI International analysis of Medicare data. 
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Table 33 presents the demonstration effects on key service utilization for the 
demonstration eligible population with LTSS use for each demonstration year. Although the 
direction of the impacts on service utilization are consistent across the two demonstration 
periods, the increase in physician E&M visits (up by 0.1216 visits per month; 90 percent CI: 
0.0750, 0.1683) was only statistically significant in demonstration year 1, while inpatient 
admissions and SNF admissions were only statistically significant in demonstration year 2, with 
increases of 0.0082 admissions per month (90 percent CI: 0.0049, 0.0115) and .0018 admissions 
per month (90 percent CI: 0.0006, 0.0029), respectively. There was no statistically significant 
effect of the demonstration on ER visits in either of the demonstration periods. 
Table 33 
Annual demonstration effects on service utilization for eligible beneficiaries, 
Massachusetts LTSS users  
(* indicates significant at p < 0.20, ** indicates significant at p < 0.10) 
Utilization measure (per month) 
Demonstration year 1  
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Inpatient admissions 0.0011 0.0082** 
ER visits  −0.0022 −0.0004 
Physician E&M visits 0.1216** 0.0359 
SNF admissions 0.0004 0.0018** 
E&M = evaluation and management; ER = emergency room; SNF = skilled nursing facility. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based on 80 
percent confidence intervals are provided here for comparison purposes only. 
SOURCE: RTI International analysis of Medicare data. 
Figure 5 displays demonstration effects on RTI quality of care and care coordination 
measures for the demonstration eligible population who were LTSS users through demonstration 
year 2. The Massachusetts demonstration increased overall and chronic ACSC admissions by 
0.0020 overall admissions per month (90 percent CI: 0.0013, 0.0027) and 0.0021 chronic 
admissions per month (90 percent CI: 0.0015, 0.0027). The demonstration also increased all-
cause 30-day readmission by 0.0480 admissions for each demonstration year over the 
demonstration period (90 percent CI: 0.0278, 0.0681), while reducing quarterly follow-up of 
mental health discharges by 0.0273 follow-up visits for each discharge (90 percent CI: −0.0531, 
−0.0014) during the demonstration period. There was no demonstration effect on preventable ER 
visits by LTSS users. 
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Table 34 displays the demonstration effects on RTI quality of care and care coordination 
measures for the demonstration eligible population with LTSS use for each demonstration year. 
In contrast to the service utilization outcomes reported in Table 34, the findings for the quality of 
care and care coordination outcomes are generally more consistent across the demonstration 
years. In both demonstration years, the Massachusetts demonstration increased overall and 
chronic ACSC admissions for beneficiaries with LTSS use. Overall ACSC admissions increased 
by 0.0024 admissions per month (90 percent CI: 0.0018, 0.0030) and 0.0014 admissions per 
month (90 percent CI: 0.0003, 0.0024) in the two demonstration periods, respectively, while 
chronic ACSC admissions increased by 0.0027 admissions per month (90 percent CI: 0.0023, 
0.0032) and 0.0014 admissions per month (90 percent CI: 0.000, 0.0023), respectively. All-cause 
Figure 5 
Demonstration effects on RTI quality of care and care coordination for eligible 
beneficiaries with LTSS use in Massachusetts—Difference-in-differences regression results 
for the demonstration period, October 1, 2013–December 31, 2015 
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ACSC = ambulatory care sensitive conditions; ER = emergency room. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent intervals are represented by the top bar 
(black), and the 80 percent intervals are represented by the bottom bar (green).. 
SOURCE: RTI International analysis of Medicare data. 
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30-day readmission also increased in both demonstration years, by 0.0375 readmissions and 
0.0632 readmissions respectively over demonstration years 1 and 2. While the direction of the 
effect of quarterly follow-up of mental health discharges was negative during both demonstration 
years, this was only statistically significant in demonstration year 2, with a decrease of 0.0404 
(90 percent CI: −0.0708, −0.0099).There was no statistically significant demonstration effect on 
preventable ER visits in either demonstration year 1 or 2.  
Table 34 
Annual demonstration effects on quality of care and care coordination for eligible 
beneficiaries with LTSS use in Massachusetts 
(  indicates significant at p < 0.20,  indicates significant at p < 0.10) ***
Quality of care and  
care coordination measures 
Demonstration year 1 
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Preventable ER visits −0.0022  * −0.0019 
ACSC admissions, overall 0.0024  ** 0.0014** 
ACSC admissions, chronic  0.0027  ** 0.0014** 
Quarterly follow-up after mental health discharges −0.0162 −0.0404** 
All-cause 30-day readmission 0.037  ** 0.0632** 
ACSC = ambulatory care sensitive conditions; ER = emergency room. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based on 80 
percent confidence intervals are provided here for comparison purposes only. 
SOURCE: RTI International analysis of Medicare data. 
5.2.3 Descriptive Statistics on the Demonstration Eligible Population with LTSS Use 
In addition to the impact results presented for the demonstration eligible population with 
LTSS use in this section, Tables C-4 through C-5 in Appendix C present descriptive statistics for 
this population for each service for the predemonstration and demonstration periods to help 
understand the utilization experience over time. We present descriptive statistics on 14 Medicare 
service utilization and 6 RTI quality of care measures. No testing was performed between groups 
or years. These results reflect the underlying experience of the two groups, and not the 
difference-in-differences estimates presented earlier.  
Relative to their comparison group, demonstration group beneficiaries with LTSS use 
generally had higher rates of service use, including higher rates of inpatient admissions, ER 
visits, SNF admissions, and hospice admissions (Table C-4). The demonstration group 
beneficiaries also tended to have higher levels of utilization for the quality of care and care 
coordination measures, including higher more preventable ER visits and ACSC admissions, and 
a higher rate of 30-day follow-up for hospitalization after mental illness than their counterparts in 
the comparison group (Table C-5).  
5.2.4 Impact Analyses on the Demonstration Eligible Population with SPMI  
Demonstration eligible beneficiaries were defined as having SPMI if there were any 
inpatient or outpatient mental health visits for schizophrenia or bipolar disorders in the last 2 
years. Approximately 54.0 percent of all eligible beneficiaries had SPMI in demonstration 
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year 2. As was true for the overall demonstration eligible population, demonstration eligible 
beneficiaries with SPMI had increased monthly inpatient admissions, SNF admissions, physician 
E&M visits, ACSC admissions, and all-cause 30-day readmission, but lower rate of 30-day 
follow-up for mental health discharges and a lower probability of any long-stay NF use. As for 
all demonstration-eligible beneficiaries, the demonstration had no impact on ER use or 
preventable ER use for beneficiaries with SPMI. 
Figure 6 displays the demonstration’s effects on key service utilization measures for the 
demonstration eligible population with an SPMI. The demonstration led to small changes in 
inpatient and SNF admissions and large changes in physician E&M visits. Under the 
demonstration, inpatient admissions among those with SPMI increased by 0.0016 admissions per 
month (90 percent CI: 0.0007, 0.0024), which corresponds to 0.0188 more inpatient admissions 
per year. SNF admission also increased slightly among those with SPMI by 0.0002 admissions 
per month (90 percent CI: 0.00004, 0.0004). Over the same period, physician E&M visits 
increased by 0.0506 visits per month (90 percent CI: 0.0166, 0.0845) among those with SPMI. 
There was no statistically significant effect of the demonstration on ER visits or SNF admissions. 
Table 35 displays the demonstration effects on key service utilization measures among 
beneficiaries with SPMI for each demonstration year. While the direction of the impacts on 
service utilization are consistent across the two demonstration periods for beneficiaries with 
SPMI, only the increase in physician E&M visits (higher by 0.0767 visits per month; 90 percent 
Figure 6 
Demonstration effects on service utilization for eligible beneficiaries with SPMI in 
Massachusetts—Difference-in-differences regression results for the demonstration period, 
October 1, 2013–December 31, 2015 
 
E&M = evaluation and management; ER = emergency room; SNF = skilled nursing facility.  
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent intervals are represented by the top bar 
(black), and the 80 percent intervals are represented by the bottom bar (green). 





-.01 0 .01 .02 .03 .04 .05 .06 .07 .08 .09
Demonstration Effect (Monthly Count)
Point Estimate Confidence Interval (90% & 80%)
 81 
CI: 0.0458, 0.1077) were statistically significant in demonstration year 1, while the increase in 
inpatient admissions (higher by 0.0029 admissions per month; 90 percent CI: 0.0017, 0.0041) 
and SNF admissions (higher by 0.0004 admissions per month; 90 percent CI: 0.0001, 0.0007) 
were the only statistically significant changes in demonstration year 2. There was no statistically 
significant effect of the demonstration on ER visits among beneficiaries with SPMI in either 
demonstration year.  
Table 35 
Annual demonstration effects on service utilization for eligible beneficiaries with SPMI in 
Massachusetts 
(  indicates significant at p < 0.20,  indicates significant at p < 0.10) ***
Utilization measure (per month) 
Demonstration year 1  
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Inpatient admissions 0.0005 0.0029** 
ER visits −0.0016 −0.0003 
Physician E&M visits 0.0767** 0.0204 
SNF admissions 0.0001 0.0004** 
E&M = evaluation and management; ER = emergency room; SNF = skilled nursing facility. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based on 80 
percent confidence intervals are provided here for comparison purposes only. 
SOURCE: RTI International analysis of Medicare data. 
Figure 7 displays the demonstration’s effects on RTI quality of care and care 
coordination measures for the demonstration eligible population with an SPMI. The 
demonstration increased both overall and chronic ACSC admissions by 0.0007 admissions per 
month (90 percent CI: 0.0005, 0.0009) for beneficiaries with SPMI, along with increasing all-
cause 30-day readmission by 0.0382 readmissions for each demonstration year over the 
demonstration period (90 percent CI: 0.0222, 0.0542). Among beneficiaries with SPMI over the 
demonstration period, quarterly follow-up after mental health discharges increased by 0.0274 
follow-ups (90 percent CI: −0.0532, −0.0017). There was no demonstration effect on preventable 
ER visits for beneficiaries with SPMI. 
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Table 36 displays the demonstration effects on RTI quality of care and care coordination 
measures for the demonstration eligible population with an SPMI for each demonstration year. In 
both demonstration periods, the Massachusetts demonstration increased overall and chronic 
ACSC admissions, with 0.0009 more ACSC admissions per month (90 percent CI for overall: 
0.0007, 0.0011; for chronic: 0.0008, 0.0011) in demonstration year 1, and 0.0004 more 
admissions per month (90 percent CI for overall: 0.0001, 0.0007; for chronic 0.0002, 0.0007) in 
demonstration year 2. While the change in all-cause 30-day readmission was statistically 
significant in both years (up by 0.0306 readmissions (90 percent CI: 0.0104, 0.0505) and 0.0486 
readmissions (90 percent CI: 0.0275, 0.0697) respectively, for each demonstration year), the 
direction of effect of quarterly follow-up after mental health discharges was negative in both 
Figure 7 
Demonstration effects on quality of care and care coordination for eligible beneficiaries 
with SPMI in Massachusetts—Difference-in-differences regression results for the 
demonstration period, October 1, 2013–December 31, 2015 
(90 and 80 percent confidence internals) 
 
 
ACSC = ambulatory care sensitive conditions; ER = emergency room.  
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. 80 percent confidence 
intervals are provided here for comparison purposes only. The 90 percent intervals are represented by the top bar 
(black), and the 80 percent intervals are represented by the bottom bar (green). 
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years, but statistically significant only in demonstration year 2 (down by 0.0406 follow-up visits, 
90 percent CI −0.0706, −0.0105). There was no statistically significant demonstration effect on 
preventable ER visits across the two demonstration years for beneficiaries with SPMI. 
Table 36 
Annual demonstration effects on quality of care and care coordination for eligible 
beneficiaries with SPMI in Massachusetts 
(  indicates significant at p < 0.20,  indicates significant at p < 0.10)  ***
Quality of care and  
care coordination measures 
Demonstration year 1 
(10/13–12/14) 
Demonstration year 2 
(1/15–12/15) 
Preventable ER visits −0.0018 −0.0014
Monthly ACSC admissions, overall 0.0009** 0.0004**
Monthly ACSC admissions, chronic 0.0009** 0.0004**
Quarterly follow-up after mental health discharges −0.0163 −0.0406**
All cause 30-day readmission 0.0306** 0.0486**
ACSC = ambulatory care sensitive conditions; ER = emergency room. 
NOTES: Standard statistical practice is to use confidence intervals of 90 percent or higher. Significance based on 80 
percent confidence intervals are provided here for comparison purposes only. 
SOURCE: RTI International analysis of Medicare data. 
5.2.5 Descriptive Statistics on the Demonstration Eligible Population with SPMI 
In addition to the impact results presented for the demonstration eligible population with 
SPMI in this section, Tables C-6 through C-7 in Appendix C present descriptive statistics for this 
population for each service by predemonstration and demonstration years to help understand the 
utilization experience over time. We present results for 14 Medicare service utilization and 6 RTI 
quality of care measures. No testing was performed between groups or years. These results 
reflect the underlying experience of the two groups, and not the difference-in-differences 
estimates presented earlier.  
Among the beneficiaries with SPMI, the demonstration group and comparison group 
tended to have similar levels of utilization, with somewhat lower rates of inpatient admissions 
and SNF admissions for the demonstration group (Table C-6). On the quality of care and care 
coordination measures, the levels of utilization were generally similar for the demonstration and 
comparison groups, although the demonstration group had higher rates of 30-day follow-up visits 
after hospitalization for mental health and 30-day all-cause readmission rates (Table C-7). 
5.2.6 Service Use for Enrollee and Non-Enrollee Populations 
Tables C-8 through C-9 in Appendix C present descriptive statistics for the enrolled 
population, compared to those demonstration eligible beneficiaries who were not enrolled, for 
each service by demonstration year, to help understand the utilization experience over time.  
There were few clear differences in patterns of service utilization for demonstration 
eligible enrollees and non-enrollees over the two demonstration years, although enrollees were 
more likely to use ER care and home health care and less likely to use hospice (Table C-8). For 
84 
the quality of care and care coordination measures, enrollees and non-enrollees have a similar 
number of ACSC admissions and rates of all-cause 30-day readmissions, while enrollees are 
more likely to have higher preventable ER visits and lower number of screenings for depression, 
as well as lower rates of 30-day follow-up for hospitalization for mental illness (Table C-9).  
5.2.7 Service Use by Demographic Characteristics of Eligible Beneficiaries 
Appendix C, Table 10 on pages C-29 to C-31 presents descriptive statistics by 
demographic group (age, gender, race, and ethnicity) for 14 Medicare service categories during 
demonstration year 2 for Massachusetts demonstration eligible beneficiaries. There were few 
consistent differences in service use across age groups, although those under age 45 had higher 
levels of ER use, psychiatric-related inpatient and ER use, and lower use of SNF, hospice, and 
primary care E&M visits relative to those 45 and older. Women appeared to have higher levels 
of physician E&M and ER visits compared to men, and Blacks appeared to have more ER visits 
compared to other racial and ethnic groups, while White beneficiaries had more physician E&M 
visits.  
To further examine any differences in racial and ethnic groups, Figures 8, 9, and 10 
provide month-level results for five settings of interest: inpatient admissions, emergency 
department visits (non-admit), hospice admissions, primary care E&M visits, and outpatient 
therapy visits (physical therapy [PT], occupational therapy [OT], and speech therapy [ST]). 
Results across these five settings are displayed using three measures: percentage with any use of 
the respective service, counts per 1,000 eligible beneficiaries with any use of the respective 
service, and counts per 1,000 demonstration eligible beneficiaries.  
Figure 8 presents the percentage of use of selected Medicare services. Asians and 
Hispanics, compared to Blacks and Whites, had lower use of inpatient services. Asians had lower 
use of emergency department and outpatient therapy compared to Hispanics, Blacks, and Whites. 
For primary care E&M services, Whites had the highest percentage of use. 
Regarding counts of services used among users of each respective service, as presented in 
Figure 9, Asians and Hispanics had slightly fewer emergency department visits, followed by 
Whites and then Blacks. Hospice admissions were slightly higher for Asians compared to 
Blacks, Whites, and Hispanics. For primary care E&M services, Whites had the highest count of 
visits compared to the other racial and ethnicity groups, followed by Hispanics and Blacks, and 
then Asians. Outpatient therapy visit counts appeared to vary widely by race and ethnicity, with 
Whites having the highest count, followed by Asians, Blacks, and then Hispanics. Figure 10 
presents counts of services across all demonstration eligible beneficiaries regardless of having 
any use of the respective services. Trends for inpatient admissions, emergency department visits, 
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6. Cost Savings Calculation 
 
 
As part of the capitated financial alignment model, Massachusetts, CMS, and health plans 
have entered into a three-way contract to provide services to Medicare-Medicaid enrollees 
(CMS, 2013). Participating health plans receive prospective blended capitation payment to 
provide both Medicare and Medicaid services for enrollees. CMS and Massachusetts developed 
risk adjusted capitation rates for Medicare Parts A, B, and D, and Medicaid services to reflect the 
characteristics of enrollees. The Medicare component of the payment is risk-adjusted using 
CMS’ hierarchical risk-adjustment model. The rate development process is described in greater 
detail in the Memorandum of Understanding and the three-way contract, and a description of the 
risk adjusted Medicare components of the rate are described in the Final Rate Reports (CMS and 
State of Massachusetts, 2013b). As noted in Chapter 3, in April 2016, CMS finalized the revised 
risk adjustment model for Medicare Advantage for payment year 2017 in the CY 2017 Final 
Rate Notice and Call Letter. See Section 3.5.2 for additional information about this change.  
The capitation payment incorporates savings assumptions over the course of the 
demonstration. The same savings percentage is prospectively applied to both the Medicare and 
Medicaid components of the capitation payment, so that both payers can recognize proportional 
savings from this integrated payment approach, regardless of whether the savings is driven 
disproportionately by changes in utilization of services typically covered by Medicare or 
Medicaid. The goal of this methodology is to minimize cost shifting, to align incentives between 
Medicare and Medicaid, and to support the best possible outcomes for enrollees.  
This chapter presents preliminary Medicare Parts A and B savings calculations for the 
first 27 months of the demonstration period using an intent-to-treat (ITT) analytic framework 
that includes beneficiaries eligible for the demonstration rather than only those who enrolled. 
Approximately 105,000 Medicare-Medicaid beneficiaries in Massachusetts were eligible for and 
over 14,000 (13 percent) enrolled in the demonstration as of December 2016.  
Highlights 
• RTI conducted a preliminary estimate of Medicare savings using a difference-in-
differences analysis examining beneficiaries eligible for the demonstration in the 
Massachusetts demonstration area and comparison areas. 
• The results of the preliminary cost analyses of beneficiaries eligible for the 
demonstration do not show statistically significant savings or losses as a result of the 
demonstration. This aligns with CMS expectations, given rate structure and 
modifications during the demonstration period covered.  
• The low rate of enrollment in the demonstration (approximately 13 percent of eligible 
beneficiaries actually enrolled) is one potential reason for the finding of no 
statistically significant savings or losses among beneficiaries eligible for the 
demonstration. For example, limited enrollment may have limited the potential impact 
on costs.  
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The Medicare calculation presented here uses the capitation rate for beneficiaries enrolled 
in the demonstration, and not the actual payments that plans made to providers for services, so 
the savings are calculated from the perspective of the Medicare program. A similar approach will 
be applied to the Medicaid savings calculation when data is available. Part D costs are not 
included in the savings analysis.  
The results shown here reflect quality withhold repayments and risk corridor payments 
and recoupments. Note that Medicare and Medicaid savings calculations will be conducted by 
RTI for each year of the demonstration as data are available.  
The following sections discuss the analytic approach and results of these analyses.  
6.1 Evaluation Design  
To assess the impact of the demonstration on Medicare costs for Medicare-Medicaid 
enrollees, RTI used an ITT approach comparing the population eligible for the Massachusetts 
demonstration with a comparison group not affected by the demonstration. An ITT approach 
diminishes the potential for selection bias and highlights the effect of the demonstration on all 
beneficiaries in the demonstration eligible population. All Medicare-Medicaid enrollees eligible 
for the demonstration constitute the evaluation sample, regardless of whether they enrolled in the 
demonstration or actively participated in the demonstration care model. Therefore, the analyses 
presented here cover demonstration eligible beneficiaries including those who opted out, or who 
participated but subsequently disenrolled; who were eligible but were not contacted by the 
Commonwealth or participating plans; and those who enrolled but did not seek services.  
Beneficiaries eligible for the demonstration were identified using quarterly files 
submitted by the Commonwealth of Massachusetts. These files include information on all 
beneficiaries eligible for the demonstration, as well as indicators for whether each beneficiary 
was enrolled.  
A comparison group was identified in two steps. First, RTI identified comparison areas 
that are most similar to Massachusetts with regard to area-level measures of health care market 
characteristics such as Medicare and Medicaid spending and State policy affecting Medicaid-
Medicare enrollees. Second, beneficiaries were selected using a propensity score model 
(described in further detail below). Further discussion of the comparison group selection process 
is detailed in Appendix A.  
RTI used a difference-in-differences (DID) approach to evaluate the impact of the 
demonstration on Medicare costs. DID refers to an analytic strategy whereby two groups—one 
affected by the policy intervention and one not affected by it—are compared on an outcome of 
interest before and after the policy intervention. The predemonstration period included 2 years 
prior to the start of the Massachusetts demonstration (October 1, 2011–September 30, 2013), the 
first demonstration period (demonstration year 1) included the first 15 months of the 
demonstration (October 1, 2013–December 31, 2014) and the second demonstration period 
(demonstration year 2) included calendar year 2015 (January 1, 2015–December 31, 2015).  
To estimate the average treatment effect on the demonstration eligible population for 
monthly Medicare expenditures, RTI ran generalized linear models (GLMs) with a gamma 
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distribution and a log link. This is a commonly used approach in analysis of skewed data or in 
cases where a high proportion of observations may have values equal to zero. The model also 
employed propensity score weighting and adjusted for clustering of observations at the county 
level. 
The GLM model included indicators for demonstration period, an indicator for 
assignment to the demonstration group versus the comparison group, and an interaction term for 
demonstration period and demonstration assignment. The model also included demographic 
variables and area level variables. The interaction term represents the combined effect of being 
part of the demonstration eligible group during the demonstration periods and is the key policy 
variable of interest. The interaction term is a way to measure the impact of both time and 
demonstration group status. Separate models were run to distinguish between overall savings 
(pre- versus post-demonstration) as well as savings for each demonstration period. Because the 
difference-in-difference variable was estimated using a non-linear model, RTI employed a post-
estimation procedure to obtain the marginal effects of demonstration impact. The aggregation of 
the individual marginal effects represents the net demonstration impact and are reported below.  
• Demographic variables included in the model were: 
– Gender,  
– Race, and  
– ESRD status.  
• Area level variables included in the savings model were:  
– Medicare spending per Medicare-Medicaid enrollee age 19 or older  
– Medicare Advantage penetration rate  
– Medicaid-to-Medicare fee for service (FFS) fee index for all services  
– Medicaid spending per Medicare-Medicaid enrollee age 19 or older  
– Proportion of Medicare-Medicaid enrollees using  
▪ Nursing facilities age 65 or older  
▪ Home and community-based services (HCBS) age 65 or older  
▪ Personal care age 65 or older  
▪ Medicaid managed care age 19 or older 
– Population per square mile, and physicians per 1,000 population  
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Additional area-based variables—such as the percent of adults with a college degree and 
proximity to hospitals or nursing facilities—were used as proxies for sociodemographic 
indicators and local area characteristics. Note that these variables were also used in the 
comparison group selection process. Though the One Care program targets beneficiaries younger 
than age 65, these variables are meant to control for health care market characteristics generally 
and will not bias the savings calculation for Massachusetts. Individual beneficiary demographic 
characteristics are controlled for in the models and are also accounted for in the propensity score 
weights used in the analysis.  
In addition to the variables noted here, the propensity score weights used in the cost 
savings analyses also include Hierarchical Condition Category (HCC) risk score. HCC risk score 
is not included as an independent variable in the regression models predicting costs because 
HCC risk score is directly related to capitated payments. Due to the potential for differences in 
diagnoses coding for enrollees compared to beneficiaries in FFS after the start of the 
demonstration, the HCC risk score used to calculate the weights was “frozen” to the value at the 
start of the demonstration period. Diagnoses codes are the basis for risk score calculations, and 
by freezing the score prior to any potential impact of the demonstration, we are able to control 
for baseline health status using diagnosis codes available prior to the demonstration. 
6.2 Medicare Expenditures: Constructing the Dependent Variable 
RTI gathered predemonstration and demonstration monthly Medicare expenditure data 
for both the demonstration and comparison groups from two data sources. Capitation payments 
paid to One Care plans during the demonstration period were obtained for all demonstration 
enrollees from CMS Medicare Advantage and Prescription Drug system (MARx) data. The 
capitation payments were the final reconciled payments paid by the Medicare program after 
taking into account risk score reconciliation and any associated retroactive adjustments in the 
system at the time of the data pull (March 2017). Medicare claims were used to calculate 
expenditures for all comparison group beneficiaries, demonstration beneficiaries in the 
predemonstration period, and demonstration eligible beneficiaries who were not enrolled during 
the demonstration period as summarized in Table 37. These FFS claims included all Medicare 
Parts A and B services. 
Table 37 
Data sources for monthly Medicare expenditures 
Group 
Predemonstration 
October 1, 2011–September 30, 2013 
Demonstration period 
October 1, 2013–December 31, 2015 
Demonstration group Medicare FFS Capitation rate for enrollees 
Medicare FFS for non-enrollees 
Comparison group Medicare FFS Medicare FFS 
FFS = fee for service. 
A number of adjustments were made to the monthly Medicare expenditures to ensure that 
observed expenditures variations are not due to differences in Medicare payment policies in 
different areas of the country or the construction of the capitation rates. Table 38 summarizes 
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each adjustment and the application of the adjustments to FFS expenditures or to the capitation 
rate.  
The capitation payments MARx reflect the savings assumptions applied to the One Care 
and Medicare components of the rate (1 percent for April 1, 2014–December 31, 2014, and zero 
percent for calendar year 2015), but do not reflect the risk corridor payments or the quality 
withhold amounts (withhold of 1 percent in the first demonstration period and zero percent in the 
second demonstration period for two of the three plans and 2 percent for one of the plans). The 
results shown here reflect quality withhold repayments for the first demonstration period and the 
risk corridor payments and recoupments for both the first and second demonstration periods.  
Table 38 
Adjustments to Medicare expenditures variable 
Data source 
Adjustment 
description Reason for adjustment Adjustment detail 
FFS Indirect Medical 
Education (IME) 
MMP capitation rates do not 
include IME 
Do not include IME amount from 
FFS payments 





The capitation rates reflect DSH 
and UCP adjustments  
Include DSH and UCP payments 
in total FFS payment amounts. 
FFS Medicare Sequestration 
Payment Reductions 
Under sequestration Medicare 
payments were reduced by 2% 
starting April 1, 2013. Because the 
predemonstration period includes 
months prior to April 1, 2013 it is 
necessary to apply the adjustment 
to these months of data. 
Reduced FFS claim payments 
incurred before April 2013 by 
2%. 
Capitation rate Medicare Sequestration 
Payment Reductions 
Under sequestration Medicare 
payments were reduced by 2% 
starting April 1, 2013. 
Sequestration is not reflected in 
the capitation rates. 
Reduced capitation rate by 2% 
Capitation rate Bad debt The Medicare portion of the 
capitation rate includes an upward 
adjustment to account for bad debt. 
Bad debt is included in the FFS 
claim payments and therefore 
needs to be removed from the 
capitation rate for the savings 
analysis. (Note, “bad debt” is 
reflected in the hospital “pass 
through” payment)  
Reduced blended capitation rate 
to account for bad debt load 
(historical bad debt baseline 
percentage). This is 0.87 for 
CY13, 0.88 for CY14, 0.89 for 
CY15, and 0.94 for CY16. 
Reduced the FFS portion of the 
capitation rate by an additional 
1.89% for CY 2014 and by an 
additional 1.71% for CY 2015 to 
account for the disproportional 
share of bad debt attributable to 
Medicare-Medicaid enrollees in 
Medicare FFS.  
(continued) 
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Table 38 (continued) 
Adjustments to Medicare expenditures variable 
Data source 
Adjustment 
description Reason for adjustment Adjustment detail 
FFS and 
capitation rate  
Average Geographic 
Adjustments (AGA) 
Medicare expenditures were 
divided by the appropriate 
county-specific AGA factor for 
each year. Note that for 2014, a 
single year-specific AGA factor 
based on claims paid in the year, 
rather than the AGA factor used 
in Medicare Advantage (based on 
5 years of data and lagged 3 
years) was used to account for 
year specific policies. Note also 
that the AGA factor applied to the 
capitated rates for 2014 reflected 
the 50/50 blend that was 
applicable to the payment year.  
Capitation rate Education user fee No adjustment needed.  Capitation rates in the MARx 
database do not reflect the 
education user fee adjust
The Medicare portion of the 
capitation rate reflects the most 
current hospital wage index and 
physician geographic practice cost 
index by county. FFS claims also 
reflect geographic payment 
adjustments. In order to ensure that 
change over time is not related to 
differential change in geographic 
payment adjustments, both the 
FFS and the capitation rates were 
“unadjusted” using the appropriate 
county-specific AGA factor. 
ment 
(this adjustment is applied at the 
contract level). Note, education 
user fees are not applicable in the 
FFS context and do not cover 
specific Part A and Part B 
services. While they result in a 
small reduction to the capitation 
payment received by MMPs, we 
did not account for this reduction 
in the capitated rate. 
Capitation rate Quality withhold A 1% quality withhold was 
applied in the first demonstration 
year but was not reflected in the 
capitation rate used in the analysis.  
Final quality withhold 
repayments for 2013, 2014 were 
incorporated into the dependent 
variable construction. Note that 
the demonstration year 2 quality 
withhold and repayment 
applicable to Fallon will be 
incorporated as this information 
becomes available. 
Capitation rate Risk corridor Risk corridor payments or 
recoupments are based on 
reconciliation after application of 
high cost risk pool or risk 
adjustment methodologies. 
Final risk corridor payments and 
recoupments for were 
incorporated into the dependent 
variable construction.  
CY = calendar year; FFS = fee for service; MMP = Medicare-Medicaid Plan. 
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6.3 Results 
The first step in the analysis was to plot the unweighted mean monthly Medicare 
expenditures for both the demonstration group and the comparison group. Figure 11 indicates 
that the demonstration group and the comparison group had parallel trends in mean monthly 
expenditures during the 24-month predemonstration period, which is an important assumption to 
the DID analysis.  
Figure 11 
Mean monthly Medicare expenditures, predemonstration and demonstration period, 
One Care eligible and comparison group, 
October 2011–December 2015 
 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
means_ma493aa). 
Figure 12 demonstrates the same plot of mean monthly Medicare expenditures for both 
the demonstration group and the comparison group, after applying the propensity weights and 
establishes the parallel trends for both groups.  
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Figure 12 
Mean monthly Medicare expenditures (weighted), predemonstration and demonstration 
period, One Care eligibles and comparison group, 
October 2011–December 2015 
 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
means_ma493aa). 
Table 39 and Table 40 show the mean monthly Medicare expenditures for the 
demonstration group and comparison group in the predemonstration and each demonstration 
period, unweighted. The unweighted tables show an increase in mean monthly Medicare 
expenditures during both demonstration periods 1 and 2 for both the demonstration group and the 
comparison group. The unweighted mean increase in demonstration period 1 was $15 for 
demonstration eligible beneficiaries and $32 for the comparison group. Increases were also 
shown for demonstration periods 1 and 2 for both the demonstration group and the comparison 
group in the weighted tables (Table 41 and Table 42).  
The DID values in each table represent the overall impact on savings using descriptive 
statistics. These effects are descriptive in that they are arithmetic combinations of simple means, 
without controlling for covariates. The change in the demonstration group minus the change in 
the comparison group is the DID value. This value would be equal to zero if the differences 
between predemonstration and the demonstration period were the same for both the 
demonstration group and the comparison group. A negative value would indicate savings for the 
demonstration group, and a positive value would indicate losses for the demonstration group. 
Although the DID values in demonstration period 1 are negative, indicating savings, none of the 
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DID values (weighted or unweighted) in period 1 or period 2 are statistically significant 
(illustrated by the 95 percent confidence intervals that include 0).  
Table 39 
Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
predemonstration period and demonstration period 1, unweighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 1 
Oct 2013–Dec 2014 Difference 












Difference-in-difference — — −$17 
(−$41.1, $6.5) 
— = data not available. 
NOTE: 95 percent confidence intervals are shown in parentheses below estimates. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
DescriptiveTables). 
Table 40 
Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
predemonstration period and demonstration period 2, unweighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 2 
Jan 2015–Dec 2015 Difference 












Difference-in-difference — — $0 
(−$21.3, $20.8) 
— = data not available. 
NOTE: 95 percent confidence intervals are shown in parentheses below estimates. 




Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
predemonstration period and demonstration period 1, weighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 1 
Oct 2013–Dec 2014 Difference 












Difference-in-difference — — −$18 
(−$46.8, $11.1) 
— = data not available. 
NOTE: 95 percent confidence intervals are shown in parentheses below estimates. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
Descriptive TablesDescriptiveTables). 
Table 42 
Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
predemonstration period and demonstration period 2, weighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 2 
Jan 2015–Dec 2015 Difference 












Difference-in-difference — — −$7 
(−$20.5, $33.6) 
— = data not available. 
NOTE: 95 percent confidence intervals are shown in parenthesis below estimates. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program: 
DescriptiveTables). 
6.3.1 Regression Analysis 
While the descriptive statistics are informative, to get a more accurate estimate of 
savings, RTI conducted a multivariate regression analysis to estimate savings controlling for 
beneficiary and area level characteristics. Given the structure of the data, RTI used the GLM 
procedure in Stata with a gamma distribution and a log link, and adjusted for clustering at the 
county level. 
In addition to controlling for beneficiary and market area characteristics, the model 
included a time trend variable (coded as months 1–51), a dichotomous variable for whether the 
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observation was from the pre-demonstration or demonstration period (“Post”), a variable to 
indicate whether the observation was from a beneficiary in the comparison group or the 
demonstration group (“Intervention”), and an interaction term (“Intervention*Post”) which is the 
difference-in-differences estimate in the multivariate model for the net effect of demonstration 
eligibility. We also ran a model specific to the year of the demonstration and for this we included 
a dummy variable for each year of the demonstration (“DemoYear1” and “DemoYear2”) and 
two interaction terms (“Intervention*DemoYear1”and “Intervention*DemoYear2”). 
Table 43 shows the main results from the DID analysis for demonstration years 1 and 2, 
and for the entire demonstration period, controlling for beneficiary demographics and market 
characteristics. To obtain the effect of the demonstration from the non-linear model we 
calculated the marginal effect of coefficient of the interaction term. The marginal effect of the 
demonstration for the intervention group over the two demonstration periods in aggregate was 
negative (−0.90) but savings were small and not statistically significant, indicating that there 
were no net savings to Medicare as a result of the demonstration using the ITT analysis 
framework. The estimate of the effect of the demonstration in period 1 indicated −$9.86 in 
savings, and $10.15 in losses for demonstration period 2; however, neither finding was 
statistically significant, which indicates no effect of the demonstration using the ITT framework.  
Table 43 
Demonstration effects on Medicare savings for eligible beneficiaries—Difference-in-
difference regression results, One Care eligibles and comparison group 
Covariate 
Adjusted 










Intervention *DemoYear1  
(October 2013–December 2014) 
−9.86 0.5212 −39.97, 20.26 −14.87, 35.17 −9.40, 29.70 
Intervention *DemoYear2  
(January 2015–December 2015) 
10.15 0.5044 −19.66, 39.97 −14.87, 35.17 −9.40, 29.70 
Intervention*Demo Period  
(October 2013-December 2015)  
−0.90 0.9470 −27.41, 25.62 −23.15, 21.35 −18.28, 16.48 
DID = difference-in-differences. 
1 80 percent confidence intervals are provided for comparison purposes only. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program 
lgs_macs591_log). 
Table 44 shows the magnitude of the DID estimate relative to the adjusted mean outcome 
value in the predemonstration and demonstration periods. The second and third columns 
represent the post-regression, mean predicted savings or loss for each group and period, based on 
the composition of a reference population (the comparison group in the demonstration period). 
These values show how different the two groups were in each period, and the relative direction 
of any potential effect in each group over time. The remaining columns show the difference-in-
differences estimate (the coefficient on Intervention*Post), the p-value demonstrating 
significance, and the relative percent change of the difference-in-differences estimate compared 
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to the mean monthly Medicare expenditures for the comparison group in the entire 
demonstration period.  
The adjusted mean for monthly expenditures decreased between the predemonstration 
and demonstration period for the demonstration and comparison groups. The DID estimate of 
−0.90 (the coefficient on Intervention*Post) is slightly negative, but the savings are not 
statistically significant (p < 0.947), indicating that there were no statistically significant savings 
in Medicare Parts A and B from the demonstration, using the ITT analysis framework. The 
adjusted coefficient on the DID estimate for the demonstration overall (−$0.9, in Table 44) is 
between the marginal effect of the DID estimate from demonstration year 1 (−$9.86 in Table 43) 
and the marginal effect of the DID estimate from demonstration year 2 ($10.15, in Table 43). 
The DID estimate for demonstration years 1 and 2 in aggregate reflected an annual relative cost 
decrease of −0.09 percent, but this was not statistically significant. 
Table 44 
Adjusted means and overall impact estimate for eligible beneficiaries in the demonstration 
and comparison groups, One Care eligibles and comparison group 
Group 









coefficient DID p-value 
Demonstration group $868.75 $847.44 
−0.09 −0.90  * <0.947 
Comparison group $985.36 $962.14 
CI = confidence interval; DID = difference-in-differences. 
* 95 percent CI: −27.41, 25.62; and 90 percent CI: −23.15, 21.35. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program 
RelativeDiffTable). 
In addition to the cost savings analysis on all eligible beneficiaries (ITT approach), RTI 
conducted several sensitivity analyses to provide additional information on potential savings or 
losses associated with the demonstration overall and for the subset of beneficiaries enrolled in 
the demonstration. These sensitivity analyses included (1) simulating capitated rates for eligible 
enrollees not enrolled in the demonstration and comparing these rates to actual FFS 
expenditures; (2) predicting FFS expenditures for beneficiaries enrolled in the demonstration and 
comparing to the actual capitated rates; and (3) calculating a DID estimate based on a subgroup 
of beneficiaries enrolled in the demonstration with at least 3 months of eligibility in the baseline 
period. The results of these analyses are presented in Appendix D.  
The findings of the sensitivity analyses indicate that the predicted capitated rates are not 
statistically significantly different than actual FFS expenditures for non-enrollees and that 
predicted FFS expenditures are lower than actual capitated rates for enrollees. The enrollee 
subgroup DID analysis indicates additional costs compared to a comparison group, and this 
finding is statistically significant. Note that these analyses do not control for unobservable 
characteristics that may be related to the decision to enroll in the demonstration. The enrollee 
subgroup DID analysis was conducted to learn more about the potential impact of the 
demonstration on the subset of beneficiaries touched by the demonstration for at least 3 months. 
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Note that similar 3-month eligibility criteria were applied to the comparison group for the 
baseline and demonstration periods for this analysis and weights were recalculated. The enrollee 
subgroup analysis is limited by the absence of person-level data on characteristics that 
potentially would lead an individual in a comparison area to enroll in a similar demonstration, 
and thus the results should be considered in the context of this limitation.  
6.4 Discussion 
The results of the preliminary multivariate analyses presented here do not indicate 
statistically significant savings or losses during the first 27 months of the Massachusetts 
demonstration. The savings calculated here are based on capitation rates paid for enrollees and 
the FFS expenditures for eligible beneficiaries that did not enroll in the demonstration. The 
estimates do not take into account actual payments for services incurred by enrollees and paid by 
the One Care plans.  
One potential reason that savings were not identified in these analyses is that that there 
was not sufficient time for the program to demonstrate impact. For example, limited enrollment 
could limit the potential impact on costs because there was “no critical mass” achieved. It is also 
important to note that given the ITT framework used to calculate savings, all eligible 
beneficiaries, regardless of their enrollment status were included in the calculation. However, 
enrollment in Massachusetts was modest at best during the first 27 months of the demonstration. 
Approximately 105,000 Medicare-Medicaid beneficiaries in Massachusetts were eligible for and 
over 14,000 (13.3 percent) enrolled in the demonstration as of December 2016. The large 
majority of the eligible beneficiaries (86.7 percent) were not enrolled in a One Care plan, and 
were therefore receiving usual FFS Medicare.43 While the ITT framework helps mitigate 
selection bias in evaluating the impact of an intervention, it may be more challenging to detect 
savings in an ITT framework where enrollment penetration is so low. It should also be noted that 
the demonstration year 2 results for the enrollee subgroup in part reflect a risk adjustment-related 
change that increased the capitation payments for eligible individuals enrolled in Massachusetts 
MMPs in 2015. The associated risk adjustment change, which took effect across Medicare 
Advantage in 2017, will not be reflected in our analyses because the comparison groups are 
exclusively beneficiaries in Medicare FFS. 
Once Medicaid data become available to the Federal evaluator, and a similar calculation 
can be conducted on the Medicaid costs, it will be possible to have a more complete 
understanding of potential savings from the first 2 years of the Massachusetts demonstration. In 
the meantime, preliminary analysis conducted by the Commonwealth of Massachusetts suggests 
the potential for savings to Medicaid and Medicare over time due to reduced inpatient and acute 
service utilization. Specifically, the Commonwealth has seen evidence that One Care Plans’ 
investment in Medicaid-covered services (e.g., LTSS) creates savings on Medicare-covered 
services (e.g., inpatient hospital, emergency department). The Commonwealth suggests that 
observed increases in Medicaid community LTSS under the demonstration is likely due, in part, 
                                                 
43 Though Medicare Accountable Care Organizations (ACOs) are prevalent in the Commonwealth, the cost savings 
methodology takes that into account. The difference-in-differences regression model used to measure the impact 
of the demonstration on cost incorporates a control variable for any Medicare ACO or shared savings initiative 
experience beneficiaries may have (both in the intervention group and comparison group). 
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to under-utilization prior to the demonstration due to a lack of navigation, care planning and 
coordination in the fee-for-service environment prior to the Financial Alignment Initiative. 
Massachusetts has also found that continuous enrollment for an extended period of time (18+ 
months) appears to be a key factor in achieving reduced acute and inpatient utilization and 
savings.44  
RTI will continue to examine these results and will rerun the analyses when complete 
information on quality withholds become available. Once Medicaid data become available for 
the first demonstration period and a similar calculation can be conducted on the Medicaid costs, 
it will be possible to have a more complete understanding of potential savings from the first 2 
years of the Massachusetts One Care plan demonstration. Additional Medicare and Medicaid 
savings calculations will be conducted by the evaluation contractor for each year of the 
demonstration as data are available and future reports will show updated results for the first 2 
years of the demonstration based on data reflecting additional claims runout, risk score 
reconciliation, and any retroactive adjustments. 
44 These estimates are assessed and provided by the Commonwealth of Massachusetts and are independent from 
analyses presented in this report. CMS has not validated these estimates. 
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7. Conclusions 
7.1 Implementation Successes, Challenges, and Emerging Issues 
Overall, MassHealth officials, One Care MMPs, and other stakeholders continue to voice 
strong support for One Care and emphasize that it is the right care model for this population. For 
many enrollees, One Care has provided access to care coordination services for the first time, as 
well as access to new and expanded benefits. A key element of the One Care demonstration is 
the use of care coordinators and, as appropriate, community-based LTS Coordinators to assess 
the enrollees’ needs and facilitate access to and coordination of services within the medical, 
behavioral health, and LTSS systems.  
Support for One Care is evidenced in part by the decision to continue to extend the 
demonstration. Based on experience to date, MassHealth officials have also expressed interest in 
potentially converting the demonstration into a permanent program when the Financial 
Alignment Initiative ends.45 MassHealth anticipates resoliciting MMPs for the demonstration for 
January 2019, potentially attracting additional plans. Moreover, MassHealth officials reported 
incorporating One Care’s goals of member-centered, coordinated, and culturally competent care 
into broader MassHealth reforms related to its 1115(a) demonstration waiver.  
Although Fallon’s departure in the fall of 2015 was operationally challenging at the time, 
the experience also strengthened the relationships between CMS, MassHealth, the MMPs, and 
the Implementation Council, all of whom worked together to keep the demonstration in place. 
Most importantly, the financial stability of the demonstration has improved significantly over the 
last 2 years, for the most part due to changes in One Care’s financing and payment model.  
As reported in the first Annual Report, all three MMPs experienced financial losses 
during demonstration year 1, and, at the time, MMPs had concerns that anticipated losses would 
continue based on the existing financial structure. Subsequently, CMS, MassHealth, and the 
remaining two MMPs negotiated several financial changes that were finalized in a contract 
amendment executed in December 2015. Changes to rates, savings percentages, and other 
financing structures helped stabilize the demonstration. Although One Care is on better footing, 
some questions remain as to its sustainability. In part, this may depend on the ability of the care 
model to bend the cost curve by providing more efficient and effective care. 
Both MMPs reported that during demonstration year 2, they focused on improving the 
assessment process and timeliness. In part, the MMPs experienced a lower volume of newly 
enrolled beneficiaries in year 2 than in the first 15 months of the demonstration, which allowed 
them to focus on process improvement, but also making adjustments based on learning from 
early implementation experiences. MassHealth officials, many stakeholders, and MMP 
representatives reported that as the demonstration matured, the focus on care coordination and 
care planning increased. MassHealth, MMPs, and stakeholders cited examples in which the 
assessment and integrated care planning between behavioral health and medical care had 
improved beneficiaries’ health. MassHealth and the MMPs have worked collaboratively with 
community-based organizations and advocates to improve the implementation of the LTS 
                                                 
45 In January 2017, CMS offered Massachusetts the ability to extend the demonstration through December 31, 
2020.  
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coordinator role; it is not yet clear whether those improvements are sufficient to address all 
concerns.  
MassHealth, MMPs, enrollees, and other stakeholders report success stories from One 
Care. One Care offers access to new services not previously available to Medicare-Medicaid 
beneficiaries. These include new community-based behavioral health services that provide an 
alternative to inpatient psychiatric care, and other LTSS community-based services to help 
people live independently in their homes. Overall experiences of participants in the 2016 focus 
groups were similar to those reported in the first Annual Report. Findings from the focus groups 
indicate that many participants report overall satisfaction with One Care. Transportation 
continues to be an area for improvement, with complaints around quality of transportation 
services constituting over half of all complaints for 2015.46 While MMPs have worked to lessen 
these complaints, this will require continued monitoring. 
The structure for soliciting stakeholder engagement has been a key element in One Care’s 
success. The Implementation Council provides ongoing advice to MassHealth; solicits input 
from stakeholders; and monitors the implementation of the demonstration. As the demonstration 
has matured, some of the early, operational challenges have lessened. Implementation Council 
members reported that key successes in demonstration year 2 included collaborating with 
MassHealth and CMS to assist enrollees affected by Fallon’s withdrawal from the 
demonstration, and successfully advocating for increased financial support for One Care. The 
Implementation Council also provides a public forum for discussion and exchange of 
information with the One Care Ombudsman, a program that assists beneficiaries with questions 
and complaints about their services. 
As reported in the first Annual Report, implementation of the demonstration has been 
challenging. Integrating the policies, procedures, and systems of Medicare and Medicaid made 
program implementation and service delivery very complex and challenging. Although 
MassHealth and other key stakeholders noted progress in achieving a greater level of integration 
in operations, challenges were still reported in eligibility, data reporting, and operational areas. 
Others noted that certain aspects of the demonstration—such as the appeals and grievance 
processes; separate encounter data reporting for Medicare and Medicaid services; and the receipt 
of three separate capitation rates—were not fully integrated as designed.  
Approximately 14 percent of eligible beneficiaries in Massachusetts were enrolled in the 
demonstration by the end of demonstration year 3. From the end of demonstration year 1 to the 
end of demonstration year 2, enrollment fell from approximately 17,900 to 12,300 individuals, 
mostly due to Fallon’s withdrawal and temporary enrollment caps. Although enrollment as of 
December 11, 2016 had increased to approximately 14,300, it still fell short of enrollment 
numbers before Fallon’s withdrawal. Enrollment continued to increase in January 2017 by 
approximately 2,000 enrollees because of additional passive enrollment. As noted in Section 3.2, 
Enrollment and Eligibility, there have been changes in the design of passive enrollment, as well 
as an added coverage area for one MMP, which provide greater potential for increasing 
enrollment numbers. However, the use and manner of implementing passive enrollment 
continues to be an area of some concern for stakeholders.  
                                                 
46 This data is for April through December 2015; prior complaint data did not track complaint categories.  
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Overall, it is still too early in the demonstration for MassHealth and the MMPs to 
evaluate and identify any trends in much of the quality reporting data. One Care is the only 
demonstration under the Financial Alignment Initiative that limits eligibility to beneficiaries 
under the age of 65 at the time of enrollment; MassHealth and the MMPs report that this makes it 
challenging to benchmark One Care against other programs in Massachusetts and against other 
Financial Alignment Initiative demonstrations.  
Beginning in demonstration year 4, stakeholders and others stressed the importance of 
ensuring a continued focus by MassHealth on One Care against the backdrop of the larger 
MassHealth reforms related to the approval and implementation of its Section 1115(a) 
demonstration waiver. Officials from MassHealth, the MMPs, and other stakeholders are 
encouraged by the improved financial stability and commitment to One Care demonstrated by 
both CMS and MassHealth. While most interviewees reported that they are cautiously optimistic 
about the future of One Care, they noted that more time and additional monitoring is needed, 
especially in areas of enrollment, finance, and quality data metrics. The continuation of the 
demonstration will allow for the maturation of data allowing for greater assessment of the ability 
of One Care to achieve its overall objectives under the Financial Alignment Initiative to alleviate 
fragmentation of care, enhance quality of care, and reduce costs. 
7.2 Demonstration Impact on Service Utilization and Costs  
Difference-in-differences regression results of demonstration impacts show that the 
Massachusetts demonstration resulted in statistically significant changes in utilization patterns, 
including changes in RTI quality of care and care coordination measures. These changes include 
higher monthly inpatient admissions (including inpatient admissions for overall and chronic 
ambulatory care sensitive conditions [ACSC]), all-cause 30-day readmissions, skilled nursing 
facility (SNF) admissions, and physician evaluation and management (E&M) visits, along with a 
lower probability of any long-stay nursing facility (NF) use over the year and lower quarterly 
follow-up after mental health discharges. The demonstration had no impact on monthly 
emergency room (ER) visits overall or on preventable ER visits. The impacts on ACSC inpatient 
admissions, all-cause 30-day readmission, and probability of long-stay NF use were factors in 
both years of the demonstration. Whereas the effects on physician E&M visits were concentrated 
in demonstration year 1, the impacts on overall inpatient admissions, SNF admissions, and 
quarterly follow-up after mental health discharges were concentrated in demonstration year 2. 
These findings are based on Medicare- and MDS-only data analysis. Massachusetts may be 
providing additional Medicaid-funded community-based follow-up services that are more 
extensive than those provided through Medicare funding. 
Regression results for the special populations analyzed were very similar. Both eligible 
beneficiaries with LTSS use and eligible beneficiaries with SPMI experienced higher monthly 
inpatient admissions (including ACSC admissions), SNF admissions, physician E&M visits, and 
all-cause 30-day readmissions, along with a lower probability of any long-stay NF use and lower 
quarterly follow-up after mental health discharges, relative to comparison group eligibles with 
LTSS use and SPMI, respectively.  
The results of cost savings analyses using a difference-in-differences regression approach 
on beneficiaries eligible for the One Care demonstration do not indicate statistically significant 
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savings or losses as a result of the Massachusetts demonstration. Savings were not identified in 
either demonstration period. 
Generally, higher utilization for many service types as found in impact analyses may be 
consistent with unmet need among those who enrolled in One Care, which may have led to MMP 
reported losses in demonstration year 1 and only small reported profits in demonstration year 2. 
Although ACSC admissions were higher in the Massachusetts demonstration, such admissions 
are not necessarily inappropriate admissions—just more likely to be inappropriate. Upon 
enrollment, if existing medical conditions have not been routinely treated, MMPs may be 
addressing unmet needs in the demonstration, which may not be relevant for the comparison 
group. In addition, the time window for creating a successful program may be longer than 2 
years, given One Care implementation challenges.  
7.3 Next Steps 
The RTI evaluation team will continue to collect information on a quarterly basis from 
Commonwealth officials through the online SDRS, covering enrollment statistics and updates on 
key aspects of implementation. The RTI evaluation team will continue conducting quarterly calls 
with CMS and the Massachusetts demonstration State staff and will request the results of any 
evaluation activities conducted by the Commonwealth or other entities. During the course of the 
demonstration, there will be additional site visits and focus groups.  
Quantitative analyses in future evaluation reports will continue to analyze demonstration 
impact using the latest demonstration year’s cost and utilization data to assess both cumulative 
and annual effects relative to a comparison group. Analyses will be made for all demonstration 
eligible beneficiaries and for important special populations of interest, including demonstration 
eligible beneficiaries who are enrolled, those with any LTSS, and those with SPMI.  
As noted previously, Massachusetts has extended the demonstration for 2 additional 
years, through December 31, 2018, which will provide further opportunities to evaluate the 
demonstration’s performance. CMS recently offered the Commonwealth the opportunity to 
extend the demonstration through December 31, 2020, and Massachusetts had responded with a 
non-binding letter of intent to extend. In 2018, CMS and the Commonwealth agreed to a 1-year 
extension through December 31, 2019. Updates on the anticipated extension will be provided in 
the third Evaluation Report on One Care. The third Evaluation Report will also include 
information on the recent decision to expand the use of passive enrollment to counties where, 
previously, it was not available; MMP Tufts’ decision to begin operations in Middlesex County; 
and any changes or developments affecting One Care related to MassHealth’s larger Medicaid 
reforms. In addition, the next report will include updated qualitative information on the status of 
the demonstration and additional analyses of quality, utilization, and cost measures for those 
eligible for the demonstration and an out-of-state comparison group that, in part, includes an 
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Comparison Group Methodology for Massachusetts 
Demonstration Year 2 
CMS contracted with RTI International to monitor the implementation of demonstrations 
under the Financial Alignment Initiative (FAI) and to evaluate their impact on beneficiary 
experience, quality, utilization, and cost. Impact analyses using costs will be estimated using 
multivariate regression models.  
Results for comparison group selection and assessment analyses are prepared for each 
demonstration period. The annual report for the first demonstration period and 2 
predemonstration years for the Massachusetts demonstration was publicly released in September 
2016. The Technical Appendix at the end of that document describes the comparison group 
identification methodology in detail. 
This report provides the comparison group results for the second performance period for 
the One Care demonstration in Massachusetts (January 1, 2015–December 31, 2015), and notes 
any major changes in the results since the previous performance period. The first Massachusetts 
demonstration period covered five quarters (October 1, 2013 to December 31, 2014).  
Demonstration and Comparison Group Characteristics 
The Massachusetts demonstration area consists of three large urban Metropolitan 
Statistical Areas (MSAs) (Boston-Cambridge-Newton; Worcester; and Springfield) plus one 
Rest-of-State area containing rural areas. The comparison area is composed of 116 counties in 24 
Metropolitan Statistical Areas. These geographic areas have not changed since the first Annual 
Report. All targeted beneficiaries in the two groups are younger than 65 years of age.  
The number of demonstration group beneficiaries has remained steady over the two 
predemonstration periods and the two demonstration periods, ranging between 106,393 to 
118,687 per period. In the comparison group, which is twice the size of the demonstration group, 
the number of beneficiaries has also been relatively stable (from 179,092 to 200,413 per period). 
Propensity Score Estimates 
RTI’s methodology uses propensity scores to examine initial differences between the 
demonstration and comparison groups in each analysis period and then to weight the data to 
improve the match between them. The comparability of the two groups is examined with respect 
to both individual beneficiary characteristics as well as the overall distributions of propensity 
scores.  
A propensity score (PS) is the predicted probability that a beneficiary is a member of the 
demonstration group conditional on a set of observed variables. Our propensity score models 
include a combination of beneficiary-level and region-level characteristics measured at the ZIP 
code (ZIP Code Tabulation Area) level. The Technical Appendix in last year’s report provides a 
detailed description of these characteristics and how the propensity scores were calculated.  
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One change in the specification of the propensity score model is that two new 
explanatory variables. One is for Black beneficiaries and the other is for those involved in other 
Medicare shared-savings initiatives (such as Accountable Care Organizations, which are 
prevalent in Massachusetts. Both have been added to the model because they now represent more 
than 10 percent of the beneficiaries in either the demonstration or comparison groups. 
Previously, any beneficiaries from practices participating in Medicare shared savings programs 
(labeled Other MDM for Master Data Management programs in our tables) were omitted from 
the analyses. 
The logistic regression coefficients and z-values for the covariates included in the 
propensity model for Massachusetts demonstration year 2 are shown in Table A-1. In the revised 
specification, the two variables most strongly associated with group status are the two new 
variables. Demonstration beneficiaries in Massachusetts are much less likely to be Black (12.7 
percent vs. 31.7 percent) and more likely to be part of a shared-savings practice (46.1 percent vs. 
19.7 percent) than their comparison group counterparts. In addition, there are ZIP code-level 
group differences associated with rates of college-educated adults and the distances to hospitals 
and nursing facilities. The magnitude of the group differences for all variables prior to propensity 
score weighting may also be seen in Table A-2. 
Propensity Score Overlap 
The distributions of propensity scores by group for demonstration year 2 are shown in 
Figure A-1 before and after propensity weighting. Estimated scores covered nearly the entire 
probability range in both groups. Like the previous analyses, the unweighted comparison group 
(dashed line) is characterized by a spike in predicted probabilities in the range from 0 to 0.20. 
Inverse Probability of Treatment Weighting (IPTW) pulls the distribution of weighted 
comparison group propensity scores (dotted line) very close to that of the demonstration group 
(solid line).  
Any beneficiaries who have estimated propensity scores below the smallest estimated 
value in the demonstration group are removed from the comparison group. Because of the very 
broad range of propensity scores found in the Massachusetts demonstration data, only 15 
beneficiaries were removed from the comparison group in demonstration year 2.    
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Table A-1 
Logistic regression estimates for Massachusetts propensity score models 
in demonstration year 2 
Characteristic 
Demonstration period 2 
Coef. Standard error z-score 
Age (years) 0.012 0.000 29.61 
Died during year −0.310 0.033 −9.26 
Female (0/1) −0.148 0.009 −16.25 
White (0/1) −0.528 0.014 −38.43 
Black (0/1) −1.897 0.016 −117.41 
Disabled (0/1) 1.289 0.019 68.59 
ESRD (0/1) −0.458 0.033 −13.97 
Share mos. elig. during period (prop.) −0.158 0.017 −9.04 
HCC risk score −0.074 0.004 −16.45 
Other MDM 1.083 0.009 117.45 
MSA (0/1) −0.335 0.027 −12.25 
% of pop. living in married household −0.013 0.001 −24.46 
% of households w/member >= 60 yrs. −0.013 0.001 −17.49 
% of households w/member < 18 yrs. 0.043 0.001 65.91 
% of adults w/college education 0.030 0.000 72.73 
% of adults w/self-care limitation −0.063 0.003 −19.57 
% of those age < 65 yrs. unemployed −0.006 0.001 −4.32 
Distance to nearest hospital (mi.) −0.032 0.002 −20.43 
Distance to nearest nursing facility (mi.) −0.187 0.003 −57.16 
Intercept −1.341 0.064 −21.01 
ESRD = end-stage renal disease; HCC = Hierarchical Condition Category; MDM = Master Data Management; MSA 




Distribution of beneficiary-level propensity scores in the Massachusetts demonstration and 
comparison groups, weighted and unweighted, demonstration year 2 
Group Comparability 
Covariate balance refers to the extent to which the characteristics used in the propensity 
score are similar (or “balanced”) for the demonstration and comparison groups. Group 
differences are measured by a standardized difference (the difference in group means divided by 
the pooled standard deviation of the covariate). An informal standard has developed that groups 






Massachusetts dual eligible beneficiary covariate means by group before and after 


















Age 50.266 50.127 49.992 0.012 0.024 
Died 0.016 0.024 0.016 −0.059 0.000 
Female 0.515 0.527 0.504 −0.024 0.023 
White 0.696 0.613 0.701 0.176 −0.011 
Black 0.127 0.317 0.122 −0.468 0.016 
Disabled 0.949 0.868 0.946 0.284 0.016 
ESRD 0.014 0.032 0.015 −0.120 −0.008 
Share mos. elig. during 
period 
0.875 0.853 0.870 0.085 0.020 
HCC score 1.139 1.181 1.131 −0.042 0.008 
Other MDM 0.461 0.197 0.450 0.584 0.021 
MSA 0.979 0.932 0.981 0.230 −0.014 
% of pop. living in married 
household 
64.722 62.962 65.816 0.103 −0.065 
% of households w/member 
>= 60 
34.221 36.375 34.181 −0.294 0.006 
% of households w/member 
< 18 
32.046 30.753 32.640 0.174 −0.074 
% of adults w/ college 
education 
31.565 24.603 32.341 0.429 −0.042 
% of adults w/self-care 
limitation 
2.095 2.638 2.048 −0.262 0.027 
% of those age < 65 yrs. 
unemployed 
10.331 11.276 10.202 −0.162 0.024 
Distance to nearest hospital 4.090 5.879 4.193 −0.418 −0.031 
Distance to nearest nursing 
facility 
2.555 3.835 2.656 −0.509 −0.062 
ESRD = end-stage renal disease; HCC = Hierarchical Condition Category; MDM = Master Data Management; MSA 
= metropolitan statistical area. 
The group means and standardized differences for all beneficiary characteristics are 
shown for demonstration year 2 in Table A-2. The column of unweighted standardized 
differences indicates that several of these variables were not balanced before running the 
propensity model. Five variables (percent Black, percent in Other MDM [shared savings] 
programs, percent of adults with a college education, and the distances [in miles] to the nearest 
hospital and nursing facility) all had unweighted standardized differences exceeding 0.40.  
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The results of propensity score weighting for Massachusetts demonstration period 2 are 
illustrated in the far-right column (weighted standardized differences) in Table A-2. Propensity 
weighting reduced the standardized differences below the threshold level of an absolute value of 
0.1 for all the covariates in our model.  
Summary 
Our Massachusetts demonstration year 2 analyses added two new covariates to our 
propensity model and included beneficiaries participating in shared savings programs. The 
Massachusetts demonstration and comparison groups were initially distinguished by differences 
in both new covariates (percent Black and shared savings percent) as well as three other region-
based variables. However, propensity-score weighting successfully reduced all covariate 
discrepancies below the threshold for standardized differences. As a result, the weighted 
Massachusetts groups are adequately balanced with respect to all 19 of the variables we consider 






We briefly describe the overall evaluation design, the data used, and the populations and 
measures analyzed.  
Evaluation Design 
RTI International is using an intent-to-treat (ITT) approach for the impact analyses 
conducted for the evaluation, comparing the eligible population under each State demonstration 
with a similar population that is not affected by the demonstration (i.e., a comparison group). 
ITT refers to an evaluation design in which all Medicare-Medicaid enrollees eligible for the 
demonstration constitute the evaluation sample, regardless of whether they actively participated 
in demonstration models. Thus, under the ITT framework, analyses include all beneficiaries 
eligible for the demonstration, including those who are eligible but are not contacted by the State 
or participating providers to enroll in the demonstration or care model; those who enroll but do 
not engage with the care model; and a group of similar eligible individuals in the comparison 
group.  
Results for special populations within each of the demonstration and comparison groups 
are also presented in this section (e.g., those with any LTSS use in the demonstration and 
comparison groups; those with any behavioral health claims in the demonstration and 
comparison groups). In addition, one group for which descriptive results are also reported are not 
compared to the comparison group because this group does not exist within the comparison 
group: Massachusetts demonstration enrollees. For this group, we compare them to in-State non-
enrollees. 
Comparison Group Identification 
The comparison group will serve to provide an estimate of what would have happened to 
the demonstration group in the absence of the demonstration. Thus, the comparison group 
members should be similar to the demonstration group members in terms of their characteristics 
and health care and long-term services and supports (LTSS) needs, and they should reside in 
areas that are similar to the demonstration State in terms of the health care system and the larger 
environment. For this evaluation, identifying the comparison group members entailed two steps: 
(1) selecting the geographic area from which the comparison group would be drawn and 
(2) identifying the individuals who would be included in the comparison group. 
To construct Massachusetts’s comparison group, we used both in-state and out-of-State 
areas. We compared demonstration and potential comparison areas on a range of measures, 
including spending per Medicare-Medicaid enrollee by each program, the shares of LTSS 
delivered in facility-based and community settings, and the extent of Medicare and Medicaid 
managed care penetration. Using statistical analysis, we selected the individual comparison 
metropolitan statistical areas (MSAs) that most closely match the values found in the 
demonstration area on the selected measures. We also considered other factors when selecting 
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comparison States, such as timeliness of Medicaid data submission to CMS. We identified a 
comparison group from MSAs in Alabama, Kentucky, Maryland, Massachusetts, Mississippi, 
North Carolina, Pennsylvania, Virginia, West Virginia, and Wisconsin at least as large as the 
eligible population in Massachusetts. For details of the comparison group identification strategy, 
see Appendix A. 
Data 
Evaluation report analyses used data from a number of sources. First, the State provided 
quarterly finder files containing identifying information on all demonstration eligible 
beneficiaries in the demonstration period. Second, RTI obtained administrative data on 
beneficiary demographic, enrollment, and service use characteristics from CMS data systems for 
both demonstration and comparison group members. Third, these administrative data were 
merged with Medicare claims and encounter data on utilization of Medicare services, as well as 
the MDS. 
Although Medicaid service data on use of LTSS, behavioral health, and other Medicaid-
reimbursed services were not available for the demonstration period and therefore are not 
included in this report, CMS administrative data identifying eligible beneficiaries who used any 
Medicaid-reimbursed long-stay nursing facility services or any Medicare behavioral health 
services were available, so that their Medicare service use could be presented in this report. 
Future reports will include findings on Medicaid service use once data are available. 
Populations and Services Analyzed 
The populations analyzed in the report include all demonstration eligible beneficiaries, as 
well as the following special populations: those receiving any long-stay nursing facility services; 
those with any behavioral health service use in the last 2 years for a severe and persistent mental 
illness (SPMI); demonstration enrollees; and three demographic groups (age, gender, and 
race/ethnicity).  
For each group and service type analyzed, we provide estimates of three access to care 
and utilization measures: the percent of demonstration eligible beneficiaries with any use of a 
service, and counts of service use for both all eligible beneficiaries and users of the respective 
service. 
The 14 service settings analyzed include both institutional (inpatient, inpatient 
psychiatric, inpatient non-psychiatric, emergency department visits not leading to admission, 
emergency department psychiatric visits, observation stays, skilled nursing facility, and hospice) 
and community settings (primary care, outpatient as well as independent physical, speech, and 
occupational therapy, home health, durable medical equipment, and other hospital outpatient 
services).  
In addition, six quality measures representing specific utilization types of interest are 
presented: 30-day all-cause risk-standardized readmission rate; preventable emergency room 
visits; rate of 30-day follow-up after hospitalization for mental illness; ambulatory care sensitive 
condition overall composite rate (Agency for Healthcare Research and Quality [AHRQ] 
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Prevention Quality Indicator [PQI] #90); ambulatory care sensitive condition chronic composite 
rate (AHRQ PQI #92); and depression screening rate. 
Five nursing facility-related measures are presented from the Minimum Data Set: two 
measures of annual NF utilization (admission rate and percentage of long-stay NF users) and 
three characteristics of new long-stay NF residents at admission (functional status, percent with 
severe cognitive impairment, percent with low level of care need).  
The analyses were conducted for each of the years in the 2-year predemonstration period 
(October 1, 2011 to September 30, 2013) and for the first and second demonstration periods 
(October 1, 2013 to December 31, 2014, and January 1 to December 31, 2015) for both the 
demonstration and comparison groups in each of the four analytic periods.  
Table B-1 presents descriptive statistics on the independent variables used in multivariate 
difference-in-differences regressions for impact analyses. Independent variables include 
demographic and health characteristics and market- and area-level characteristics. Results are 
presented for six groups: all demonstration eligible beneficiaries in the FAI State, its comparison 
group, demonstration enrollees, non-enrollees, demonstration eligible beneficiaries with any 
long-stay nursing facility use, and demonstration eligible beneficiaries with an SPMI.  
The most prevalent age group was 45 and older, ranging from 91.1 percent in the LTSS 
user group to 69.2 percent in the group with SPMI. In the comparison group, 68.1 percent were 
45 years and older, whereas 71.5 percent were 45 years and older in the demonstration group. 
Across all groups except SPMI, the majority of eligible beneficiaries were female (SPMI was 
44.1 percent; the other groups ranged from 51.6 to 4.1 percent), White (58.5 to 79.8 percent in 
the enrollee and LTSS groups, respectively), and had disability as their original entitlement to 
Medicare (86.1 to 96.5 percent in the comparison and SPMI populations, respectively). HCC 
scores ranged from 1.1 in the demonstration and comparison group to 2.7 in the LTSS user 
group. The Hierarchical Condition Category (HCC) score is a measure of the predicted relative 
annual cost of a Medicare beneficiary based on the diagnosis codes present in recent Medicare 
claims. Beneficiaries with a score of 1 are predicted to have average cost in terms of annual 
Medicare expenditures. Beneficiaries with HCC scores less than 1 are predicted to have below 
average costs, whereas beneficiaries with scores of 2 are predicted to have twice the average 
annual cost. The vast majority of eligible beneficiaries resided in the metropolitan areas, 
compared to non-metropolitan areas. The percent of months of dual-eligibility was lowest for 
LTSS users.  
There were limited differences in area- and market-level characteristics. Those who were 
in the comparison group resided in counties with a slightly lower rate of patient care physicians 
per 1,000 population, relative to those in the demonstration group (0.9 vs 1.1). Additionally, 
those in the comparison group resided in counties with higher Medicare spending per dual-
eligible, relative to counties in the demonstration group ($18,091 vs $16,902). Enrollees resided 
in counties with a lower percentage of the population living in married households, relative to 
non-enrollees (58.8 vs 65.7), as well as counties with a higher percentage of nonelderly with self-
care limitations (2.4 vs. 2.0), and lower distance to nearest hospital (3.3 vs. 4.2), and lower 






Characteristics of demonstration eligible beneficiaries in current demonstration year by group 
Characteristics Demonstration Comparison Enrollees Non-enrollees LTSS users 
SPMI 
diagnosis 
Number of beneficiaries 104,303  199,075  12,777  91,526  1,546  56,370  
Demographic characteristics             
Age             
21 to 44 28.5 31.9 28.3 28.5 8.9 30.8 
45 and older 71.5 68.1 71.7 71.5 91.1 69.2 
Female             
No 48.3 47.3 48.4 48.3 45.9 55.9 
Yes  51.7 52.7 51.6 51.7 54.1 44.1 
Race/Ethnicity              
White 69.4 61.3 58.5 71.0 79.8 72.7 
Black 13.0 31.7 21.1 11.9 11.4 11.3 
Hispanic 10.1 2.5 13.5 9.6 4.3 9.8 
Asian 2.1 1.3 2.1 2.0 1.3 1.6 
Disability              
No (0) 5.6 13.9 4.2 5.8 11.2 3.5 
Yes (1) 94.4 86.1 95.8 94.2 88.8 96.5 
ESRD status             
No (0) 98.6 96.9 98.9 98.6 96.1 99.1 
Yes (1) 1.4 3.1 1.1 1.4 3.9 0.9 
MSA              
Non-metro (0) 2.2 6.8 0.6 2.4 2.5 2.2 
Metro (1) 97.8 93.2 99.4 97.6 97.5 97.8 
Months with full-dual eligibility during year (%)  0.9 0.9 1.0 0.9 0.8 0.9 






Table B-1 (continued) 
Characteristics of demonstration eligible beneficiaries in current demonstration year by group 
Characteristics Demonstration Comparison Enrollees Non-enrollees LTSS users 
SPMI 
diagnosis 
Market characteristics             
Medicare spending per dual, ages 19+ ($) 16,902 18,091 16,795 16,917 17,058 16,927 
MA penetration rate 0.2 0.2 0.2 0.2 0.2 0.2 
Medicaid-to-Medicare fee index (FFS) 0.8 0.7 0.8 0.8 0.8 0.8 
Medicaid spending per dual, ages 19+ ($) 22,450 22,430 22,496 22,443 22,446 22,447 
Fraction of duals using NF, ages 65+  0.2 0.3 0.2 0.2 0.2 0.2 
Fraction of duals using HCBS, ages 65+ 0.1 0.1 0.1 0.1 0.1 0.1 
Fraction of duals using personal care, ages 65+  0.0 0.0 0.0 0.0 0.0 0.0 
Patient care physicians per 1,000 population  1.1 0.9 1.1 1.1 1.1 1.1 
Area characteristics             
% of pop. living in married households  64.9 65.8 58.8 65.7 69.0 65.3 
% of nonelderly with college education  32.0 32.3 30.0 32.3 36.0 33.0 
% of nonelderly who are unemployed  10.3 10.2 11.5 10.1 9.4 10.0 
% of nonelderly with self-care limitations 2.1 2.1 2.4 2.0 1.8 2.0 
Distance to nearest hospital  4.0 4.2 3.3 4.2 4.0 4.0 
Distance to nearest nursing facility  2.5 2.7 2.2 2.6 2.5 2.5 
% of household with individuals younger than 18 32.0 32.6 31.9 32.0 31.3 31.6 
% of household with individuals older than 60 34.2 34.2 32.2 34.5 35.2 34.1 
ESRD = end-stage renal disease; FFS = fee for service; HCC = Hierarchical Condition Category; LTSS = long-term services and supports; MA = Medicare 
Advantage, MSA = metropolitan statistical area; NF = nursing facility; SPMI = severe and persistent mental illness.  
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Detailed Population Definitions 
Demonstration eligible beneficiaries. Beneficiaries are identified in a given month if they 
were a Medicare-Medicaid enrollee and met any other specific demonstration eligibility criteria. 
Beneficiaries in the demonstration period are identified from quarterly State finder files, whereas 
beneficiaries in the 2-year period preceding the demonstration implementation date are identified 
by applying the eligibility criteria in each separate predemonstration quarter. 
Additional special populations were identified for the analyses as follows: 
• Enrollees. A beneficiary was defined as an enrollee if they were enrolled in the 
demonstration during the demonstration period.  
• Age. Age was defined as a categorical variable where beneficiaries were identified as 
21 to 44, 45 years and older during the observation year (e.g., predemonstration 
period 1, predemonstration period 2, and demonstration years 1 and 2). 
• Gender. Gender was defined as binary variable where beneficiaries were either male 
or female.  
• Race/Ethnicity. Race/ethnicity was defined as a categorical variable where 
beneficiaries were categorized as White, Black, Hispanic, or Asian.  
• Long-term care services and supports (LTSS). A beneficiary was defined as using 
LTSS if there was any use of institutional based services during the observation year. 
Information on home and community-based services was not available. 
• Severe and persistent mental illness (SPMI). A beneficiary was defined as having a 
SPMI if a beneficiary had incurred a claim for severe and persistent mental illness 
within the past 2 years.  
Detailed Utilization and Expenditure Measure Definitions 
For any health care service type, the methodology for estimating average monthly 
utilization and the percentage of users takes into account differences in the number of eligibility 
months across beneficiaries. Because full-benefit dual eligibility status for the demonstration can 
vary by month over time for any individual, the methodology used determines dual eligibility 
status for the demonstration for each person on a monthly basis during a predemonstration or 
demonstration period. That is, an individual can meet the demonstration’s eligibility criteria for 
up to 12 months during the observation year. The methodology adds the total months of full-
benefit dual eligibility for the demonstration across the population of interest and uses it in the 
denominator in the measures in Section 5, creating average monthly utilization information for 
each service type. The methodology effectively produces average monthly use statistics for each 
year that account for variation in the number of dual eligible beneficiaries in each month of the 
observation year.  
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The utilization measures below were calculated as the aggregate sum of the unit of 
measurement (e.g., counts) divided by the aggregated number of eligible member months [and 
user months] within each group (g) where group is defined as (1) Massachusetts base year 1, 
(2) Comparison base year 1, (3) Massachusetts base year 2, (4) Comparison base year 2,
(5) Massachusetts demonstration year 1, (6) Comparison demonstration year 1,
(7) Massachusetts demonstration year 2, (8) Comparison demonstration year 2.
We calculated the average number of services per 1,000 eligible months and per 1,000 
user months by beneficiary group (g). In the Massachusetts first Annual Report, we defined user 
month as an eligible month among those with any utilization of the respective service in the 
period. In this second Evaluation Report, we have updated our methodology to define user month 
as an eligible month where the number of units of utilization used [for a given service] was 
greater than zero during the month. We weight each observation using yearly propensity weights. 
The average yearly utilization outcomes are measured as:  
Where  Yɡ = average count of the number services used [for a given service] per eligible or 
user month within group g.  
Ȥiɡ = the total units of utilization [for a given service] for individual i in group g. niɡ = the total number of eligible/user months for individual i in group g.  
The denominator above is scaled by such that the result is interpreted in terms of 
average monthly utilization per 1,000 eligible beneficiaries. This presentation is preferable, 
compared with per eligible, because some of the services are used less frequently and would 
result in small estimates. 
The average percentage of users [of a given service] per eligible month during the 
predemonstration or demonstration year is measured as follows: 
 x 100 
Where 
Uig  = average percentage of users [for a particular service] in a given month among 




Quality of Care and Care Coordination Measures 
Similar to the utilization measures, for the appendix tables of descriptive statistics, the 
quality of care and care coordination measures were calculated as the aggregated sum of the 
numerator divided by the aggregated sum of the denominator for each respective outcome within 
each beneficiary group, except for the average 30-day all-cause risk standardized readmission 
rate and the 30-day followup after hospitalization for mental illness, which are reported as 
percentages.  
Average 30-day all-cause risk standardized readmission rate (percent) was calculated as 
follows: 
Where  
C = the national average of 30-day readmission rate, .238. 
Xiɡ = the total number of readmissions for individual i in group g. 
niɡ = the total number of hospital admissions for individual i in group g. 
Probg = the annual average adjusted probability of readmission for individuals in 
group g. The average adjusted probability equals: 
Average adjusted probability of readmission by 
demonstration group 
Demonstration group 
Average adjusted probability 
of readmission 
Predemonstration period 1 
Massachusetts 0.212 
Comparison 0.223 
Predemonstration period 2 
Massachusetts 0.214 
Comparison 0.223 
Demonstration year 1 
Massachusetts 0.221 
Comparison 0.228 




Rate of 30-day follow-up in a physician or outpatient setting after hospitalization for 
mental illness (percent) was calculated as follows: 
 
Where 
MHFU  = the average rate of 30-day follow-up care after hospitalization for a mental 
illness (percent) for individuals in group g.  Xiɡ = the total number of discharges from a hospital stay for mental health that had a 
follow-up for mental health within 30 days of discharge for individual i in group 
g.  niɡ = the total number of discharges from a hospital stay for mental health for 
individual i in group g.  
Average ambulatory care sensitive condition admissions per eligible beneficiary, overall 
and chronic composite (PQI #90 and PQI #92) was calculated as follows:  
 
Where ACSCɡ =  the average number of ambulatory care sensitive condition admissions per 
eligible month for overall/chronic composites for individuals in group g.  Xiɡ =  the total number of discharges that meet the criteria for AHRQ PQI #90 [or PQI 
#92] for individual i in group g.  niɡ = the total number of eligible months for individual i in group g. 
Preventable ER visits per eligible month was calculated as follows: 
 
Where  ERɡ = the average number of preventable ER visits per eligible month for individuals 
in group g.  Xiɡ = the total number ER visits that are considered preventable based in the diagnosis 
for individual i in group g.  niɡ = the total number of eligible months for individual i in group g. 
Average number of beneficiaries per eligible month who received depression screening 
during the observation year was calculated as follows: 
𝑀𝑀𝑀𝑀𝑀𝑀𝑈𝑈 = Σ𝑖𝑖𝑔𝑔𝑥𝑥𝑖𝑖𝑔𝑔
Σ𝑖𝑖𝑔𝑔n𝑖𝑖𝑔𝑔 ∗ 100 
𝐴𝐴𝐶𝐶𝑆𝑆𝐶𝐶𝑖𝑖𝑔𝑔  = Σ𝑖𝑖𝑔𝑔𝑥𝑥𝑖𝑖𝑔𝑔Σ𝑖𝑖𝑔𝑔n𝑖𝑖𝑔𝑔  
𝐸𝐸𝑅𝑅𝑖𝑖𝑔𝑔  = Σ𝑖𝑖𝑔𝑔𝑥𝑥𝑖𝑖𝑔𝑔Σ𝑖𝑖𝑔𝑔n𝑖𝑖𝑔𝑔  
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Where  Dɡ = the average number of beneficiaries per eligible month who received depression 
screening in group g. Xiɡ = the total number eligible beneficiaries age 65+ who ever received depression 
screening in group g.  niɡ = the total number of eligible months among beneficiaries in group g. 
Average rate of beneficiaries per positive depression screening who received a follow-up 
plan during the observation year was calculated as follows: 
 
Where  PDɡ = the average number of beneficiaries per positive depression screening who 
received a follow-up plan among beneficiaries in group g.  Xiɡ = the total number beneficiaries who received a positive depression screen and a 
follow up plan in group g. niɡ = the total number of beneficiaries who received a positive depression screen in 
group g.  
Minimum Data Set Measures 
Two measures of annual nursing facility-related utilization are derived from the MDS. 
The rate of new long-stay NF admissions per 1,000 eligible beneficiaries is calculated as the 
number of NF admissions for whom there is no record of NF use in the 100 days prior to the 
current admission and who subsequently stay in the NF for 101 days or more. Individuals are 
included in this measure only if their NF admission occurred after their first month of 
demonstration eligibility. The percentage of long-stay NF users is calculated as the number of 
individuals who have stayed in a NF for 101 days or more, who were long-stay after the first 
month of demonstration eligibility. The probability of any long-stay NF use includes both new 
admissions from the community and continuation of a stay in a NF.  
Characteristics of new long-stay NF residents at admission are also included in order to 
monitor nursing facility case mix and acuity levels. Functional status and low level of care need 
are determined by the Resource Utilization Groups Version IV (RUG-IV). Residents with low 
care need are defined as those who did not require physical assistance in any of the four late-loss 
activities of daily living (ADLs) and who were in the three lowest RUG-IV categories. Severe 
cognitive impairment is assessed by the Brief Interview for Mental Status (BIMS), poor short-
term memory, or severely impaired decision-making skills. 
𝐷𝐷𝑔𝑔  = Σ𝑖𝑖𝑔𝑔𝑥𝑥𝑖𝑖𝑔𝑔Σ𝑖𝑖𝑔𝑔n𝑖𝑖𝑔𝑔  
𝑃𝑃𝐷𝐷𝑔𝑔  = Σ𝑖𝑖𝑔𝑔𝑥𝑥𝑖𝑖𝑔𝑔Σ𝑖𝑖𝑔𝑔n𝑖𝑖𝑔𝑔  
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Regression Methodology for Determining Demonstration Impact  
The regressions across the entire demonstration period compare all demonstration eligible 
beneficiaries in the FAI State to its comparison group. The regression methodology accounts for 
both those with and without use of the specific service (e.g., for inpatient services, both those 
with and without any inpatient use). A restricted difference-in-differences equation will be 
estimated as follows: 
Equation 1: Dependent variablei = β0 + β1PostYear + β2Demonstration +  
β3PostYear * Demonstration + β4Demographics + β5-j Market + ε 
where separate models will be estimated for each dependent variable. PostYear is an 
indicator of whether the observation is from the pre- or postdemonstration period, Demonstration 
is an indicator of whether the beneficiary was in the demonstration group, and PostYear * 
Demonstration is an interaction term. Demographics and Market represent vectors of beneficiary 
and market characteristics, respectively. 
Under this specification, the coefficient β0 reflects the comparison group 
predemonstration period mean adjusted for demographic and market effects, β1 reflects the 
average difference between postperiod and predemonstration period in the comparison group, β2 
reflects the difference in the demonstration group and comparison group at predemonstration, 
and β3 is the overall average demonstration effect during the demonstration period. This last term 
is the difference-in-differences estimator and the primary policy variable of interest, but in all 
regression models, because of nonlinearities in the underlying distributions, post-regression 
predictions of demonstration impact are performed to obtain the marginal effects of 
demonstration impact. 
In addition to estimating the model described in Equation 1, a less restrictive model was 
estimated to produce year-by-year effects of the demonstration. The specification of the 
unrestricted model is as follows: 
Equation 2: Dependent variable = β0 + β1-kPostYear1-n + β2Demonstration +  
 β3-kPostYear1-n * Demonstration + β4 Demographics + β5-j Market + ε  
This equation differs from the previous one in that separate difference-in-differences 
coefficients are estimated for each year. Under this specification, the coefficients β3-k would 
reflect the impact of the demonstration in each respective year, whereas the previous equation 
reflects the impact of the entire demonstration period. This specification measures whether 
changes in dependent variables occur in the first year of the demonstration only, continuously 
over time, or in some other pattern. Depending on the outcome of interest, we will estimate the 
equations using logistic regression, Generalized Linear Models with a log link, or count models 
such as negative binomial or Poisson regressions (e.g., for the number of inpatient admissions). 
We used regression results to calculate the marginal effects of demonstration impact. 
Impact estimates across the entire demonstration period are determined using the 
difference-in-differences methodology and presented in figures for all demonstration eligible 
beneficiaries, and then for two special populations of interest—demonstration eligible 
beneficiaries with any LTSS use, and demonstration eligible beneficiaries with SPMI. A table 
 B-12 
follows each figure displaying the annual demonstration difference-in-differences effect for each 
separate demonstration period for each of these populations. In each figure, the point estimate is 
displayed for each measure, as well as the 90 percent confidence interval (black) and the 80 
percent confidence interval (green). The 80 percent confidence intervals are provided for 
comparison purposes only. The 80 percent confidence interval is narrower than the 90 percent 
confidence interval. If the confidence interval includes the value of zero, it is not statistically 
significant at that confidence level. 
For only the full demonstration eligible population and not each special population, an 
additional table presents estimates of the regression-adjusted mean values of the utilization 
measures for the demonstration and comparison groups by year for each service. The purpose of 
this table is to understand the magnitude of the difference-in-differences estimate relative to the 
adjusted mean outcome value in each period. The adjusted mean values show how different the 
two groups were in each period, and the relative direction of any potential effect in each group 
over time. The values in the third and fourth columns represent the post-regression, mean 
predicted value of the outcomes for each group and period, based on the composition of a 
reference population (the comparison group in the demonstration period). The difference-in-
differences estimate is also provided for reference, along with the p-value and the relative 
percent change of the difference-in-differences estimate compared to an average mean use rate 
for the comparison group in the entire demonstration period. 
The relative percent annual change for the difference-in-differences estimate for each 
outcome measure is calculated as [Overall monthly difference-in-differences effect] / 
{[(proportion of eligible beneficiaries in the comparison group in demonstration year 1 of the 
total comparison group eligible beneficiaries in demonstration year 1 + demonstration year 2) x 
(weighted comparison group demonstration year 1 mean value)] + [(proportion of eligible 
beneficiaries in the comparison group in demonstration year 2 of the total comparison group 
eligible beneficiaries in demonstration year 1 + demonstration year 2) x (weighted comparison 
group demonstration year 2 mean value)]}. The mean values for the comparison group for the 2 
demonstration years are averaged to obtain an annual average mean. 
Table B-2 provides an illustrative example of the regression output for each independent 





Negative binomial regression results on monthly inpatient admissions 
(n = 12,287,543 person months) 
Independent variables Coefficient Standard error z-value p-value 
Post period −0.0934 0.0147 −6.370 0.000 
Demonstration group −0.0204 0.0330 −0.620 0.536 
Interaction of post period x demonstration group 0.0385 0.0127 3.020 0.002 
Trend −0.0036 0.0005 −6.790 0.000 
Age −0.0040 0.0010 −3.880 0.000 
Female −0.0032 0.0137 −0.240 0.814 
Black −0.0377 0.0286 −1.320 0.187 
Asian −0.5099 0.0712 −7.160 0.000 
Other race −0.3234 0.0363 −8.910 0.000 
Hispanic −0.2371 0.0333 −7.120 0.000 
Disability as reason for original Medicare entitlement 0.0773 0.0163 4.730 0.000 
End stage renal disease 1.4337 0.0353 40.620 0.000 
Hierarchical Condition Category (HCC) score 0.4474 0.0071 63.380 0.000 
Percent of months of demonstration eligibility −1.0250 0.0355 −28.840 0.000 
Metropolitan statistical area (MSA) residence −0.0142 0.0662 −0.210 0.830 
Percent of population living in a married household −0.0017 0.0009 −1.820 0.068 
Percent of households with family member greater than or 
equal to 60 years old 
−0.0059 0.0013 −4.470 0.000 
Percent of households with family member less than 18 
years old 
−0.0059 0.0013 −4.680 0.000 
Percent of adults with college education −0.0007 0.0009 −0.760 0.446 
Percent adult unemployment rate 0.0039 0.0021 1.810 0.070 
Percent of adults with self care limitation −0.0058 0.0076 −0.750 0.451 
Distance to nearest hospital 0.0001 0.0028 0.020 0.985 
Distance to nearest nursing facility −0.0028 0.0052 −0.530 0.598 
Medicare spending per full-benefit dual eligible  0.0000 0.0000 2.090 0.036 
Medicare Advantage penetration rate −0.1277 0.1879 −0.680 0.497 
Medicaid spending per full-benefit dual eligible  0.0000 0.0000 −1.490 0.136 
Nursing facility users per full-benefit dual eligible over 65 0.3203 0.2747 1.170 0.244 
State plan personal care users per full-benefit dual eligible 
over 65 
−0.3718 0.4830 −0.770 0.441 
HCBS users per full-benefit dual eligible over 65 0.4179 0.3246 1.290 0.198 
Medicaid-to-Medicare fee index 0.1609 0.4039 0.400 0.690 
Patient care physicians per 1,000 (total) population 0.1238 0.0705 1.760 0.079 
Participating in shared savings program 0.1837 0.0397 4.630 0.000 
Intercept −2.8119 0.4662 −6.030 0.000 
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Tables in Appendix C present results on the average percentage of demonstration eligible 
beneficiaries using selected Medicare service types during the months in which they met 
demonstration eligibility criteria in the predemonstration and demonstration periods. In addition, 
average counts of service use and payments are presented across all such eligible months, and for 
the subset of these months in which eligible beneficiaries were users of each respective service 
type. Data is shown for the predemonstration and demonstration period for both Massachusetts 
eligible beneficiaries (a.k.a. the demonstration group) and the comparison group. Similar tables 
of Medicaid service utilization are also presented, as well as tables for the RTI quality of care 
and care coordination measures.  
Tables are presented for the overall demonstration eligible population (Tables C-1 
through C-3), followed by tables on special populations of interest: demonstration eligible 
beneficiaries with LTSS use (Tables C-4 through C-5), demonstration eligible beneficiaries with 
SPMI use (Tables C-6 through C-7), Massachusetts demonstration eligible beneficiaries who 
were enrollees and non-enrollees (Tables C-8 through C-9), and a final table on service use 





Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration eligible 
beneficiaries and comparison groups 









Number of demonstration beneficiaries   109,027 118,663 96,915 104,333 
Number of comparison beneficiaries    178,795 191,725 198,338 199,988 
Institutional setting           
Inpatient admissions1  Demonstration group         
% with use   3.5 3.4 3.3 3.3 
Utilization per 1,000 user months   1,178.9 1,170.4 1,169.6 1,172.9 
Utilization per 1,000 eligible months   41.6 39.7 38.6 38.8 
Inpatient admissions1 Comparison group         
% with use   3.4 3.4 3.3 3.2 
Utilization per 1,000 user months   1,164.5 1,164.4 1,162.0 1,152.4 
Utilization per 1,000 eligible months   39.9 40.1 38.1 37.4 
Inpatient psychiatric Demonstration group         
% with use   0.8 0.7 0.7 0.7 
Utilization per 1,000 user months   1,085.6 1,086.3 1,078.7 1,081.0 
Utilization per 1,000 eligible months   8.6 8.0 8.0 7.8 
Inpatient psychiatric Comparison group         
% with use   0.7 0.7 0.7 0.6 
Utilization per 1,000 user months   1,100.5 1,109.3 1,094.8 1,084.0 





Table C-1 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration eligible 
beneficiaries and comparison groups 









Inpatient non-psychiatric Demonstration group     
% with use   2.8 2.7 2.6 2.7 
Utilization per 1,000 user months   1,164.8 1,156.6 1,157.4 1,162.1 
Utilization per 1,000 eligible months   33.0 31.7 30.6 31.0 
Inpatient non-psychiatric Comparison group         
% with use   2.8 2.8 2.7 2.7 
Utilization per 1,000 user months   1,150.3 1,145.0 1,146.7 1,139.8 
Utilization per 1,000 eligible months   32.2 32.3 30.6 30.7 
Emergency department use (non-admit) Demonstration group         
% with use   7.7 7.6 7.6 7.7 
Utilization per 1,000 user months   1,320.9 1,315.6 1,334.3 1,331.7 
Utilization per 1,000 eligible months   102.0 99.7 100.8 102.3 
Emergency department use (non-admit) Comparison group         
% with use   6.8 6.8 7.0 7.4 
Utilization per 1,000 user months   1,336.5 1,319.7 1,330.0 1,322.9 
Utilization per 1,000 eligible months   90.8 89.8 93.0 97.3 
Emergency department use (psychiatric) Demonstration group         
% with use   0.8 0.8 0.9 0.9 
Utilization per 1,000 user months   1,285.6 1,321.8 1,358.7 1,378.2 
Utilization per 1,000 eligible months   10.7 10.7 12.1 12.6 
Emergency department use (psychiatric) Comparison group         
% with use   0.6 0.6 0.6 0.6 
Utilization per 1,000 user months   1,239.8 1,235.0 1,228.8 1,260.9 





Table C-1 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration eligible 
beneficiaries and comparison groups 









Observation stays Demonstration group         
% with use   0.7 0.8 0.8 0.8 
Utilization per 1,000 user months   1,071.4 1,073.8 1,078.4 1,075.3 
Utilization per 1,000 eligible months   7.5 8.3 8.6 8.5 
Observation stays Comparison group         
% with use   0.6 0.6 0.7 0.7 
Utilization per 1,000 user months   1,058.7 1,059.5 1,066.6 1,058.2 
Utilization per 1,000 eligible months   5.9 6.6 7.6 7.9 
Skilled nursing facility Demonstration group         
% with use   0.4 0.4 0.4 0.4 
Utilization per 1,000 user months   1,091.5 1,089.4 1,097.7 1,090.9 
Utilization per 1,000 eligible months   4.0 4.3 3.9 3.9 
Skilled nursing facility Comparison group         
% with use   0.5 0.5 0.5 0.4 
Utilization per 1,000 user months   1,093.2 1,089.3 1,083.3 1,090.8 
Utilization per 1,000 eligible months   5.1 5.7 4.9 4.8 
Hospice  Demonstration group         
% with use   0.2 0.2 0.1 0.1 
Utilization per 1,000 user months   1,047.9 1,037.2 1,038.8 1,037.6 
Utilization per 1,000 eligible months   1.6 1.6 1.2 1.1 
Hospice  Comparison group         
% with use   0.2 0.2 0.2 0.2 
Utilization per 1,000 user months   1,059.2 1,033.3 1,017.2 1,026.6 





Table C-1 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration eligible 
beneficiaries and comparison groups 









Non-institutional setting           
Primary care E&M visits Demonstration group         
% with use   43.0 49.7 52.2 51.5 
Utilization per 1,000 user months   1,678.1 1,755.9 1,832.2 1,823.9 
Utilization per 1,000 eligible months   720.9 872.8 956.1 940.0 
Primary care E&M visits Comparison group         
% with use   42.2 47.8 49.4 51.8 
Utilization per 1,000 user months   1,700.0 1,769.0 1,782.6 1,827.2 
Utilization per 1,000 eligible months   716.9 844.7 880.7 947.3 
Outpatient therapy (PT, OT, ST) Demonstration group         
% with use   2.5 2.5 2.4 2.4 
Utilization per 1,000 user months   9,546.7 9,379.2 10,123.0 9,816.8 
Utilization per 1,000 eligible months   235.7 231.1 242.6 239.7 
Outpatient therapy (PT, OT, ST) Comparison group         
% with use   2.5 2.5 2.5 2.7 
Utilization per 1,000 user months   13,786.8 13,493.5 15,620.3 15,828.0 
Utilization per 1,000 eligible months   339.7 339.3 389.3 426.3 
Independent therapy (PT, OT, ST) Demonstration group         
% with use   1.3 1.3 1.4 1.4 
Utilization per 1,000 user months   9,605.7 9,711.7 11,645.1 11,457.6 
Utilization per 1,000 eligible months   120.3 123.2 158.4 159.8 
Independent therapy (PT, OT, ST) Comparison group         
% with use   1.3 1.3 1.4 1.6 
Utilization per 1,000 user months   11,006.3 11,447.5 12,749.5 13,678.7 





Table C-1 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration eligible 
beneficiaries and comparison groups 









Home health episodes2 Demonstration group         
% with use   1.3 1.4 1.4 1.7 
Utilization per 1,000 user months   1,011.4 1,010.1 1,323.1 1,828.6 
Utilization per 1,000 eligible months   13.6 13.9 18.4 31.2 
Home health episodes Comparison group         
% with use   1.1 1.1 1.2 1.2 
Utilization per 1,000 user months   1,010.3 1,007.3 1,005.9 1,005.4 
Utilization per 1,000 eligible months   10.8 11.3 11.6 11.7 
Durable medical equipment Demonstration group         
% with use   12.4 12.5 12.1 12.0 
Utilization per 1,000 user months   — — — — 
Utilization per 1,000 eligible months   — — — — 
Durable medical equipment Comparison group         
% with use   12.9 12.8 11.9 14.3 
Utilization per 1,000 user months   — — — — 






Table C-1 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration eligible 
beneficiaries and comparison groups 









Other hospital outpatient services  Demonstration group         
% with use   37.3 36.5 36.2 36.0 
Utilization per 1,000 user months   — — — — 
Utilization per 1,000 eligible months   — — — — 
Other hospital outpatient services  Comparison group         
% with use   21.5 22.1 22.3 23.0 
Utilization per 1,000 user months   — — — — 
Utilization per 1,000 eligible months   — — — — 
— = data not available. E&M = evaluation and management; OT = occupational therapy, PT = physical therapy, ST = speech therapy. 
1 Includes acute admissions, inpatient rehabilitation, and long-term care hospital admissions. 
2 Results for the Demonstration group may be inflated due to a data anomaly under investigation. 






Quality of care and care coordination outcomes for demonstration eligible and comparison beneficiaries for the Massachusetts 
demonstration 










30-day all-cause risk-standardized 
readmission rate (%) 
Demonstration group 21.3 21.1 20.4 21.2 
  Comparison group 19.7 19.6 19.1 18.4 
Preventable ER visits per eligible 
months 
Demonstration group 0.0482 0.0466 0.0466 0.0465 
  Comparison group 0.0452 0.0449 0.0464 0.0459 
Rate of 30-day follow up after 
hospitalization for mental illness 
(%) 
Demonstration group 59.1 59.5 58.8 53.2 
  Comparison group 50.5 52.0 53.1 49.9 
Ambulatory care sensitive 
condition admissions per eligible 
months—overall composite 
(AHRQ PQI # 90) 
Demonstration group 0.0039 0.0037 0.0043 0.0043 
  Comparison group 0.0042 0.0042 0.0038 0.0043 
Ambulatory care sensitive 
condition admissions per eligible 
months—chronic composite 
(AHRQ PQI # 92) 
Demonstration group 0.0023 0.0022 0.0031 0.0031 
  Comparison group 0.0024 0.0025 0.0023 0.0030 
Screening for clinical depression 
per eligible months 
Demonstration group 0.0001 0.0008 0.0023 0.0038 
  Comparison group 0.0001 0.0007 0.0018 0.0034 
AHRQ PQI =Agency for Healthcare Research and Quality Prevention Quality Indicator; ER = emergency room. 
NOTES: The last quarter of demonstration year 2 (October–December 2015) was the first quarter of the switch from ICD9 to ICD10 codes. Some differences 





Minimum Data Set long-stay nursing facility utilization and characteristics at admission for the 
Massachusetts demonstration and comparison groups 









Annual nursing facility utilization           
Number of demonstration beneficiaries Demonstration group 87,609 95,857 80,441 89,563 
New long-stay nursing facility admissions per 
1,000 eligible beneficiaries 
  3.2 2.7 3.7 2.3 
Number of comparison beneficiaries  Comparison group 105,354 115,131 117,096 126,676 
New long-stay nursing facility admissions per 
1,000 eligible beneficiaries 
  4.0 3.6 3.9 3.4 
Number of demonstration beneficiaries Demonstration group 89,204 97,621 81,315 90,384 
Long-stay nursing facility users as % of eligible 
beneficiaries 
  2.1 2.1 1.5 1.2 
Number of comparison beneficiaries  Comparison group 110,497 120,177 121,387 131,005 
Long-stay nursing facility users as % of eligible 
beneficiaries 
  5.0 4.6 3.9 3.6 
Characteristics of new long-stay nursing facility 
residents at admission 
          
Number of admitted demonstration beneficiaries Demonstration group 284 261 297 206 
Number of admitted comparison beneficiaries  Comparison group 420 415 460 429 
Functional status (RUG-IV ADL scale) Demonstration group 6.5 7.3 6.7 7.3 
Functional status (RUG-IV ADL scale) Comparison group 7.5 7.6 7.6 7.7 
Percent with severe cognitive impairment Demonstration group 14.5 13.9 14.2 17.9 
Percent with severe cognitive impairment Comparison group 26.0 24.9 16.3 19.2 
Percent with low level of care need Demonstration group 2.7 4.0 3.3 2.4 
Percent with low level of care need Comparison group 2.9 4.4 2.4 4.0 
RUG-IV ADL = Resource Utilization Group IV Activities of Daily Living. 





Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration and 
comparison groups, LTSS population 









Number of demonstration beneficiaries   2,939 3,108 1,899 1,546 
Number of comparison beneficiaries    8,973 10,117 9,350 9,696 
Institutional setting           
Inpatient admissions   1 Demonstration group         
% with use   8.9 8.5 11.0 11.6 
Utilization per 1,000 user months   1,203.6 1,193.2 1,223.9 1,211.8 
Utilization per 1,000 eligible months   106.8 101.8 134.6 140.3 
Inpatient admissions  1 Comparison group         
% with use   7.4 7.7 7.9 7.7 
Utilization per 1,000 user months   1,180.1 1,172.7 1,194.3 1,175.2 
Utilization per 1,000 eligible months   87.8 90.5 93.9 90.1 
Inpatient psychiatric Demonstration group         
% with use   0.9 0.9 1.5 1.8 
Utilization per 1,000 user months   1,070.0 1,081.2 1,093.7 1,091.9 
Utilization per 1,000 eligible months   10.0 10.0 16.8 19.7 
Inpatient psychiatric Comparison group         
% with use   0.6 0.7 0.9 0.7 
Utilization per 1,000 user months   1,100.1 1,097.4 1,114.5 1,097.5 





Table C-4 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration and 
comparison groups, LTSS population 









Inpatient non-psychiatric Demonstration group         
% with use   8.1 7.8 9.7 10.1 
Utilization per 1,000 user months   1,195.3 1,179.6 1,214.4 1,193.7 
Utilization per 1,000 eligible months   96.7 91.7 117.7 120.4 
Inpatient non-psychiatric Comparison group         
% with use   7.0 7.1 7.2 7.1 
Utilization per 1,000 user months   1,168.7 1,157.5 1,170.7 1,160.0 
Utilization per 1,000 eligible months   81.5 82.4 84.3 82.6 
Emergency department use (non-admit) Demonstration group         
% with use   6.3 6.6 8.5 8.5 
Utilization per 1,000 user months   1,288.4 1,290.3 1,439.9 1,492.6 
Utilization per 1,000 eligible months   81.7 85.7 122.5 126.7 
Emergency department use (non-admit) Comparison group         
% with use   5.3 5.4 6.3 6.1 
Utilization per 1,000 user months   1,240.7 1,304.3 1,362.0 1,361.1 
Utilization per 1,000 eligible months   65.2 70.6 85.6 83.7 
Emergency department use (psychiatric) Demonstration group         
% with use   0.7 0.9 1.4 1.6 
Utilization per 1,000 user months   1,189.1 1,243.6 1,396.1 1,469.4 
Utilization per 1,000 eligible months   8.8 11.6 20.0 23.9 
Emergency department use (psychiatric) Comparison group         
% with use   0.4 0.4 0.6 0.5 
Utilization per 1,000 user months   1,246.8 1,381.5 1,283.8 1,492.8 





Table C-4 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration and 
comparison groups, LTSS population 









Observation stays Demonstration group         
% with use   1.0 1.4 1.9 1.7 
Utilization per 1,000 user months   1,081.1 1,058.1 1,077.7 1,074.5 
Utilization per 1,000 eligible months   11.2 14.7 20.0 18.2 
Observation stays Comparison Group         
% with use   0.6 0.8 1.0 1.0 
Utilization per 1,000 user months   1,058.9 1,088.4 1,082.8 1,125.6 
Utilization per 1,000 eligible months   6.4 8.7 10.4 11.6 
Skilled nursing facility Demonstration group         
% with use   4.9 5.1 6.2 6.7 
Utilization per 1,000 user months   1,113.9 1,109.7 1,130.4 1,100.8 
Utilization per 1,000 eligible months   54.3 56.7 70.5 73.8 
Skilled nursing facility Comparison group         
% with use   4.3 4.8 4.5 4.3 
Utilization per 1,000 user months   1,112.7 1,100.1 1,093.8 1,104.2 
Utilization per 1,000 eligible months   48.1 52.4 48.8 47.8 
Hospice  Demonstration group         
% with use   2.0 2.3 2.1 1.8 
Utilization per 1,000 user months   1,050.4 1,021.7 1,029.1 1,029.5 
Utilization per 1,000 eligible months   21.5 24.0 21.4 18.5 
Hospice  Comparison group         
% with use   1.8 1.8 1.8 1.7 
Utilization per 1,000 user months   1,054.8 1,015.9 1,013.9 1,025.6 





Table C-4 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration and 
comparison groups, LTSS population 









Non-institutional setting           
Primary care E&M visits Demonstration group         
% with use   65.0 68.1 75.4 77.9 
Utilization per 1,000 user months   2,459.3 2,641.7 3,044.0 3,056.3 
Utilization per 1,000 eligible months   1,598.7 1,798.4 2,294.3 2,380.0 
Primary care E&M visits Comparison group         
% with use   69.2 71.7 73.0 77.7 
Utilization per 1,000 user months   2,302.7 2,454.4 2,600.3 2,689.9 
Utilization per 1,000 eligible months   1,593.7 1,759.0 1,897.9 2,090.3 
Outpatient therapy (PT, OT, ST) Demonstration group         
% with use   17.6 17.0 20.2 23.1 
Utilization per 1,000 user months   23,392.8 21,995.8 26,625.4 26,665.9 
Utilization per 1,000 eligible months   4,126.8 3,744.2 5,381.8 6,170.9 
Outpatient therapy (PT, OT, ST) Comparison group         
% with use   14.0 15.2 16.5 18.6 
Utilization per 1,000 user months   24,154.7 23,049.1 27,643.5 28,945.7 
Utilization per 1,000 eligible months   3,374.0 3,505.3 4,554.5 5,397.9 
Independent therapy (PT, OT, ST) Demonstration group         
% with use   0.3 0.2 0.3 0.3 
Utilization per 1,000 user months   9,295.5 7,590.4 11,661.8 8,000.0 
Utilization per 1,000 eligible months   25.5 18.9 36.9 23.3 
Independent therapy (PT, OT, ST) Comparison group         
% with use   0.8 0.6 0.4 0.6 
Utilization per 1,000 user months   17,181.1 16,816.2 13,877.9 13,315.4 





Table C-4 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration and 
comparison groups, LTSS population 









Home health episodes  2 Demonstration group         
% with use   1.9 1.9 2.7 2.9 
Utilization per 1,000 user months   1,008.2 1,017.6 1,110.3 1,819.8 
Utilization per 1,000 eligible months   19.2 19.0 29.5 53.5 
Home health episodes Comparison group         
% with use   1.3 1.7 1.9 1.8 
Utilization per 1,000 user months   1,019.6 1,011.8 1,004.6 1,002.2 
Utilization per 1,000 eligible months   12.8 17.2 19.1 18.5 
Durable medical equipment Demonstration group         
% with use   19.2 17.4 21.7 20.7 
Utilization per 1,000 user months   — — — — 
Utilization per 1,000 eligible months   — — — — 
Durable medical equipment Comparison group         
% with use   16.8 16.0 16.7 26.1 
Utilization per 1,000 user months   — — — — 






Table C-4 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration and 
comparison groups, LTSS population 









Other hospital outpatient services  Demonstration group         
% with use   34.6 32.1 38.9 37.5 
Utilization per 1,000 user months   — — — — 
Utilization per 1,000 eligible months   — — — — 
Other hospital outpatient services  Comparison group         
% with use   26.8 27.0 28.7 28.4 
Utilization per 1,000 user months   — — — — 
Utilization per 1,000 eligible months   — — — — 
— = data not available. E&M = evaluation and management; LTSS = long-term services and supports; OT = occupational therapy; PT = physical therapy; ST = 
speech therapy. 
1 Includes acute admissions, inpatient rehabilitation, and long-term care hospital admissions. 
2 Results for the demonstration group may be inflated due to a data anomaly under investigation.  







Quality of care and care coordination outcomes for eligible beneficiaries with LTSS use 
for the Massachusetts demonstration 









30-day all-cause risk-standardized 
readmission rate (%) 
Demonstration group 21.2 20.7 22.5 22.2 
  Comparison group 20.7 20.4 20.9 19.5 
Preventable ER visits per eligible 
months 
Demonstration group 0.0293 0.0291 0.0440 0.0422 
  Comparison group 0.0244 0.0278 0.0333 0.0306 
Rate of 30-day follow up after 
hospitalization for mental illness (%) 
Demonstration group 35.1 44.9 50.0 50.4 
  Comparison group 25.9 41.3 51.2 39.4 
Ambulatory care sensitive condition 
admissions per eligible months—
overall composite (AHRQ PQI # 90) 
Demonstration group 0.0118 0.0112 0.0169 0.0143 
  Comparison group 0.0098 0.0094 0.0100 0.0097 
Ambulatory care sensitive condition 
admissions per eligible months—
chronic composite (AHRQ PQI # 92) 
Demonstration group 0.0054 0.0058 0.0122 0.0098 
  Comparison group 0.0044 0.0055 0.0057 0.0062 
Screening for clinical depression per 
eligible months 
Demonstration group 0.0000 0.0002 0.0007 0.0037 
  Comparison group 0.0003 0.0011 0.0035 0.0027 






Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration and 
comparison groups, SPMI population 









Number of demonstration beneficiaries   51,585 55,300 48,739 56,393 
Number of comparison beneficiaries    61,744 65,318 68,722 82,745 
Institutional setting           
Inpatient admissions   1 Demonstration group         
% with use   4.9 4.7 4.4 4.5 
Utilization per 1,000 user months   1,200.3 1,183.0 1,180.9 1,185.3 
Utilization per 1,000 eligible months   59.3 55.8 52.5 53.1 
Inpatient admissions  1 Comparison group         
% with use   5.2 5.2 4.8 4.6 
Utilization per 1,000 user months   1,184.0 1,184.1 1,180.7 1,169.2 
Utilization per 1,000 eligible months   61.4 61.5 57.1 54.1 
Inpatient psychiatric Demonstration group         
% with use   1.6 1.5 1.4 1.3 
Utilization per 1,000 user months   1,085.8 1,086.5 1,078.9 1,081.1 
Utilization per 1,000 eligible months   17.4 16.5 15.1 13.8 
Inpatient psychiatric Comparison group         
% with use   1.7 1.7 1.6 1.3 
Utilization per 1,000 user months   1,100.8 1,109.7 1,095.0 1,084.2 






Table C-6 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration and 
comparison groups, SPMI population 









Inpatient non-psychiatric Demonstration group         
% with use   3.5 3.4 3.2 3.3 
Utilization per 1,000 user months   1,185.6 1,165.1 1,166.0 1,174.2 
Utilization per 1,000 eligible months   41.8 39.3 37.4 39.3 
Inpatient non-psychiatric Comparison group         
% with use   3.7 3.7 3.4 3.5 
Utilization per 1,000 user months   1,165.5 1,155.4 1,160.8 1,154.2 
Utilization per 1,000 eligible months   42.9 42.3 39.6 40.0 
Emergency department use (non-admit) Demonstration group         
% with use   9.9 9.7 9.4 9.5 
Utilization per 1,000 user months   1,389.0 1,381.5 1,403.0 1,381.7 
Utilization per 1,000 eligible months   136.9 133.7 131.7 131.8 
Emergency department use (non-admit) Comparison group         
% with use   9.5 9.6 9.5 9.7 
Utilization per 1,000 user months   1,417.6 1,401.3 1,402.5 1,398.0 
Utilization per 1,000 eligible months   135.0 134.5 133.7 135.7 
Emergency department use (psychiatric) Demonstration group         
% with use   1.5 1.5 1.5 1.5 
Utilization per 1,000 user months   1,296.8 1,327.3 1,367.1 1,371.0 
Utilization per 1,000 eligible months   19.6 19.8 20.8 20.3 
Emergency department use (psychiatric) Comparison group         
% with use   1.2 1.2 1.1 1.1 
Utilization per 1,000 user months   1,257.3 1,258.9 1,252.1 1,282.7 






Table C-6 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration and 
comparison groups, SPMI population 









Observation stays Demonstration group         
% with use   0.9 1.0 1.0 1.0 
Utilization per 1,000 user months   1,091.9 1,093.5 1,086.7 1,088.6 
Utilization per 1,000 eligible months   10.1 11.0 10.7 10.9 
Observation stays Comparison group         
% with use   0.8 0.9 1.0 1.0 
Utilization per 1,000 user months   1,077.9 1,077.1 1,079.9 1,071.6 
Utilization per 1,000 eligible months   8.4 9.7 10.5 10.9 
Skilled nursing facility Demonstration group         
% with use   0.5 0.5 0.5 0.5 
Utilization per 1,000 user months   1,094.9 1,092.7 1,097.5 1,094.0 
Utilization per 1,000 eligible months   5.5 5.9 5.1 5.4 
Skilled nursing facility Comparison group         
% with use   0.7 0.8 0.7 0.7 
Utilization per 1,000 user months   1,099.0 1,096.4 1,079.8 1,095.7 
Utilization per 1,000 eligible months   8.1 9.1 7.7 7.5 
Hospice  Demonstration group         
% with use   0.2 0.2 0.1 0.1 
Utilization per 1,000 user months   1,046.4 1,028.7 1,038.1 1,043.6 
Utilization per 1,000 eligible months   1.7 1.6 1.1 0.9 
Hospice  Comparison group         
% with use   0.2 0.2 0.2 0.2 
Utilization per 1,000 user months   1,041.9 1,028.1 1,013.4 1,026.9 






Table C-6 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration and 
comparison groups, SPMI population 









Non-institutional setting           
Primary care E&M visits Demonstration group         
% with use   45.9 58.1 60.5 59.8 
Utilization per 1,000 user months   1,750.6 1,858.5 1,928.9 1,918.4 
Utilization per 1,000 eligible months   803.3 1,079.7 1,166.2 1,146.4 
Primary care E&M visits Comparison group         
% with use   48.3 58.6 61.1 61.7 
Utilization per 1,000 user months   1,785.8 1,891.9 1,912.0 1,955.9 
Utilization per 1,000 eligible months   862.6 1,109.2 1,169.2 1,206.6 
Outpatient therapy (PT, OT, ST) Demonstration group         
% with use   2.9 2.9 2.6 2.7 
Utilization per 1,000 user months   10,599.0 10,284.7 10,902.4 10,666.1 
Utilization per 1,000 eligible months   306.2 296.2 288.2 293.0 
Outpatient therapy (PT, OT, ST) Comparison group         
% with use   3.1 3.2 3.1 3.4 
Utilization per 1,000 user months   15,371.3 14,989.5 17,405.9 17,752.1 
Utilization per 1,000 eligible months   475.4 474.9 546.6 600.8 
Independent therapy (PT, OT, ST) Demonstration group         
% with use   1.4 1.4 1.4 1.5 
Utilization per 1,000 user months   9,324.9 9,278.0 11,184.6 11,060.2 
Utilization per 1,000 eligible months   127.7 126.8 160.4 164.1 
Independent therapy (PT, OT, ST) Comparison group         
% with use   1.5 1.5 1.6 1.7 
Utilization per 1,000 user months   10,669.3 11,477.2 12,508.9 13,863.7 






Table C-6 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration and 
comparison groups, SPMI population 









Home health episodes  2 Demonstration group         
% with use   1.5 1.6 1.6 2.3 
Utilization per 1,000 user months   1,008.5 1,009.8 1,477.0 2,052.4 
Utilization per 1,000 eligible months   15.0 15.8 23.9 46.9 
Home health episodes Comparison group         
% with use   1.2 1.2 1.3 1.4 
Utilization per 1,000 user months   1,007.6 1,008.9 1,006.5 1,005.5 
Utilization per 1,000 eligible months   11.6 12.6 12.8 14.1 
Durable medical equipment Demonstration group         
% with use   11.8 12.1 11.6 12.0 
Utilization per 1,000 user months   — — — — 
Utilization per 1,000 eligible months   — — — — 
Durable medical equipment Comparison group         
% with use   13.4 13.4 12.2 14.6 
Utilization per 1,000 user months   — — — — 







Table C-6 (continued) 
Proportion and utilization for institutional and non-institutional services for the Massachusetts demonstration and 
comparison groups, SPMI population 









Other hospital outpatient services  Demonstration group         
% with use   42.6 41.6 39.8 40.0 
Utilization per 1,000 user months   — — — — 
Utilization per 1,000 eligible months   — — — — 
Other hospital outpatient services  Comparison group         
% with use   26.3 26.8 26.5 26.7 
Utilization per 1,000 user months   — — — — 
Utilization per 1,000 eligible months   — — — — 
— = data not available. E&M = evaluation and management; OT = occupational therapy; PT = physical therapy; SPMI = severe and persistent mental illness; 
ST = speech therapy. 
1 Includes acute admissions, inpatient rehabilitation, and long-term care hospital admissions. 
2 Results for the demonstration group may be inflated due to a data anomaly under investigation.  








Quality of care and care coordination outcomes for Massachusetts demonstration eligible beneficiaries with SPMI 










30-day all-cause risk-standardized 
readmission rate (%) 
Demonstration group 22.5 21.8 21.1 21.8 
  Comparison group 20.5 20.7 19.7 19.0 
Preventable ER visits per eligible 
months 
Demonstration group 0.0619 0.0595 0.0581 0.0572 
  Comparison group 0.0616 0.0617 0.0617 0.0619 
Rate of 30-day follow up after 
hospitalization for mental illness (%) 
Demonstration group 59.1 59.5 58.8 53.5 
  Comparison group 50.5 52.0 53.1 49.9 
Ambulatory care sensitive condition 
admissions per eligible months—
overall composite (AHRQ PQI #90) 
Demonstration group 0.0046 0.0043 0.0051 0.0053 
  Comparison group 0.0052 0.0051 0.0046 0.0055 
Ambulatory care sensitive condition 
admissions per eligible months—
chronic composite (AHRQ PQI #92) 
Demonstration group 0.0027 0.0025 0.0036 0.0038 
  Comparison group 0.0030 0.0029 0.0027 0.0037 
Screening for clinical depression per 
eligible months 
Demonstration group 0.0001 0.0010 0.0032 0.0049 
  Comparison group 0.0002 0.0009 0.0026 0.0040 
AHRQ PQI =Agency for Healthcare Research and Quality Prevention Quality Indicator; ER = emergency room. 
 C-24 
Table C-8 
Proportion and utilization for institutional and non-institutional services for the 
Massachusetts demonstration enrollees and non-enrollees 





Number of enrollees   14,268 13,272 
Number of non-enrollees   86,274 94,371 
Institutional setting       
Inpatient admissions   1 Enrollees     
% with use   2.4 3.0 
Utilization per 1,000 user months   1,136.3 1,158.2 
Utilization per 1,000 eligible months   27.70 34.51 
Inpatient admissions  1 Non-enrollees     
% with use   3.3 3.4 
Utilization per 1,000 user months   1,173.5 1,177.6 
Utilization per 1,000 eligible months   39.3 39.9 
Inpatient psychiatric Enrollees     
% with use   0.4 0.6 
Utilization per 1,000 user months   1,065.7 1,093.0 
Utilization per 1,000 eligible months   4.7 6.8 
Inpatient psychiatric Non-enrollees     
% with use   0.8 0.8 
Utilization per 1,000 user months   1,080.2 1,080.3 
Utilization per 1,000 eligible months   8.3 8.1 
Inpatient non-psychiatric Enrollees     
% with use   2.1 2.4 
Utilization per 1,000 user months   1,121.8 1,142.0 
Utilization per 1,000 eligible months   23.0 27.7 
Inpatient non-psychiatric Non-enrollees     
% with use   2.7 2.7 
Utilization per 1,000 user months   1,160.5 1,166.5 
Utilization per 1,000 eligible months   31.0 31.7 
Emergency department use (non-admit) Enrollees     
% with use   7.5 8.6 
Utilization per 1,000 user months   1,352.4 1,390.2 
Utilization per 1,000 eligible months   101.0 119.2 
Emergency department use (non-admit) Non-enrollees     
% with use   7.4 7.6 
Utilization per 1,000 user months   1,327.5 1,327.8 
Utilization per 1,000 eligible months   97.9 101.2 
 (continued) 
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Table C-8 (continued) 
Proportion and utilization for institutional and non-institutional services for the 
Massachusetts demonstration enrollees and non-enrollees 





Emergency department use (psychiatric) Enrollees     
% with use   1.0 1.2 
Utilization per 1,000 user months   1,374.7 1,494.2 
Utilization per 1,000 eligible months   14.4 17.7 
Emergency department use (psychiatric) Non-enrollees     
% with use   0.8 0.9 
Utilization per 1,000 user months   1,354.7 1,361.8 
Utilization per 1,000 eligible months   11.5 12.3 
Observation stays Enrollees     
% with use   0.6 0.9 
Utilization per 1,000 user months   1,056.9 1,068.7 
Utilization per 1,000 eligible months   6.0 9.6 
Observation stays Non-enrollees     
% with use   0.8 0.8 
Utilization per 1,000 user months   1,079.0 1,078.6 
Utilization per 1,000 eligible months   8.5 8.4 
Skilled nursing facility Enrollees     
% with use   0.2 0.3 
Utilization per 1,000 user months   1,097.9 1,080.3 
Utilization per 1,000 eligible months   2.6 3.5 
Skilled nursing facility Non-enrollees     
% with use   0.4 0.4 
Utilization per 1,000 user months   1,098.2 1,092.1 
Utilization per 1,000 eligible months   4.1 4.0 
Hospice  Enrollees     
% with use   0.0 0.0 
Utilization per 1,000 user months   1,000.0 1,122.4 
Utilization per 1,000 eligible months   0.3 0.4 
Hospice  Non-enrollees     
% with use   0.1 0.1 
Utilization per 1,000 user months   1,038.7 1,034.8 
Utilization per 1,000 eligible months   1.3 1.2 
 (continued) 
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Table C-8 (continued) 
Proportion and utilization for institutional and non-institutional services for the 
Massachusetts demonstration enrollees and non-enrollees 





Non-institutional setting       
Primary care E&M visits Enrollees     
% with use   43.0 42.8 
Utilization per 1,000 user months   1,885.7 1,745.7 
Utilization per 1,000 eligible months   810.1 747.9 
Primary care E&M visits Non-enrollees     
% with use   52.3 52.6 
Utilization per 1,000 user months   1,827.2 1,834.4 
Utilization per 1,000 eligible months   955.2 964.3 
Outpatient therapy (PT, OT, ST) Enrollees     
% with use   1.4 1.9 
Utilization per 1,000 user months   5,192.8 5,416.5 
Utilization per 1,000 eligible months   75.1 103.4 
Outpatient therapy (PT, OT, ST) Non-enrollees     
% with use   2.5 2.5 
Utilization per 1,000 user months   10,669.7 10,364.5 
Utilization per 1,000 eligible months   265.5 259.4 
Independent therapy (PT, OT, ST) Enrollees     
% with use   1.1 0.7 
Utilization per 1,000 user months   10,280.2 11,951.3 
Utilization per 1,000 eligible months   110.1 85.1 
Independent therapy (PT, OT, ST) Non-enrollees     
% with use   1.3 1.5 
Utilization per 1,000 user months   11,843.1 11,456.7 
Utilization per 1,000 eligible months   159.5 170.5 
Home health episodes  2 Enrollees     
% with use   3.9 5.8 
Utilization per 1,000 user months   2,143.6 2,873.5 
Utilization per 1,000 eligible months   84.6 166.0 
Home health episodes  2 Non-enrollees     
% with use   1.1 1.1 
Utilization per 1,000 user months   1,008.6 1,005.9 
Utilization per 1,000 eligible months   11.0 10.9 
 (continued) 
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Table C-8 (continued) 
Proportion and utilization for institutional and non-institutional services for the 
Massachusetts demonstration enrollees and non-enrollees 





Durable medical equipment Enrollees     
% with use   7.9 10.0 
Utilization per 1,000 user months   — — 
Utilization per 1,000 eligible months   — — 
Durable medical equipment Non-enrollees     
% with use   12.4 12.2 
Utilization per 1,000 user months   — — 
Utilization per 1,000 eligible months   — — 
Other hospital outpatient services  Enrollees     
% with use   26.0 31.5 
Utilization per 1,000 user months   — — 
Utilization per 1,000 eligible months   — — 
Other hospital outpatient services  Non-enrollees     
% with use   36.2 36.3 
Utilization per 1,000 user months   — — 
Utilization per 1,000 eligible months   — — 
— = data not available. E&M = evaluation and management; OT = occupational therapy; PT = physical therapy; 
ST = speech therapy. 
1 Includes acute admissions, inpatient rehabilitation, and long-term care hospital admissions. 
2 Results for the demonstration group may be inflated due to a data anomaly under investigation. 




Quality of care and care coordination outcomes for enrollees and non-enrollees for the 
Massachusetts demonstration 





30-day all-cause risk-standardized 
readmission rate (%) 
Enrollees 21.4 20.2 
  Non-enrollees 21.0 21.2 




  Non-enrollees 0.0458 0.0460 
Rate of 30-day follow up after 
hospitalization for mental illness (%) 
Enrollees 
48.7 40.6 
  Non-enrollees 60.5 55.9 
Ambulatory care sensitive condition 
admissions per eligible months—overall 
composite (AHRQ PQI #90) 
Enrollees 
0.0045 0.0048 
  Non-enrollees 0.0043 0.0042 
Ambulatory care sensitive condition 
admissions per eligible months—chronic 
composite (AHRQ PQI #92) 
Enrollees 
0.0035 0.0037 
  Non-enrollees 0.0031 0.0030 




  Non-enrollees 0.0026 0.0043 
AHRQ PQI =Agency for Healthcare Research and Quality Prevention Quality Indicator; ER = emergency room.  







Utilization of health care services during demonstration year 2 for Massachusetts demonstration eligible beneficiaries, 
by demographic group 
  Age category Gender Race/Ethnicity 
Measures by setting Less than 45 45-plus Male Female White Black Hispanic Asian 
Institutional setting                 
Inpatient admissions   1                 
% with use 3.2 3.3 3.4 3.2 3.5 3.4 2.3 1.9 
Utilization per 1,000 user months 1,174.0 1,172.5 1,185.4 1,160.6 1,179.5 1,170.3 1,145.6 1,107.7 
Utilization per 1,000 eligible months 37.8 39.2 40.6 37.2 41.8 40.0 26.4 20.7 
Inpatient psychiatric                 
% with use 1.1 0.6 0.8 0.7 0.8 0.6 0.5 0.5 
Utilization per 1,000 user months 1,093.0 1,071.2 1,082.6 1,079.3 1,081.6 1,099.2 1,071.3 1,037.7 
Utilization per 1,000 eligible months 12.2 6.0 8.4 7.2 8.7 6.5 4.9 4.9 
Inpatient non-psychiatric                 
% with use 2.2 2.9 2.7 2.6 2.8 2.9 1.9 1.4 
Utilization per 1,000 user months 1,157.4 1,163.6 1,175.0 1,149.6 1,167.3 1,163.2 1,137.0 1,120.6 
Utilization per 1,000 eligible months 25.6 33.3 32.2 30.0 33.1 33.5 21.5 15.8 
Emergency department use (non-admit)                 
% with use 9.3 7.0 7.2 8.2 7.6 8.5 8.3 3.3 
Utilization per 1,000 user months 1,378.3 1,306.5 1,368.4 1,302.0 1,339.8 1,376.3 1,253.1 1,218.8 
Utilization per 1,000 eligible months 128.3 91.7 97.8 106.5 102.4 116.7 103.4 40.6 
Emergency department use (psychiatric)                 
% with use 1.3 0.8 1.1 0.7 1.0 0.8 0.6 0.4 
Utilization per 1,000 user months 1,296.3 1,435.0 1,470.1 1,247.3 1,375.6 1,478.5 1,352.9 1,347.8 







Table C-10 (continued) 
Utilization of health care services during demonstration year 2 for Massachusetts demonstration eligible beneficiaries, 
by demographic group 
  Age category Gender Race/Ethnicity 
Measures by setting Less than 45 45-plus Male Female White Black Hispanic Asian 
Observation stays                 
% with use 0.6 0.9 0.7 0.8 0.8 1.1 0.6 0.3 
Utilization per 1,000 user months 1,120.7 1,061.7 1,073.0 1,077.1 1,063.7 1,137.8 1,049.9 1,013.2 
Utilization per 1,000 eligible months 7.1 9.2 8.0 9.0 8.3 12.6 6.8 3.4 
Skilled nursing facility                 
% with use 0.1 0.5 0.4 0.3 0.4 0.4 0.1 0.2 
Utilization per 1,000 user months 1,099.6 1,090.3 1,102.1 1,079.6 1,089.7 1,100.0 1,068.5 1,078.9 
Utilization per 1,000 eligible months 0.9 5.1 4.1 3.7 4.5 3.9 1.4 1.8 
Hospice                  
% with use 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 
Utilization per 1,000 user months 1,046.0 1,036.9 1,055.1 1,020.9 1,036.5 1,044.2 1,021.5 1,105.3 
Utilization per 1,000 eligible months 0.3 1.4 1.1 1.0 1.2 0.8 0.8 0.9 
Non-institutional setting                 
Primary care E&M visits                 
% with use 45.0 54.2 47.0 55.7 53.6 45.0 48.1 47.2 
Utilization per 1,000 user months 1,748.8 1,849.4 1,749.7 1,881.7 1,864.4 1,732.3 1,725.5 1,604.4 
Utilization per 1,000 eligible months 787.7 1,002.2 822.2 1,048.9 999.2 779.3 830.4 756.7 
Outpatient therapy (PT, OT, ST)                 
% with use 1.6 2.8 1.9 2.9 2.5 2.4 2.3 1.6 
Utilization per 1,000 user months 8,129.5 10,207.5 10,802.9 9,208.3 10,419.2 8,470.9 7,631.8 9,164.8 







Table C-10 (continued) 
Utilization of health care services during demonstration year 2 for Massachusetts demonstration eligible beneficiaries, 
by demographic group 
  Age category Gender Race/Ethnicity 
Measures by setting Less than 45 45-plus Male Female White Black Hispanic Asian 
Independent therapy (PT, OT, ST)                 
% with use 1.0 1.5 0.9 1.8 1.5 1.3 1.1 1.0 
Utilization per 1,000 user months 10,682.2 11,671.0 11,866.4 11,266.4 11,140.7 12,609.5 12,078.8 13,475.8 
Utilization per 1,000 eligible months 110.9 179.8 109.8 206.1 163.6 164.4 133.9 136.7 
Home health episodes  2                 
% with use 1.0 2.0 1.7 1.7 1.8 2.2 1.0 1.2 
Utilization per 1,000 user months 2,077.0 1,776.1 1,880.4 1,783.0 1,787.7 1,819.7 2,245.8 2,592.1 
Utilization per 1,000 eligible months 21.4 35.3 31.3 31.2 31.6 40.4 22.0 32.1 
Durable medical equipment                 
% with use 7.7 13.8 11.4 12.6 12.5 11.8 11.2 8.4 
Utilization per 1,000 user months — — — — — — — — 
Utilization per 1,000 eligible months — — — — — — — — 
Other hospital outpatient services                  
% with use 29.3 38.7 32.4 39.3 34.9 40.7 37.2 36.5 
Utilization per 1,000 user months — — — — — — — — 
Utilization per 1,000 eligible months — — — — — — — — 
— = data not available. E&M = evaluation and management; OT = occupational therapy; PT = physical therapy; ST = speech therapy. 
1 Includes acute admissions, inpatient rehabilitation, and long term care hospital admissions. 
2 Results for the demonstration group may be inflated due to a data anomaly under investigation.  
SOURCE: RTI International analysis of Medicare data. 
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Sensitivity Analysis Tables 
Tables in Appendix D present results from sensitivity analyses focusing on the Massachusetts 
demonstration cost saving models.  
D.1 Predicting Medicare Capitated Rates for Non-Enrollees 
D.1.1 Sample Identification 
• Eligible but non-enrolled Massachusetts beneficiaries in demonstration period 1 
(October 1, 2013–December 31, 2014). Predicted Medicare capitated rates were 
calculated using the beneficiary risk score and the county of residence.  
D.1. 2 Calculating the Medicare Capitated Rate for Eligible but Non-Enrolled 
Beneficiaries 
• Predicted Medicare capitated rates were calculated using the monthly beneficiary risk 
score (final resolved) and the base rate associated with the beneficiary’s county of 
residence. Differences in ESRD, non-ESRD, and dialysis risk scores and base rates 
were taken into account. 
• Mean predicted Medicare capitated rates were compared to mean Medicare FFS 
expenditures (non-Winsorized). Note that bad debt was removed from the Medicare 
capitated rate as this is not reflected in Medicare FFS payments. Sequestration was 
reflected in both the FFS payments and the capitated payment. Disproportionate share 
hospital payments and uncompensated care payment amounts were included in the 
FFS expenditures as these amounts are reflected in the capitated rates.  
Table D-1 
Observed Medicare FFS and predicted cap rates for eligible but not enrolled beneficiaries 
Variable Obs Mean Std. err. Std. dev. [95% conf. interval] 
Predicted cap  1,158,079 $978.4 $1.0 $1,118.4 $976.4 $980.4 
Observed FFS  1,158,079 $981.0 $4.1 $4,389.4 $973.0 $989.0 
diff   −$2.59 $3.9 $4,240.3 −$10.3 $5.1 
FFS = fee for service. 
RTI also tested the accuracy of the predicted capitated rate by generating a predicted 
capitated rate for enrollees and comparing it to the actual capitated rate from the plan payment 
files. RTI’s mean predicted capitated rate for enrollees was $891.3 compared to an actual 




D.2 Predicting Medicare FFS Expenditures for Enrollees 
The goal of this analysis is the converse of what is presented in Analysis D.1. Here, we 
look at predicted Medicare FFS expenditures for enrollees based on a model predicting Medicare 
FFS expenditures for non-enrollees. 
D.2.1 Methods 
A dataset with observations from base year 2 and from demonstration year 1 was created 
from the full data set to allow us to look at Medicare expenditures between the two periods. 
Beneficiary expenditures were summed across all months of each period and then “annualized” 
to represent the full 12 months of base year 1 (or 15 months of base year 2).  
The estimation process involved two steps. First, using non-enrollees, we regressed 
demonstration year 1 expenditures on base year 2 expenditures, base year 2 Hierarchical 
Condition Category (HCC) score, and a set of base year 2 demographic and area level variables. 
We used an unlogged dependent variable and ran ordinary least squares (OLS) models with and 
without propensity score weights (using the frozen HCC scores in the composition of the 
weights). The data were clustered by Federal Information Processing Standards (FIPS) code. 
This model explained 26.8 percent of the variation in expenditures for non-enrollees. 
In the second step, we used the covariate values for demonstration enrollees estimated in 
the OLS non-enrollee model (from step 1) to calculate predicted expenditures for enrollees. We 
compared the predicted expenditure values for enrollees to the actual capitated payments made 
under the demonstration. 
D.2.2 Results 
Table D-2 shows enrollees had lower predicted Medicare expenditures in base year 2 
($8,825 for enrollees versus $11,313 for non-enrollees) and a mean HCC score below 1 (0.969 
for enrollees versus 1.022 for non-enrollees). 
Table D-3 shows that actual Medicare capitated PMPM payments for enrollees were, on 
average, $22 per month higher than the predicted mean Medicare expenditures for enrollees in 
demonstration year 1. Mean predicted Medicare expenditures for enrollees were $2,962 lower 
than actual expenditures for non-enrollees (mean = $16,279, not shown). Translating these 
findings into monthly Medicare expenditures, the mean predicted FFS expenditures for enrollees 
was $887 per month which was $198 per month lower than actual mean expenditures for non-




Mean values of model covariates by group 
Covariate  
Non-enrolled, both comparison 
group and eligible 
(observations = 215,198) 
Enrolled 
(N = 21,880) 
FFS expenditures in base year 2  $11,313 $8,825 
HCC Score in base year 2 1.022 0.969 
Age 46.029 46.25 
Also in another CMS demonstration  0.427 0.473 
Female 0.520 0.519 
Black 0.249 0.164 
Asian 0.014 0.017 
Other 0.014 0.026 
Hispanic 0.047 0.146 
Disabled 0.933 0.955 
ESRD  0.025 0.011 
Patient care physicians per 1,000 population 0.930 1.019 
% of households with member >= 60 years  35.085 32.772 
% of households with member < 18 years 31.790 32.981 
% of those aged < 65 years, with college education  26.903 26.922 
% of those aged < 65 years, unemployed  11.169 11.868 
% of those aged < 65 years, with self-care limitation  2.331 2.497 
Fraction of duals with Medicaid managed care, ages 19 0.297 0.093 
Medicare Advantage penetration rate  0.207 0.229 
% of pop. living in married household  64.384 59.676 
Population per square mile, all ages  1,067 981 
Medicaid spending per dual, ages 19+  $21,723 $22,682 
Medicare spending per dual, ages 19+  $17,444 $16,436 
Fraction of duals using nursing facilities, ages 65+  0.261 0.258 
Fraction of duals using personal care, ages 65+  0.041 0.047 
Distance to nearest hospital (miles) 5.293 3.796 
Distance to nearest nursing home (miles) 3.380 2.604 




Expenditures prediction results from an unweighted OLS model 
Enrollee observations = 21,880 
Mean expenditures over the first year of 
the demonstration (15 months) 95% confidence interval 
Actual PMPM for enrollees $13,642 $13,455 $13,829 
Predicted FFS for enrollees $13,317 $13,098 $13,535 
Difference $325 ($22 per month) P = 0.0000 
FFS = fee for service; PMPM = per member per month. 
SOURCE: RTI program: predictFFSJan29 unweighted FFS3b 
D.3 Enrollee-Subgroup Analyses  
The enrollee-subgroup analyses focused on a subgroup of beneficiaries identified as 
enrolled for at least 3 months in the demonstration period and with at least 3 months of baseline 
eligibility. Note that a subset of the comparison group developed for the ITT analysis was used 
in the enrollee subgroup analyses. Comparison group beneficiaries used in the enrollee subgroup 
analyses were required to have at least 3 months of eligibility in the demonstration period 
(October 1, 2013–December 31, 2015) and at least 3 months of eligibility in the 
predemonstration period (October 1, 2011–September 30, 2013), analogous to the criteria for 
identifying enrollees. The results indicate additional costs associated with enrollees. This 
enrollee sub-group analysis is limited by the absence of person-level data on characteristics that 
potentially would lead an individual in a comparison area to enroll in a similar demonstration, 
and thus the results should be considered in the context of this limitation. 
Table D-4 
Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
enrollee subgroup analysis, predemonstration period and demonstration period 1, weighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 1 
Oct 2013–Dec 2014 Difference 












Difference-in-difference N/A N/A 86.80 
(56.67, 116.92) 
95 percent confidence intervals are shown in parenthesis below estimates. 




Mean monthly Medicare expenditures for One Care eligibles and comparison group, 
enrollee subgroup analysis, predemonstration period and demonstration period 2, weighted  
Group 
Predemonstration period 
Oct 2011–Sept 2013 
Demonstration period 2 
Jan 2015–Dec 2015 Difference 












Difference-in-difference N/A N/A 82.74 
(52.53, 112.94) 
95 percent confidence intervals are shown in parenthesis below estimates. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program 
EnrolleeSubanalysis). 
Table D-6 
Demonstration effects on Medicare savings, enrollee subgroup analysis, difference-in-














Intervention *DemoYear1  
(October 2013–December 2014) 
102.55 0.0000 66.29, 138.81 72.12, 132.98 78.87, 126.23 
Intervention *DemoYear2  
(January 2015–December 2015) 
84.55 0.0000 52.19, 116.91 57.39, 111.71 63.42, 105.68 
Intervention*Demo Period 
(October 2013–December 2015)  
93.32 0.0000 63.24, 123.40 68.07, 118.57 73.67, 112.97 
DID = difference-in-differences. 
1 80 percent confidence intervals are provided for comparison purposes only. 
SOURCE: RTI Analysis of Massachusetts demonstration eligible and comparison group Medicare data (program 
EnrolleeSubanalysis). 
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